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Fosfomycin, produced by a few strains of Streptomyces, is a clinically 
useful antibiotic against both gram-positive and gram-negative bacteria.  The 
unique structure of fosfomycin, characterized by a carbon-phosphorous bond and 
an epoxide ring, has attracted many attentions to its biosynthetic pathway.  (S)-2-
hydroxylpropanylphosphonic acid epoxidase (HppE) catalyzes the last step in the 
pathway, conversion of a secondary alcohol, (S)-2-hydroxylpropanylphosphonic 
acid ((S)-HPP), to the final epoxide product.  This is a completely new 
enzymatic reaction in contrast to many other biological epoxidation reactions that 
usually involve olefin oxidation.  It is worth noting that the oxygen atom in the 
hydroxyl group of (S)-HPP is retained during the ring closure.  
 
                                                                     iv 
The previous studies of HppE have led to the discovery of a novel 
biological epoxidation system, (S)-HPP + NADH + O2 + H+→ fosfomycin + 
NAD+ + 2H2O.  The further biochemical and EPR spectral analyses suggested 
that HppE is a new type of mononuclear non-heme iron-dependent enzyme 
carrying a 2-His-1-carboxylate triad iron-binding motif.  In addition to three 
amino acid ligands, both phosphonate and hydroxyl groups of (S)-HPP also 
coordinate to the iron center in the enzyme-substrate complex.  The bidentate 
substrate-binding mode is presumably responsible for the strict regiospecificity 
and stereospecificity in the HppE-catalyzed epoxidation.   
A catecholate-to-FeIII charge transfer complex was identified in the HppE 
active site, by UV-visible absorption and resonance Raman spectroscopies.  The 
catechol is derived from a hydroxylated amino acid residue, Tyr105, as a product 
of the self-catalytic hydroxylation.  The oxidation of Try105 to DOPA is a side 
reaction that occurs only in the absence of substrate, and the presence of DOPA 
has no apparent effects on the epoxidase activity of HppE.   
Mechanistic information of HppE has been continuously garnered by EPR 
spectral analysis.  Using NO as a dioxygen analogue and a probe for ferrous 
center, the first step of the catalytic cycle has been revealed to be the reduction of 
substrate-bound iron center from its ferric state to ferrous state by FMN/NADH.  
Besides, the presence of a spin-coupled adduct of protein-centered radical and 
ferric center has been supported by experimental evidence.  However, it is still 
not clear whether the “hidden” radical plays any roles in HppE catalysis.   
 v
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Chapter 1:  Background and Significance 
1.1 THE ANTIBIOTIC FUNCTION OF FOSFOMYCIN 
In 1929, Alexander Fleming discovered the antibacterial properties of 
penicillin and opened the era of antibiotics.  Since then, a great variety of 
antibiotics have been developed and are widely used in fighting numerous 
bacteria that cause infections and diseases.  A useful antibiotic must target 
reactions and/or structures within the bacteria (prokaryotic cells) that are different 
from the hosting organisms (eukaryotic cells).  The most common targets are the 
processes and/or organelles involved in cell wall synthesis, protein synthesis, and 
DNA replication.   
1.1.1 Cell Wall Biosynthesis 
On the basis of the procedure developed by Christian Gram in 1884, in 
which heat-fixed cells are successively treated with the crystal violet dye and 
iodine, and then destained with either ethanol or acetone, bacteria are labeled as 
either Gram-negative or Gram-positive depending on whether or not they take up 
gram stain.  Gram-positive bacteria take up the stain because they possess a 
mono-layered cell wall, while Gram-negative bacteria possess at least two 
structurally distinct layers and thus do not absorb dye.  Both types of bacteria 
have a cell wall made up of covalently linked polysaccharide and polypeptide 
chains called peptidoglycan, which provides strength and shape to the bacterial 
cell, and allows bacteria to withstand the osmotic pressure generated by its 
hyperosmolar cytoplasm.  The polysaccharide component of peptidoglycan 
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consists of linear chains of alternating β(1,4)-linked N-acetylglucosamine (NAG) 
and N-acetyl-muramic acid (NAM) (Figure 1-1).  The lactyl side chain of the 
repeating NAG-NAM disaccharide unit forms an amide bond with a pentapeptide.  
These peptide subunits are cross-linked so that the overall structure is an 























































Figure 1-1. The peptidoglycan structures of Gram-positive (A) and Gram-
negative (B) bacteria.   
Peptidoglycan synthesis occurs in three distinct stages (Figure 1-2).  The 
first stage, the formation of cell wall building blocks, UDP-acetylmuramyl-
pentapeptide (UDP-MurNAc-pentapeptide), takes place in the cytoplasm.  This 
stage is initiated by the conversion of uridine tri-phosphate (UTP) and N-
acetylglucosamine α-1-P (GlcNAc-1-P, 1-1) to UDP-GlcNAc (1-2).  The second 
enzyme, UDP-GlcNAc-3-enolpyruvyl-transferase catalyzes the coupling of a 
pyruvate enol ether moiety from phosphoenolpyruvate (PEP) to UDP-GlcNAc.  
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The newly formed UDP-GlcNAc-enolpyruvate (1-3) is then reduced by a 
NADPH-dependent reductase giving rise to the first key intermediate, UDP-N-
acetylmuramic acid (UDP-MurNAc, 1-4).  In the subsequent steps, three amino 
acids and a preformed dipeptide D-alanyl-D-alanine are added sequentially to the 
carboxyl group of the muramic acid residue to form UDP-MurNAc-pentapeptide 
(1-5).   
The second stage of peptidoglycan synthesis occurs in the membrane since 
all the enzymes involved in this stage are membrane-bound.  MurNAc-
pentapeptide is first transferred to a lipophilic carrier in the cytoplasmic 
membrane by a pyrophosphate bridge, followed by the coupling of N-
acetylglucosamine from UDP-GlcNAc.  The nascent product of these reactions 
is GlcNAc-β-(1,4)-MurNAc-(pentapeptide)-P-P-phospholipid.  Subsequent 
transformations result in the addition of five glycines to the ε-amino group of 
lysine.  In the next step, the modified disaccharide-pentapeptide is cleaved from 
its lipophilic carrier in the membrane and covalently linked to the GlcNAc end of 
a saccharide-peptide that is already attached to the bacterial membrane.  At the 
same time, phospholipid will be regenerated and enter the next cycle to react with 
another product (1-5) of stage I.   
The third and final stage of peptidoglycan synthesis takes place outside the 
cell.  It involves the polymerization of the subunits and attachment of these units 
to the growing peptidoglycan chain.  The new peptidoglycan is attached to the 
preexisting cell wall peptidoglycan by a transpeptidase reaction that crosslinks 
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peptide chains from two polymers, one end of which must possess a D-alanyl-D-














































































































Figure 1-2. The peptidoglycan biosynthesis in Gram-positive bacteria. 
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1.1.2 The Antibiotic Function of Fosfomycin 
The antibiotics that interfere the cell wall peptidoglycan biosynthesis have 
been proven effective in preventing bacterial growth.  Without the restraining 
influence of the cell wall, the high osmotic pressure inside the cell will lead to the 
burst of the inner and/or outer membranes of bacteria.  The antibiotics that are 
capable of inhibiting the synthesis of peptidoglycan include fosfomycin, 
cycloserine, bacitracin, β-lactams, and vancomycin.   
Fosfomycin is a broad-spectrum antibiotic produced by some strains of 
Streptomyces (1, 2). The target of fosfomycin is UDP-GlcNAc-3-O-enolpyruvyl-
transferase (MurA), which catalyzes the first committed step of peptidoglycan 
biosynthesis, namely, the transfer of enolpyruvate from PEP to UDP-GlcNAc (1-
2), releasing inorganic phosphate as a by-product (Figure 1-2) (3, 4).  MurA is 
conserved across both gram-positive and gram-negative bacterial species but has 
no mammalian counterparts.  MurA is an essential enzyme in that its deletion 
from bacterial genome has been proven lethal (5).  The mechanism of inhibition 
of MurA by fosfomycin has been well characterized, in which fosfomycin acts as 
an analogue of PEP, a cosubstrate of MurA (Figure 1-3).  The negatively 
charged phosphonate moiety is important for anchoring fosfomycin in the active 
site of MurA with a proper orientation.  The subsequent nucleophilic attack by 
the enzymatic active site Cys115 results in the ring opening of fosfomycin 
epoxide and the formation of a covalent adduct between MurA and fosfomycin 
(Figure 1-3) (6, 7).  Since the C-P bond of fosfomycin is chemically inert, the 
resulting adduct is fairly stable.  This is the mode of action in which fosfomycin 
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irreversibly inhibits the catalytic function of MurA.  Because fosfomycin is not a 
close structural mimic of PEP, the antibiotic has no or little effect on the functions 
of many other PEP-dependent enzymes.  This explains why fosfomycin has low 















































Figure 1-3. The catalytic mechanism of MurA (A) and the mechanism of MurA 
inactivation by fosfomycin (B).   
Fosfomycin utilizes two uptake systems to gain entry into microorganisms: 
the L-α-glycerophosphate and the hexose phosphate transport systems (8).  
Because of the difference in the uptake of fosfomycin, bacteria exhibit various 
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levels of sensitivity to fosfomycin.  Most resistant strains are found to be 
defective in one of the transport systems (9, 10).  Besides decreased antibiotic 
uptake, resistance to fosfomycin can be achieved by several other mechanisms, 
e.g., enzymatic modification of the antibiotic (11) and overexpression of MurA 
(12).  In addition, MurA containing a Cys115Asp mutation was found to be 
catalytically active but resistant to fosfomycin (6).   
1.2 FOSFOMYCIN BIOSYNTHESIS 
 Structurally, fosfomycin belongs to a steadily growing family of natural 
products containing a C-P bond (13).  Members of this family, such as 
fosfomycin (1-7), aminoethylphosphonic acid (AEP, 1-8), and bialaphos (1-9), are 
all derived from phosphoenolpyruvate (PEP, 1 -10) (14).  The C-P bonds in 
these compounds are formed through an intramolecular rearrangement reaction 
catalyzed by PEP mutase, resulting in the conversion of PEP (1-10) to 
phosphopyruvate (PnPy, 1-11) (Figure 1-4) (15-17).  Since the equilibrium 
between PEP and PnPy highly favors the cleavage of the C-P bond, the 
decarboxylation catalyzed by a second enzyme, PnPy decarboxylase, which 
converts PnPy (1-10) to phosphonoacetaldehyde (PnAA, 1-12), provides the 

















































































Figure 1-4. The gene cluster and pathway of fosfomycin biosynthesis in 
Streptomyces wedmorensis.   
1.2.1. Fosfomycin Biosynthetic Pathway 
Recently, the entire fosfomycin biosynthetic gene cluster has been cloned 
from Streptomyces wedmorensis (Figure 1-4) (18), and part of the gene cluster 
from Pseudomonas syringae has also been isolated (19).  Ten genes have been 
identified in the gene cluster from S. wedmorensis.  Accordingly, the 
biosynthesis of fosfomycin has also been proposed to involve at least four steps 
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(Figure 1-4) (18).  In contrast to the early transformations involved in C-P bond 
formation that have been well established and characterized, little is known about 
the remaining steps of the biosynthesis of fosfomycin.   
To explore the later stages of fosfomycin biosynthesis, a mutant of 
fosfomycin producing strain, NP-7, was constructed, in which the second step in 
the biosynthetic pathway is blocked.  In the absence of self-produced PnAA (1-
12), this mutant strain can convert hydroxyethylphosphonic acid (HEP, 1-13) (20) 
and 2-hydroxypropylphosphonic acid (HPP, 1-14) (21), respectively, to 
fosfomycin.  Interestingly, no fosfomycin was produced upon feeding cis-
propenylphosphonic acid (PPOH, 1-17) to the strain (21).  On the basis of these 
findings, a methylation step and an epoxidation step were proposed as part of a 
minimum pathway to complete fosfomycin biosynthesis (Figure 1-4).   
As indicated by the radiolabeling experiments, the 2-methyl group of 
fosfomycin is derived from methionine (22).  The identity of the methyl source 
has been confirmed by utilizing another mutant strain of S. wedmorensis, A-16, 
which lacks the ability to synthesize cobalamin (23).  A-16 can convert PnAA 
(1-12) or its equivalent HEP (1-13) to fosfomycin in the presence of endogenous 
cobalamin, by incorporating [14CH3]-group from [14CH3]methylcobalamin into 
fosfomycin (23).  This result strongly supports the presence of a 
methyltransferase that is dependent on methylcobalamin for its activity and 
catalyzes the addition of a methyl group to a two-carbon intermediate in 
fosfomycin biosynthetic pathway.  This two-carbon intermediate may either be 
PnAA (1-12) or HEP (1-13).   
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After the above steps, an epoxidation reaction is necessary to produce 
fosfomycin.  In nature, most epoxide rings are generated via oxidation of the 
corresponding alkenes by either heme-dependent cytochrome P450s (24, 25) or 
non-heme iron-dependent monooxygenases (26).  However, all attempts to 
convert PPOH (1-17) to fosfomycin by mutant NP-7 failed.  Instead, NP-7 can 
produce fosfomycin upon feeding with HPP (1-14) (21).  Further evidence 
supporting HPP as the immediate precursor for fosfomycin was provided by 
Hammerschmidt et al. (27, 28).  When S. fradiae was fed with 18O-labeled HEP 
(1-13) in their experiments, 18O was found to be incorporated into fosfomycin.   
The function of two more genes, orfA and orfB, in the fosfomycin 
biosynthesis gene cluster from S. wedmorensis have recently been established as 
self-resistance genes (29).  The encoded proteins of these two genes inactivate 
fosfomycin by adding one phosphate group at a time to the phosphonate group to 
give a biologically inert product, 1-16.  
1.2.2. Methyltransferase (Fom3) 
Four genes have been tentatively assigned to encode the putative enzymes 
responsible for the four proposed steps (Figure 1-4).  The assignments of genes 
fom1 and fom2 to encode the enzymes involved in C-P bond formation have been 
biochemically verified.  The gene product of fom3 is believed to be responsible 
for the methylation step.   
As previously stated, methylcobalamin is likely the methyl source for the 
methylation reaction catalyzed by Fom3, a putative methyltransferase (23).  As 
the carbonyl carbon of PnAA (1-12) is electrophilic, it is unlikely the methyl 
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source is a methyl cation supplied by S-adenosyl-L-methionine (SAM), which is 
the most common methyl donor in biological systems.  Instead, the methylation 
reaction might involve a methyl anion or even a methyl radical derived from 
methylcobalamin.  A similar case can be found in the formation of the second C-
P bond in bialaphos biosynthesis (Figure 1-5).  There are experimental evidence 
showing that this P-methylation is also dependent on methylcobalamin as the 
methyl donor (30).  Since the phosphorus atom of the phosphinate group is 
electrophilic, its methylation may also proceed via a similar radical or anionic 




























































Figure 1-6. Methylation reaction in clorobiocin biosynthesis.   
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According to a recently reported protein sequence analysis (31), Fom3 
enzyme contains not only a cobalamin-binding domain but also a radical SAM 
iron-sulfur binding domain.  Along with the new finding, a group of sequence 
homologous methyltransferases were identified as well.  Other than the 
aforementioned P-methylase in bialaphos biosynthesis, the so-called BchE-
like/methyltransferase subgroup includes fortimicin KL1 methyltransferase (32) 
and CloN6 in clorobiocin biosynthesis (Figure 1-6) (33).  Interestingly, the 5’-
site of pyrrole ring is actually nucleophilic, which is opposite to the methylation 
sites in the cases of fosfomycin and bialaphos biosynthesis.  This means that the 
CloN6-catalyzed methylation reaction may favor a methyl cation over a methyl 
anion as the methyl source.  If we assume that all these enzymes proceed via a 
similar mechanism, the most likely scenario should be the transfer of a methyl 
radical from methylcobalamin.   
A relevant enzymatic methylation system that may provide inspirations in 
understanding the above unprecedented type of methyltransferases is cobalamin-
dependent methionine synthase (MetH).  MetH catalyzes the final step in the de 
novo biosynthesis of methionine in Escherichia coli, formation of methionine (1-
19) by a methyl transfer to homocysteine (1-18) from methylcobalamin (1-24) 
(Figure 1-7) (34).  To regenerate methylcobalamin, a methyl group is transferred 
from methyltetrahydrofolate (CH3-H4folate) (1-20) to cob(I)alamin (1-22), 
forming methylcobalamin and H4folate (1-21).  Methionine synthase is a 
modular enzyme that binds CH3-H4folate (1-20), homocysteine (1-18), 
methylcobalamin (1-24), and SAM (1-25) in each of its four modules.  During 
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catalytic turnover, a methyl cation is formally transferred from methylcobalamin 
(1-24) to the homocysteine (1-18) thiolate while another methyl cation is 
transferred from CH3-H4folate (1-20) to cob(I)alamin (1-22).  Occasionally, 
cob(I)alamin (1-22) is oxidized to cob(II)alamin (1-23), which is inactive and 
needs to be converted to methylcobalamin (1-24) by a reductive methylation 
involving electron transfer from reduced flavodoxin and methyl group donation 













































































Figure 1-7. The hypothetic catalytic model of methionine synthase.  
Combining all the information above, we attempt to propose a common 
catalytic mechanism for the enzymes in the BchE-like/methyltransferase 
subgroup.  The mechanism is based on a radical methyl transfer from 
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methylcobalamin (1-24) to substrate radical that is pre-generated by radical SAM 
chemistry, forming cob(II)alamin (1-23) and product (X-CH3).  Similarly, the 
regeneration of methylcobalamin (1-24) needs another radical methyl transfer 
from SAM (1-25) to cob(II)alamin (1-23).  This catalytic model takes advantage 
of the dual function of SAM to generate radical on substrate and to regenerate 
methylcobalamin.  Both functions of SAM have been seen in several enzyme 

















































































Figure 1-8. The hypothetic catalytic model of the putative enzymes dependent 
on both cobalamin and SAM for their activities.   
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1.2.3. Epoxidase (Fom4) 
The final step in the proposed fosfomycin biosynthetic pathway is 
epoxidation.  The gene fom4 from Streptomyces wedmorensis encodes the 
epoxidase responsible for this reaction.  In a separate effort, a fom4 homolog, 
orf3, was also identified in the fosfomycin biosynthetic gene cluster from 
Pseudomonas syringae PB-5123 (19).  Fom4 has been our primary research 
focus in studying fosfomycin biosynthesis.  Since the isolated Fom4 was only an 
apoprotein, a considerable amount of work has been devoted to find conditions 
for reconstitution of the enzyme activity and to confirm its identity as the desired 
epoxidase (35, 36).  Through this effort, Fom4 has been verified as the desired 2-
hydroxypropylphosphonic acid epoxidase (HppE) that takes (S)-HPP (1-14) as the 
preferred substrate.  The purified enzyme is capable of catalyzing the 
epoxidation reaction in vitro in the presence of an exogenous electron mediator, 
such as FMN.  Preliminary characterization of HppE has established it as an 
NADH dependent mononuclear non-heme iron dependent enzyme.   
In nature, the most common enzymatic epoxidation is olefin epoxidation.  
The responsible enzymes are either heme enzymes such as cytochrome P450s (24, 
25) or non-heme iron enzymes such as methane monooxygenase (MMO) (26).  
Among them, P450s represent the largest group of natural epoxidases.  The 
general mechanism of P450-catalyzed epoxidation is almost the same as that of 






































































































Figure 1-9. The catalytic model of olefin epoxidation catalyzed by P450s.   
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The resting state (A) is a six-coordinate low-spin ferric state with water (or 
hydroxide) as the exchangeable distal ligand trans to the proximal cysteine.  The 
addition of olefin substrate results in a five-coordinate high-spin ferric state (B) 
with a vacant coordination site available for dioxygen binding.  Accompanied 
with the conversion of enzymatic ferric iron from low to high spin is a significant 
increase in the redox potential, which facilitates the reduction of ferric ion 
generating a five-coordinate high-spin deoxyferrous state (C).  Dioxygen binds 
to the ferrous center to form FeII-dixoygen (D1) and FeIII-superoxide (D2) 
complexes in equilibrium.  The second electron transfer is the rate-limiting step 
in the cycle, leading to the formation of FeIII-hyperoxide (E) complex or its 
protonated equivalent FeIII-hyperoxy complex (F).  Upon further protonation of 
the distal oxygen in complex F, the O-O bond breaks heterolytically, generating 
the hypothetic compound I, the oxoferryl (O=FeIV) porphyrin radical cation 
complex (G).  For some P450 enzymes, H2O2 can react with ferric center to 
directly form F and its immediate product, G (compound I).  This shortcut is 
called “peroxide shunt”.  It is generally accepted that the highly oxidative 
intermediate G is used to oxidize olefins to generate epoxides.  Currently, there 
are at least two possible mechanisms that are used to describe the process of 
olefin epoxidation by G, stepwise mechanism (Figure 1-9 II) and concerted 
mechanism (not shown).   
The ability to activate and transfer molecular oxygen into organic 
molecules is not restricted to the cytochrome P450 family.  Some non-heme 
monooxygenases such as methane monooxygenase (MMO) are also able to 
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catalyze epoxidation reactions.  The natural function of MMO is to convert 
methane to methanol in methanotrophic bacteria (37).  MMO can also 
hydroxylate a wide range of substrates, including alkanes (38).  MMO catalytic 
system consists of three separate protein components, a hydroxylase (MMOH), a 
reductase (MMOR) and a component B protein (MMOB).  The central 
component is MMOH that contains a binuclear non-heme iron in the active site 


















































Figure 1-10. The catalytic model of olefin epoxidation catalyzed by MMO.   
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The established catalytic cycle of MMO starting with the resting state 
(Ho), involves initial reduction by two electrons from MMOR and NADH to the 
reduced form Hr (Figure 1-10) (39).  In the following step, dioxygen binds in the 
MMOH active site (O) and then oxidizes Hr to the intermediate P.  As a result of 
further oxidation, a transient chromophoric species, intermediate Q, is formed.  
Q can be considered as the equivalent of compound I (G) in MMO non-heme iron 
catalytic system.  It has been suggested to be the activated form of MMOH and 
the oxidative species responsible for substrate oxidation.  Although the stepwise 
radical-based epoxidation mechanism by MMO is preferred and presented in 
Figure 1-10, other mechanistic alternates are also possible.   
In contrast to the above alkene epoxidation catalyzed by P450s and MMO, 
alcohol epoxidation catalyzed by HppE is a rare case in nature.  To date, there is 
only one precedent of such an epoxidation reaction, which is catalyzed by 
hyoscyamine 6β-hydroxylase (H6H) in the biosynthesis of scopolamine (1-29) 
(Figure 1-11) (40, 41).  However, H6H belongs to the α-ketoglutarate dependent 
oxygenase family.  Besides its epoxidase activity in conversion of both 6-
hydroxyhyoscyamine (1-27) and dehydrohyoscyamine (1-28) to scopolamine (1-
29), H6H can also catalyze the hydroxylation of hyoscyamine (1-26) to form 6β-
hydroxyhyoscyamine (1-27) (Figure 1-11).  Furthermore, the amino acid 
sequence analysis of HppE and H6H fails to show any sequence homology.  
These apparent differences between HppE and H6H strongly imply that these two 






















Figure 1-11. The hydroxylation and epoxidation reactions catalyzed by 
hyoscyamine 6β-hydroxylase.   
Clearly, the alcohol epoxidation in the final step of fosfomycin 
biosynthesis catalyzed by HppE is unique among all enzymatic epoxidation 
reactions.  Since HppE belongs to the family of mononuclear non-heme iron-
dependent enzymes, it must share some common structural and functional 
characteristics with other enzymes of the family.  Thus, learning knowledge of 
other mononuclear non-heme iron enzymes may shed light on the catalysis of 
HppE.   
1.3 MONONUCLEAR NON-HEME IRON ENZYMES 
Non-heme iron enzymes are known to catalyze a range of oxidative 
reactions more diverse than those associated with heme enzymes (42, 43).  
Depending on the type of reaction they catalyze and the cofactor(s) they need for 
their catalytic activities, they can be divided into a few categories (Table 1-1).  
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Except that intradiol dioxygenases and lipoxygenases are dependent on ferric ion, 
all other enzymes require ferrous ion for their activities.  In the following 
sections, a brief review of each of the mononuclear non-heme iron enzymes listed 
in Table 1-1 is presented dealing in particular with their particular structural and 
catalytic features.   
1.3.1. Lipoxygenase 
Lipoxygenases (LOs) are a group of enzymes that catalyze regio- and 
stereospecific hydroperoxidation of 1,4-diene units in fatty acids (1-30) (44, 45).  
The produced hydroperoxide compounds (1-33) play important regulatory roles in 
animals (44) and plants (45).  The X-ray structures of lipoxygenases show a 
clear picture of the enzymatic metal active site (46) (Figure 1-12).  The iron 
center is coordinated with five amino acid ligands in a distorted octahedral 
geometry.  The iron ligands in soybean LOs is slightly different from those in 
rabbit LOs (Figure 1-12, I vs. II).  As shown in the proposed catalytic cycle 
(Figure 1-12, III), hydrogen abstraction is the key step in the whole reaction.  
Ferric hydroxide is believed to be the species that homolytically cleaves the C-H 
bond and creates a substrate radical (1-31) (47).  The pentadienyl radical 
intermediate (1-31) then reacts with dioxygen giving rise to an organic superoxide 
radical intermediate (1-32).  The reaction is completed with the formation of the 
hydroperoxide product and the oxidation of iron from ferrous state to ferric state.  
Under anaerobic conditions, the pentadienyl radical intermediate (1-31) could 
diffuse out of enzyme active site and react with each other.  In support of the 
proposed mechanism, the resulting dimer has been experimentally detected (48).   
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Figure 1-12. Lipoxygenase active site structure (I. Soybean LOs; II. Rabbit LOs) 
and the proposed hydroperoxidation mechanism.   
1.3.2. Intradiol Cleaving Catechol Dioxygenase 
The catechol dioxygenases are part of the bacterial machinery for aromatic 
ring degradation.  They catalyze the oxidative cleavage of the aromatic ring of 
catechol and its derivatives (49).  Catechol dioxygenases can be divided into two 
classes, intradiol and extradiol cleaving dioxygenases.  The difference between 
them can be easily told by their names.  Briefly, intradiol dioxygenases cleave 
the C-C bond of enediol unit while extradiol dioxygenases cleave the C-C bond 

































































Figure 1-14 Intradiol cleaving catechol dioxygenases: active site structure (I) and 
proposed catalytic mechanism (II).   
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Intradiol cleaving dioxygenases utilize a mononuclear non-heme ferric ion 
for substrate binding and catalysis.  The representative enzyme of this class is 
protocatechuate 3,4-dioxygenase (PCD).  PCD has a trigonal-bipyramidal iron 
core in the active site that consists of two histidines, two tyrosines, and a 
hydroxide ion (50) (Figure 1-14, I).  Both the axial and equatorial tyrosine 
ligands contribute the ligand-to-metal charge transfer (LMCT) bands, 500 nm and 
450 nm, to the UV-vis absorption spectrum of the enzyme (51).  These LMCT 
transitions give a characteristic red-brown color to the enzyme.  When its 
substrate, protocatechuate (PCA, 1-34), binds to the metal center, a new broad 
low-energy band appears around 600 nm, which has been assigned to another 
LMCT transition from the catecholate-to-FeIII charge transfer complex (1-36) 
(52).  Given that ferric ion cannot activate dioxygen, the key step in the proposed 
mechanism is the formation of an FeII-bound semiquinone intermediate (1-37).  
The intermediate 1-37 then binds dioxygen (1-38) to form a tri-bridged FeIII-
peroxy complex (1-39).  The aromatic C-C bond cleavage is another key step, in 
which an anhydride (1-40) is formed via a Criegee rearrangement.  Hydrolysis of 
the anhydride (1-40) gives the final ring-cleaved product (1-35).  In an 
alternative mechanism, the FeIII-peroxy complex (1-39) is proposed to proceed 
through a dioxetane rather than the anhydride intermediate (1-40) (49).  
However, the much less than 100% incorporation of oxygen atom in the final 
product from isotope-labeled dioxygen makes the former mechanism involving 
the anhydride intermediate a favorable one (53).   
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1.3.3. Extradiol Cleaving Catechol Dioxygenase 
Catalyzing very similar types of catechol cleavage reactions, extradiol and 
intradiol dioxygenases are actually very different.  Instead of using a ferric ion in 
their catalysis, the extradiol cleaving catechol dioxygenases, represented by 2,3-
dihydroxybiphenyl 1,2-dioxygenase (1,2-DHBD), catechol 2,3-dioxygenase (2,3-
CTD), and protocatechuate 4,5-dioxygenase (4,5-PCD), have a ferrous ion in their 
active site (54).  Moreover, all of these enzymes have a common metal-binding 















































Figure 1-15 Extradiol cleaving catechol dioxygenases: active site structure (I) 
and proposed catalytic mechanism (II).   
Like their intradiol counterpart, extradiol dioxygenases start the catalysis 
with the formation of an iron-catecholate complex (1-43).  Since the extradiol 
dioxygenases have a ferrous active site, the enzyme substrate binary complexes 
have no visible colors.  It is also because of the ferrous center, dioxygen can 
easily bind to the enzyme active site and be activated, generating a Fe(III)-
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superoxide intermediate (1-44).  Very similar to the intermediate 1-39 in the 
catalysis of intradiol dioxygenases (Figure 1-14), a tri-bridged iron peroxy 
intermediate (1-45) is also proposed (49).  In the following step, the intermediate 
1-45 undergoes a Criegee rearrangement that breaks down the aromatic ring by 
inserting an oxygen atom to it.  It is worthy of noting that the Criegee 
rearrangements proposed in the catalytic cycles of intradiol and extradiol 
dioxygenases are different.  The acyl group is transferred to the proximal oxygen 
atom in bound peroxy in the intradiol cleaving mechanism.  In contrast, it is the 
alkenyl group that is transferred in the extradiol cleaving mechanism.  The 
distinction between these two mechanisms is proposed to account for the different 
ring cleavage regiochemistry (1-35 vs. 1-42).  There is an alternative way to 
explain the difference, in which another tri-bridged peroxy complex (1-47) is 
formed in place of complex 1-45.  Subsequent acyl transfer-based Criegee 
rearrangement should lead to the same product (1-42).  However, in the crystal 
structure of enzyme-substrate-NO ternary complex (56), the dioxygen mimic NO 
seems to have access only to the C2 position rather than the C3 position on the 
aromatic ring, which is incompatible with the intermediacy of 1-47.  As a result, 
the alternative mechanism is disfavored.   
1.3.4. Pterin-dependent Aromatic Amino Acid Hydroxylases 
Pterin-dependent aromatic amino acid hydroxylases include phenylalanine 
(PheH), tyrosine (TyrH), and tryptophan (TrpH) hydroxylases (57).  Like the 
above extradiol cleaving catechol dioxygenases, they are also dependent on FeII 
for activities.  The metal binding ligands for these enzymes have been 
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established to consist of two histidines and one glutamate (58).  The 
hydroxylation of aromatic amino acids is a two-electron redox reaction.  To fully 
reduce dioxygen, however, requires four electrons in total.  The other two 
electrons are provided by tetrahydrobiopterin (BH4, 1-48).  The reaction is 
highly ordered.  The binding of either aromatic amino acid substrate (1-49) or 
BH4 (1-48) does not perturb the hexa-coordinated active site.  Only when 
substrate and BH4 are both bound, the resulting ternary complex becomes penta-
coordinated, as indicated by the crystal structure of the ternary complex of PheH‚ 
BH4 and substrate analogue (59).  This structural change that results in an open 
coordinate site for dioxygen binding is presumed to facilitate the attack on pterin 
by dioxygen.  Following O2 attack is the formation of an FeII-O-O-pterin 
intermediate (1-50), which then heterolytically cleaves to yield 4a-hydroxy-BH4 
(1-51) and FeIV=O.  The oxoferryl (FeIV=O) species has not been experimentally 
observed yet.  However, it is believed to be responsible for substrate 
hydroxylation, because the pterin-dependent enzymes can carry out sulfoxidation, 
epoxidation, and benzylic hydroxylation that are usually associated with 
FeIV=O/porphyrin radical intermediate of cytochrome P450 (57).  Arene 
hydroxylation is often accompanied by NIH shift (2-H/D shift, Figure 1-16), 
which is due to the formation of a cationic intermediate during the oxo atom 
transfer (1-53).  The formation of the intermediate 1-50 and its subsequent 
heterolysis are the center of the proposed mechanism.  The isotope-labeling 
studies revealed nearly quantitative incorporation of 18O from 18O2 in both 4a-
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hydroxy-BH4 (1-51) (60) and the hydroxylated product (1-54) (61).  The result 




















































































Figure 1-16 The proposed catalytic mechanism of pterin-dependent aromatic 
amino acid hydroxylases.   
1.3.5. α-Keto Acid-dependent Dioxygenases  
Enzymes that require an α-keto acid as a cosubstrate comprise the largest 
group of mononuclear nonheme iron-dependent enzymes (62).  Like pterin-
dependent hydroxylation, α-keto acid-dependent oxidation also needs totally four 
electrons to fully reduce dioxygen.  Besides two electrons generated from 
substrate oxidation, α-keto acid donates the other two electrons.  Again, enzymes 
in this subfamily all have a 2-His-1-carboxylate iron-binding motif in their active 
site (55).  Their catalytic functions rely on the ferrous center for dioxygen 
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activation.  A good example that illustrates the great catalytic diversity of this 
subfamily of enzymes is clavaminate synthase (CAS).  Dependent on α-
ketoglutarate (α-KG), CAS catalyzes three different types of reactions, 
hydroxylation, cyclization and desaturation (Table 1-1).  In each of the reactions, 
the substrate turnover is coupled with the oxidative cleavage of an α-KG 















































Figure 1-17 The proposed catalytic mechanism of α-keto acid-dependent 
hydroxylases.  
From the mechanistic point of view, α-keto acid-dependent dioxygenases 
are probably the best-studied class of mononuclear non-heme iron enzymes.  
When α-keto acid binds to the enzymatic ferrous center in a bidentate pattern (1-
55, Figure 1-17), a typical metal-to-ligand charge transfer (MLCT) band appears 
in the UV-vis absorption spectrum of the binary complex (63).  Accompanying 
with substrate binding, the ferrous center becomes penta-coordinated leaving one 
site open for dioxygen binding (64).  The molecular oxygen would then bind to 
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the ferrous center at the open site to form an FeIII-superoxo radical anion 
intermediate (1-56).  In the next step, the iron-bound activated dioxygen attacks 
the α-keto carbon, giving rise to a tri-bridged intermediate (1-57), which is 
reminiscent of the structurally similar intermediates 1-39 (Figure 1-14) and 1-45 
(Figure 1-15) in earlier discussions.  The following Criegee rearrangement with 
an acyl transfer results in the decarboxylation of α-keto acid, and, more 
importantly, the generation of an FeIV-oxo species (1-58).  The involvement of 
this high valent iron-oxo intermediate (1-58) in the catalytic cycle has long been 
speculated and was strongly supported by a recent rapid freeze-quench Mössbauer 
study (65).  The experimentally trapped intermediate shows characteristic 
spectral features of FeIV and is catalytically competent capable of taking hydrogen 
atom from substrate (66).  This is the first time that such an intermediate is 
spectroscopically observed.  Some enzymes in this class can catalyze olefin 
epoxidation, sulfoxidation, and N-demethylation, a typical reactivity pattern of 
reminiscent of cytochrome P450s (67), which also supports the participation of 
the FeIV-oxo species in the catalytic mechanism of α-keto acid-dependent 
enzymes.  In the postulated two-step process of substrate hydroxylation, the 
hydrogen atom is first abstracted by the FeIV-oxo species, which is followed by 
oxygen rebound.  However, it is worthy of noting that P450 uses the FeIII/FeV=O 
couple, while the α-keto acid-dependent enzymes use the FeII/FeIV=O couple.  
For enzymes that catalyze cyclization and desaturation like CAS, the oxygen 
rebound step in the hydroxylation reaction is replaced with a ring closure or a 
second hydrogen-abstraction reaction.   
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Similar to the proposed catalytic cycles of pterin-dependent hydroxylases 
(Figure 1-16), the reactions catalyzed by α-keto acid-dependent enzymes can also 
be divided into two half-reactions.  The first half-reaction is to form an oxoferryl 
oxidative species at the expense of α-keto acid, while the second half is to use the 
oxoferryl species to oxidize substrate.  The presence of substrate is essential to 
couple these two half-reactions.  In the absence of substrate, uncoupled 
oxidation of cofactors often led to side reactions, such as protein self-modification 
(68, 69).   
1.3.6. IPNS and ACCO 
Isopenicillin N synthase (IPNS) and 1-aminocyclopropane-1-carboxylate 
oxidase (ACCO) are both mononuclear nonheme iron enzymes that are 
biologically important.  IPNS is a bacterial enzyme that catalyzes the formation 
of antibiotics isopenicillin N from δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine 
(ACV), while ACCO is a plant enzyme that produces plant hormone ethylene to 
regulate plant growth (Table 1-1).  Although they both share the sequence 
HX(D/E)XmHXnRXS that is highly conserved among all α-keto acid-dependent 
enzymes (55), their catalyses are completely independent of any α-keto acid.  
Both of their reactions involve the four-electron redox chemistry.  For IPNS, all 
four electrons are originated from substrate, ACV, while for ACCO, ACC 
degradation provides two electrons and ascorbate provides the other two.   
Thanks to the recent advances in crystallographic study, a great deal of 
structural and mechanistic information that would otherwise be hard to obtain has 
become available.  The crystal structure of FeII-IPNS-ACV-NO adduct not only 
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confirmed the direct coordination between Cys thiolate of ACV and the ferrous 
center (1-59), but also showed the position of NO, a dioxygen analogue, relative 
to the cysteinyl β-carbon (70).  This information provided the structural evidence 
for the first hydrogen abstraction step by an FeIII-superoxide species in the 
proposed mechanism of IPNS (Figure 1-18).  This step leads to the formation of 
a Cys thioaldehyde (1-61), and an FeIII-hydroperoxy intermediate.  The next step 
features a heterolytic cleavage of the O-O bond forming the FeIV-oxo intermediate 
coupled with a nucleophilic attack of the amino group at thioaldehyde to close the 
β-lactam ring (1-62).  The second ring-closure step is reminiscent of a typical 
cyclization mediated by an oxoferryl species, which starts with the abstraction of 
the valinyl C3-H, followed by C3-S bond formation, generating the thiazolidine 
ring in the final product, isopenicillin N (IPN, 1-63).   
Using a variety of substrate analogues, the proposed mechanism has been 
tested.  The presence of FeIV-oxo in the catalytic cycle is supported by the 
alternative activity of IPNS in sulfoxidation and double bond epoxidation (71).   
Like IPNS, ACCO is also a nonheme iron enzyme with the 
HX(D/E)XmHXnRXS sequence motif conserved in many α-KG dependent 
enzymes but does not require α-KG for activity.  Instead, the enzyme requires 
carbon dioxide (or carbonate) as a catalytic activator, in addition to the essential 
cosubstrates, dioxygen and ascorbate.  Its crystal structure that was available 
only weeks ago identified a 2-His-1-carboxylate iron-binding motif (72).  
ENDOR study using 15N- and 17O-labeled alanine has demonstrated a bidentate 
binding pattern for ACC, in which both its amino and carboxylate groups 
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coordinate the active site iron (1-65) (73).  In the same study, ACC (1-64) and 
NO were also found to bind simultaneously.  Taken with the previous finding 
that ascorbate binding is competitive with NO, these observations led to the 

















































Figure 1-18 The proposed catalytic mechanism of IPNS. 
1.3.7. Rieske Dioxygenases  
Rieske dioxygenases catalyzes the first step in the biodegradation of 
aromatic compounds, the cis-dihydroxylation of arenes.  These enzymes contain 
a unique Rieske-type [2Fe-2S] cluster that consists of a 2His (on one iron), 2Cys 
(on the other iron) coordination pattern (74) (1-70).  This coordination pattern is 
distinct from the more common 4Cys ligation pattern found in plant ferredoxins 
iron sulfur cluster.  Rieske dioxygenases are multi-component enzymes 
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comprising of an oxygenase component responsible for dioxygen activation and 
substrate hydroxylation, and a reductase component responsible for electron 










































Figure 1-19 The proposed catalytic mechanism of ACCO. 
As the representative enzyme of this class, naphthalene 1,2-dioxygenase 
(NDO) has been well studied both structurally and mechanistically.  The crystal 
structure of its oxygenase component shows a mononuclear non-heme iron bound 















bidentate carboxylate ligand.  This mononuclear iron center has a neighboring 



















Figure 1-20 The proposed catalytic mechanism of Rieske dioxygenase.   
The recently resolved crystal structures of NDO-O2 adduct, in the absence 
and in the presence of substrate, naphthalene (1-72), marks the first structural 
characterization of a non-heme enzyme dioxygen adduct (75).  The dioxygen is 
bound to the iron center in a very unusually side-on mode (1-73), instead of an 
end-on mode.  Given that the cis-dihydroxylated product (1-75) also binds to the 
iron center in a bidentate manner (1-74), as shown in the crystal structure of 
enzyme-product complex (76), a catalytic cycle can be proposed by lining up all 
these known structures.  As depicted in Figure 1-20, the reaction involves 
dioxygen activated to generate 1-73 followed by arene dihydroxylation to form 1-
75.  The Rieske cluster mediates electron transfer from the reductase component 
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to the oxygenase active site, using NADPH as the ultimate electron source.  At 
the end stage of the catalytic cycle, both non-heme iron center and Rieske cluster 
are in their oxidized forms.  To release the product (1-75) and regenerate the 
redox cofactors, an electron is transferred to non-heme ferric ion.  The 
subsequent electron transfer that reduces Rieske center renders the enzymatic 
active site ready for the next cycle of catalysis.   
1.4 THESIS STATEMENT 
The focus of this dissertation is to study HppE, the enzyme catalyzing the 
last step of fosfomycin biosynthesis.  The transformation catalyzed by HppE is 
an unique epoxidation, because its substrate is a secondary alcohol rather than an 
alkene, which is much more common in other biological epoxidation reactions.  
In contrast to other natural epoxidases, which are either heme-based cytochrome 
P450s or binuclear non-heme iron enzymes, HppE is a novel type of mononuclear 
non-heme iron enzyme.  The only similar case is found in the scopamine 
biosynthesis, where a mononuclear non-heme iron-dependent 6β-hydroxylase 
(H6H) can also convert an alcohol substrate to an epoxide product.  However, 
H6H is an α-KG dependent enzyme while HppE is independent of α-KG but 
instead relies on NADH for two exogenous electrons essential to its epoxidation.   
Previously, Dr. Pinghua Liu has successfully reconstituted the epoxidase 
activity of HppE using recombinant enzyme originally from Streptomyces 
wedmorensis.  This dissertation focuses on further structural and mechanistic 
studies of the epoxidation reaction catalyzed by HppE.  The work towards better 
understanding of HppE itself and its catalysis involves many collaborative efforts.  
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The dissertation describes the exploration of the reaction sequence (Chapter 2), 
the metal-couple protein radical (Chapter4), the active site structure (Chapter 5), 
and the substrate binding (Chapter 6) by EPR, which were conducted in 
collaboration with Dr. John D. Lipscomb at the University of Minnesota and Dr. 
Aimin Liu at University of Mississippi Medical Center.  The identification and 
characterization of a green chromophore in the modified HppE, covered in 
Chapter 3, was undertaken in collaboration with Dr. Mark P. Mehn and Dr. 
Lawrence Que at the University of Minnesota.   
The results obtained from the studies depicted in this dissertation firmly 
established that HppE is unique among all known mononuclear non-heme iron 
enzymes.  It requires no organic coenzyme or metal cluster and its activity is 
independent of pterin, α-KG and ascorbate.  Instead, its catalysis consumes a 
stoichiometric amount of NADH with molecular oxygen.  Our data reveal that 
HppE is in a class of its own within the mononuclear non-heme iron enzyme 
superfamily and the reaction catalyzed by HppE is beyond the scope encompassed 
by common biological epoxidation and C-O bond formation reactions.   
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Chapter 2:  Initial Characterization of HppE 
2.1 INTRODUCTION 
(S)-2-hydroxypropylphosphonic acid epoxidase (HppE) from 
Streptomyces wedmorensis catalyzes the final step of the biosynthesis of 
fosfomycin (2-1, (1R,2S)-1,2-epoxypropylphosphonic acid) using (S)-2-hydroxy-
propylphosphonic acid ((S)-HPP, 2-2) as the substrate (Figure 2-1) (1-3).  In 
contrast to most epoxide rings in nature, which are generated via oxidation of the 
corresponding alkenes by heme-dependent cytochrome P450s (4, 5) or non-heme 
iron-dependent monooxygenases (6), the epoxide functionality in fosfomycin is 
converted from a secondary alcohol, (S)-HPP (2-2), rather than an alkene, cis-
propenylphosphonic acid (2-3) (7).  In addition, the hydroxyl oxygen of HPP (2-
2) has been found to be retained in fosfomycin (8). Thus far, there has been only 
one other known enzyme that can convert an secondary alcohol to an epoxide, 
which is hyoscyamine 6β-hydroxylase (H6H) in scopamine biosynthesis (9).  
However, H6H can also take the corresponding alkene as substrate and convert it 
to epoxide (10).  The unique substrate specificity that HppE exhibits is another 
good indication that its catalytic mechanism must be distinct from above other 
natural epoxidases.   
The original clone of HppE was constructed by Drs. Haruo Seto and 
Tomohisa Kuzuyama at Tokyo University using fom4 gene from fosfomycin 
biosynthesis gene cluster of S. wedmorensis (1).  Using HppE produced by 
heterologously expressing this clone in E. coli, Dr. Pinghua Liu successfully 
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reconstituted its epoxidase activity for the first time in vitro (Figure 2-1) (2).  
The in vitro reconstitution of the enzymatic epoxidation is based on a four-
electron reduction of O2 to H2O, in which two electrons are provided by the 
substrate, (S)-HPP (2-2), and the other two electrons are supplied by an 
exogenous reductant, NAD(P)H.  The key component responsible for the 
enzymatic catalysis is a mononuclear non-heme iron that can facilitate activation 
of dioxygen and/or substrate.  To make the overall reaction more efficient, an 
electron mediator is needed to transfer electron from NAD(P)H to the enzyme 
active site.  This electron mediator should be a reductase protein also from S. 
wedmorensis.  However, efforts in searching for the reductase have thus far been 
unsuccessful.  Fortunately, FMN was found to be an effective alternate and has 


















Figure 2-1 The epoxidation reaction catalyzed by HppE in vitro.  
HppE produced from the original clone contained a N-terminal His6-tag 
that was attached to the enzyme to ease protein purification.  However, the metal 
binding affinity of His6-tag is a potential problem in studying the iron-dependent 
catalytic function of HppE.  To avert the potential complications associated with 
the presence of His6-tag, Dr. Pinghua Liu constructed a new clone to produce 
non-tagged HppE in E. coli.  Since the His6-tag was removed, the previous 
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protein purification procedure based on Ni-NTA affinity chromatography was 
replaced by a multi-step purification protocol including ammonium sulfate 
precipitation and DEAE column chromatography (2).  However, a considerable 
degree of iron loss from HppE was observed under new purification conditions.  
To restore the catalytically essential iron ion in the as-purified HppE, a few more 
modifications were made to improve the purification procedure.  First, EDTA 
and DTT were added to the purification buffers to remove all iron from enzyme, 
so the as-purified HppE was totally free of any iron ions (3).  The apo-protein 
was reconstituted with more than one equivalent of FeII(NH4)2(SO4)2 under 
aerobic conditions and then passed over a gel filtration column to remove 
adventurously bound iron.  The subsequent iron titration analysis verified that 
the ratio of protein to iron is close to 1:1.  In contrast to the HppE with His6-tag, 
the newly purified and reconstituted HppE exhibited significant enhancement in 
its epoxidase activity (11).   
As previously discussed in Chapter 1, mononuclear non-heme iron 
enzymes can be classified in two categories, FeII- and FeIII-dependent.  The 
former class includes the majority of mononuclear non-heme iron enzymes, e.g. 
the extradiol cleaving catechol dioxygenases, α-keto acid-dependent oxidases and 
oxygenases, pterin-dependent hydroxylases, Rieske-type dioxygenases, the 
ethylene forming enzyme, and isopenicillin N synthase (12).  While these 
enzymes catalyze a wide variety of reactions, their proposed mechanisms all 
involve a high valent iron-oxo species as the oxidant in the course of an overall 
four-electron reduction of dioxygen to water (13).  An organic co-substrate, such 
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as ascorbate, tetrahydropterin, or α-ketoglutarate (α-KG), is often required to 
provide the additional electrons to complete the four-electron redox cycle (14-17).  
Alternatively, an iron-sulfur cluster, such as that built into the Rieske-type 
dioxygenases (18), can also be used to mediate electron transfer from NADH.  
Unlike members in this class of enzymes, which are aided by an organic co-
substrate or a Rieske center in oxygen activation, HppE has no built-in iron-sulfur 
cluster and is ascorbate-, pterin-, and α-KG-independent.  On the other hand, the 
members of the FeIII-dependent class are very few, solely represented by 
lipoxygenases and intradiol cleaving catechol dioxygenases, and their catalyses 
involve FeIII-dependent substrate activation more than oxygen activation (12).  
Although the FeIII-reconstituted HppE was used to establish the in vitro enzymatic 
epoxidation system (2), neither the mechanism of lipoxygenases nor that of the 
intradiol cleaving catechol dioxygenases can be applied to HppE.  Clearly, the 
reaction catalyzed by HppE is beyond the scope encompassed by common 
biological epoxidation and C-O bond formation reactions. Thus, HppE should be 
in a class of its own within the mononuclear non-heme iron enzyme superfamily.   
This chapter begins with the expression and purification of the 
recombinant HppE from S. wedmorensis, followed by experiments to characterize 
the purified enzyme.  As all the basic properties of HppE were confirmed to be 
the same as previously reported, the enzyme was then subjected to EPR spectral 
analysis.  The EPR study showed that the enzymatic ferric center is reduced to 
its ferrous state by FMN/NADH in the presence of substrate.  The EPR results 
strongly imply an FeII-dependent catalytic mechanism of HppE.   
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2.2 MATERIALS AND METHODS  
General.  The E. coli strain BL21(DE3) for protein expression was 
obtained from Novagen (Madison, WI).  The plasmid pPL1001 containing the 
HppE gene (fom4) was constructed by Dr. Pinghua Liu using pET24b(+) 
expression vector from Novagen (3).  DNA minipreps were performed using 
Qiaprep  spin miniprep kit from Qiagen (Valencia, CA).  Culture medium 
ingredients were purchased from Difco (Detroit, MI).  Protein concentrations 
were determined by the procedure of Bradford using bovine serum albumin as the 
standard (19).  All chemicals were analytical grade or the highest quality 
commercially available.  Biochemicals including fosfomycin disodium salt 
standard were purchased from Sigma (St. Louis, MO), unless 
noted otherwise.  The catalytic inhibitor of HppE, (S)-1-
difluoro-2-hydroxypropylphosphonate ((S)-FHPP, 2-4), was 







The NMR spectra were acquired on a Varian Unity 300 spectrometer and 
chemical shifts (δ in ppm) are given relative to those for Me4Si (for 1H and 13C) 
and aqueous 85% H3PO4 (external, for 31P), with coupling constants reported in 
hertz (Hz).  The UV-vis absorption spectra were recorded on a HP 8453A diode 
array or a Beckman DU 650 spectrophotometer.   
Heterologous Expression of fom4 in E. coli.  An overnight culture of E. 
coli BL21(DE3)/pPL1001 grown at 37 °C in LB medium supplemented with 
kanamycin (50 µg/mL) was used, in a 200-fold dilution, to inoculate 6 L of the 
same medium supplemented with 0.1 mM FeII(NH4)2(SO4)2.  When the OD600 
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reached 0.4 - 0.6, the incubation temperature was lowered to 18 °C and then IPTG 
was added to a final concentration of 0.1 mM to induce gene expression.  After 
incubation for an additional 15 - 20 h at 18 °C, cells were harvested by 
centrifugation (5,000 g, 10 min) at 4 °C, washed with Tris·HCl buffer (20 mM, 
pH 7.5), collected again by centrifugation (8,000 g, 15 min), and stored at - 80 °C 
for future use.  The typical yield was 6 g of wet cells per liter of culture.   
Purification of Recombinant HppE.  All purification operations were 
carried out at 4 °C except for the FPLC step, and all buffers were degassed and 
saturated with nitrogen before use.  Thawed cells were resuspended in 5 fold 
(w/v) of lysis buffer (20 mM Tris HCl, pH 7.5, 0.1 mM DTT; 1 mM EDTA was 
included to remove trace amount of iron ion when necessary) and subjected to 8 × 
30 s ultrasonic bursts, with 2 min cooling interval between each blast.  Cellular 
debris was removed by centrifugation at 30,000 g for 25 min.  The supernatant 
was fractionated by (NH4)2SO4 and the 30-65% (NH4)2SO4 precipitate was 
collected.  The protein pellet was resuspended in a minimal amount of dialysis 
buffer (Tris·HCl 20 mM, pH 7.5, 0.18 M KCl).  The resulting protein solution 
was dialyzed against 2 L of the same buffer for 4 h with two buffer changes.   
The dialysate was applied to a DEAE-Sepharose CL-6B column (5 × 17 
cm) pre-equilibrated with the dialysis buffer (20 mM Tris·HCl, pH 7.5, 0.18 M 
KCl).  The elution was then continued with a linear gradient of KCl from 0.18 to 
0.3 M in 20 mM Tris HCl buffer, pH 7.5 (2 L total volume).  The flow rate was 
2 mL/min and fractions of 15 mL were collected throughout the gradient elution.  
The fractions containing HppE, as determined by SDS-PAGE, were pooled, 
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concentrated to about 10 mL by ultrafiltration on an Amicon concentrator using 
an YM 10 membrane (Millipore, Bedford, MA), and desalted by dialyzing against 
20 mM Tris·HCl buffer, pH 7.5.   
The protein from last step was further purified at room temperature by 
FPLC equipped with a Mono Q HR 10/10 (Amersham Biosciences, Uppsala, 
Sweden) using the solvent systems A (20 mM Tris·HCl buffer, pH 7.5) and B (A 
plus 0.6 M NaCl).  The elution profile included a linear gradient of 0 to 60% B 
from 0 to 25 min, followed by a linear gradient of 60 to 100% B from 25 to 26 
min, and concluded with a 5 min wash at 100% B.  The flow rate was 3 mL/min 
and the detector was set at 280 nm.  A sharp peak with a retention time of about 
19 min was collected, concentrated by ultrafiltration as described before, desalted 
with 20 mM Tris·HCl buffer (pH 7.5), and stored at -80 °C.   
Polyacrylamide Gel Electrophoresis.  The subunit molecular mass and 
the purity of the protein samples were assessed by SDS-PAGE.  The separation 
gel and the stacking gel for electrophoresis were 12% and 4%, respectively.  
Prior to electrophoresis, protein samples were mixed with 10 µL of loading buffer 
(62.5 mM Tri-HCl buffer, pH 6.8, containing 10% glycerol, 2% SDS, 5% β-
mercaptoethanol, and 0.0025% bromophenol blue) and heated in boiling water for 
5 min except for the His6-tagged proteins.  For proteins with either N- or C-
terminal His6-tag, the corresponding mixtures were incubated at 37 °C for 10 min.  
Electrophoresis was run in 25 mM Tris·HCl buffer containing 192 mM glycine, 
and 0.1% SDS (pH 8.3) at 25 mA.  Gels were stained with Coomassie blue and 
destained with acetic acid/ethanol/water (15:29:165 by volume).  Protein 
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standards for SDS-PAGE include α-lactalbumin (14 kDa), trypsinogen (24 kDa), 
carbonic anhydrase (29 kDa), glyceraldehyde-3-phosphate dehydrogenase (36 
kDa), egg albumin (45 kDa), and bovine serum albumin (66 kDa).   
Molecular Mass Determination.  The molecular mass of HppE was 
determined by size exclusion chromatography performed on a Pharmacia FPLC 
Superdex 200 HR 10/30 column with 20 mM Tris HCl, 0.15 M NaCl, pH 7.5 at a 
flow rate of 0.8 mL/min.  Calibration of the column was achieved using the 
following protein standards (Sigma): cytochrome C (14.2 kDa), carbonic 
anhydrase (29 kDa), egg albumin (45 kDa), bovine serum albumin (66 kDa).  
The void volume (V0) of the column was measured using blue dextran.  A linear 
fit to a plot of the molecular weight versus Ve/V0 was used to estimate the native 
molecular mass (Mr) of protein sample.   
Preparation of Reconstituted HppE.  The original reconstitution strategy 
was initiated with dilution of concentrated as-purified apo-HppE (usually 1 - 2 
mM in 20 mM Tris·HCl, pH 7.5) in ddH2O to a final concentration of 1 mg/mL.  
The protein solution was mixed with FeII(NH4)2(SO4)2 to an enzyme/iron ratio of 
1:2 - 2.5 and stirred at 4 °C in air for 30 min.  The excess or weakly bound Fe 
was removed by a G-10 column (2.5 × 75 cm).  The elution was run at 5-6 
mL/min with Tris·HCl buffer (20 mM, pH 7.5).  The green fractions (5-mL 
fractions) were collected, concentrated, and the final concentration was 
determined by A280 (1 OD ~ 0.7 mg).  The reconstituted epoxidase was aliquoted 
and stored at –80 °C.   
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This reconstitution protocol was modified for samples subjected to 
biophysical studies.  Briefly, the apo-HppE was mixed with FeII(NH4)2(SO4)2 in 
a ratio of 1:1 and then exposed to pure O2 for 0.5 - 1 h.  The reconstituted 
enzyme was used directly in the EPR studies without further purification (e.g. G-
10).   
Iron Titration.  Protein samples for iron titration analysis (1 mL each) 
were mixed with 500 µL of reagent A (1:1 of 4.5% KMnO4:1.2 N HCl) and 
incubated at 60 °C for 2 h.  To these samples were added 100 µL of reagent B 
(8.8 g of ascorbic acid, 9.7 g of ammonium acetate, 80 mg of ferrozine, 80 mg of 
neocuprione, ddH2O to 25 mL total volume) followed by immediate vortexing.  
The samples were read at 562 nm after the color was fully developed by a 1 h 
incubation period at room temperature.   
Preparation of HppE Substrate.  The substrates of HppE in its 
enantiomerically pure forms were chemically synthesized.  To a solution of 
diethyl 2-oxopropylphosphonate (2-5, 3.3 g, 17 mmol) in anhydrous 
tetrahydrofuran (THF, 100 mL) was added NaBH4 (1.5 g, 40 mmol).  The 
reaction mixture was stirred at room temperature for 3 h.  The product, diethyl 2-
hydroxypropylphosphonate (2-6), was extracted by chloroform (100 mL) and 
washed with 1 M HCl (100 mL × 3).  After the extract had been dried by MgSO4 
powder, the chloroform was evaporated.  To the colorless oil left in the flask 
were added vinyl acetate (40 mL), isopropyl ether (60 mL) and lipase from 
Pseudomonas fluorescens (Amano Enzymes Inc., Nagoya, Japan, 1 g).  The 
reaction mixture was shaken at 30 °C, and the progress was monitored by NMR 
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until the ratio between the acetylated and unacetylated compounds reached 1:1.  
The acetylated product, diethyl (R)-2-acetoxypropylphosphonate (2-7), was 
separated from the unreacted diethyl (S)-2-hydroxypropylphosphonate (2-8) by 
silica gel chromatography using ethyl acetate as solvent.   
To the isolated acetylated compound (2-7) was added NH3 (5 mL, 2M 
solution in MeOH).  The solution was stirred at room temperature for 24 h and 
the desired product, diethyl (R)-2-hydroxypropylphosphonate (2-9), was purified 
by chromatography on silica gel using mixed solvent of ethyl acetate and ethanol.   
The enantiomers of diethyl 2-hydroxypropylphosphonate (2-8 and 2-9, 0.7 
g, 3.5 mmol each) were separately added with trimethylsilyl bromide (TMSBr, 2 
g, 13 mmol) in dichloromethane (4 mL).  The reaction solution was stirred for 24 
h at room temperature.  After dichloromethane was removed, the residue was 
vigorously stirred with 5 mL of water for 10 min.  The aqueous layer was 


























Figure 2-2. Synthetic scheme for (S)-2-hydroxypropyl phosphonic acid (2-2) and 
(R)-2-hydroxypropyl phosphonic acid (2-10).  Reagents and 
conditions: a) NaBH4/THF; b) lipase/vinyl acetate/isopropyl ether; c) 
NH3/MeOH; d) TMSBr/CH2Cl2. 
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The spectral data of the final products, (S)-2-hydroxypropylphosphonic 
acid (2-2) and (R)-2-hydroxypropylphosphonic acid (2-10) are the same: 1H NMR 
(300 MHz, D2O) δ 3.80 (1H, m, J = 6.5, 2-H), 1.39 (2H, dd, J = 18.0, 6.6, 15.3, 1-
H), 0.97 (3H, d, J = 6.5, 3-H); 13C NMR (300 MHz, D2O) δ 65.0 (d, J = 2.0, C-2), 
37.9 (d, J = 132.0, C-1), 22.1 (C-3); 31P NMR (300 MHz, D2O) δ 19.9 (s).   
NMR Assay.  In order to directly determine the percentage of HPP 
conversion to fosfomycin catalyzed by HPP epoxidase, an NMR assay was 
developed.  A typical assay mixture (100 µL) contained 10.5 mM (S)-HPP (2-2), 
21.6 µM HppE, 21.8 mM NADH and 60 µM E3 in 20 mM Tris HCl buffer, pH 
7.5.  The reaction was carried out at room temperature with vigorous shaking 
and was quenched at an appropriate time by adding EDTA to a final concentration 
of 100 mM, followed by freezing with liquid nitrogen.  The frozen sample was 
thawed immediately before NMR analysis.  The amount of fosfomycin produced 
was determined based on integration of the appropriate NMR peaks.  Spectral 
data of fosfomycin (2-1): 1H NMR (300 MHz, D2O) δ 3.03 (1H, m, J = 5.0, 2-H), 
2.57 (1H, d, J = 5.0, 14.0, 1-H), 1.21 (3H, d, J = 5.5, 3-H); 13C NMR (300 MHz, 
D2O) δ 54.2 (s, C-2), 54.3 (d, J = 176.0, C-1), 13.2 (C-3); 31P NMR (300 MHz, 
D2O) δ 10.9 (s).   
EPR Spectroscopy.  EPR first derivative spectra of HppE were collected 
at X-band microwave frequency with 100-kHz field modulation on a Bruker 
Elexsys E500 spectrometer.  A calibrated frequency counter and a Bruker 
ER035M NMR Gauss meter were used for the g-value determinations.  The 
cryo-temperature measurements were achieved with an Oxford Instruments ESR-
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10 continuous flow liquid helium cryostat and a digitalized temperature 
controller.  Spin quantitation was performed by double integration of the 
corresponding spectra recorded under non-saturating conditions at 20 K using a 
Cu-EDTA standard (1 mM) for calibration.  The EPR parameters were obtained 
using an EPR program written by Dr. Frank Neese (21) and were further verified 
in Bruker SimFonia.   
The isolated, FeII-loaded (reduced) and FeIII-reconstituted (oxidized) HppE 
were individually mixed with (S)-HPP (2-2) and/or FMN/NADH and then 
examined by EPR spectroscopy at 2 - 50 K.  To prevent interference from 
oxidation by the air, the majority of the samples were prepared under strict 
anaerobic conditions.  Oxygen was then removed by repeated cycles of 
vacuuming and argon flushing from all samples prior to NO exposure.  The 
anaerobic solutions of purified enzyme, (S)-HPP, FeII(NH4)2(SO4)2, FMN, and 
NADH were made ready prior to mixing with each other.  The solutions were 
transferred through gas-tight Hamilton syringes and the mixings took place in the 
EPR tubes under the protection of argon.  Only the samples of FeIII-reconstituted 
HppE, alone and with substrate, were prepared in the air.   
In the nitric oxide (NO) experiments, the stricter anaerobic conditions 
were required.  Oxygen was removed from all samples prior to NO exposure.  
NO gas was quantitatively introduced to the samples in EPR tubes through a gas-
tight Hamilton syringe under the protection of argon.  The samples were slowly 
chilled by liquid nitrogen for later EPR analysis.   
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2.3 RESULTS  
Expression and Purification of Recombinant HppE.  Wild-type HppE 
from S. wedmorensis was expressed using E. coli BL21(DE3)/pPL1001 
constructed by Dr. Pinghua Liu and purified according to a previously reported 
procedure (2).  As shown in SDS-PAGE (Figure 2-3), the desired protein was 
isolated in nearly homogeneous form after ammonium sulfate fractionation and 
two anion exchange chromatographic steps (DEAE-Sepharose and FPLC-Mono 
Q).   
Figure 2-3. The SDS-PAGE gel of HppE purification.  Lanes: M, Molecular 
weight markers: α-lactalbumin (14 kDa), trypsinogen (24 kDa), 
carbonic anhydrase (29 kDa), glyceraldehyde-3-phosphate 
dehydrogenase (36 kDa), egg albumin (45 kDa), and bovine serum 
albumin (66 kDa); 1, 35-60% (NH4)2SO4 precipitate; 2, after DEAE-
Sepharose column, 3, after FPLC-Mono Q column.   
The subunit molecular mass of 21,208.9 Da, assessed by MALDI mass 
spectroscopy, correlates well with the predicted value of 21,210 Da calculated 
from the deduced amine acid sequence.  The purified recombinant HppE exists 
as a homo-tetramer having a mass of 89 kDa as determined by gel filtration 
chromatography.  Due to the inclusion of EDTA and DTT in the protein 
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purification procedure, the purified HppE is essentially free of iron.  Indeed, iron 
titration analysis revealed less than 0.05% iron per monomer in the as-isolated 
HppE.  The apo-HppE was found inactive in the epoxidase activity assay.  
After it was reconstituted with iron in vitro, the holo-enzyme regained its activity 
to produce fosfomycin (2-1) from (S)-HPP (2-2).   
The Electronic Absorption Spectrum of HppE.  When the isolated HppE 
was reconstituted with FeII(NH4)2(SO4)2 under anaerobic conditions, the resulting 
protein was colorless.  However, when this sample was exposed to air, it slowly 
turned green in color.  The optical spectrum of this green protein exhibits a 
broad band around 650 − 700 nm with a molar absorption coefficient of 
approximately 450 (M of Fe)-1.cm-1 (Figure 2-4).  This absorption is likely due to 
a ligand−to−metal charge transfer (LMCT) transition.  Detailed characterization 
of this chromophore will be reported in Chapter 3.   
Figure 2-4. The electronic absorption spectrum of reconstituted HppE.  Protein 
concentration is 1.4 mM.   
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EPR Characterization of Reconstituted HppE.  As mentioned above, 
HppE as isolated contains little iron and thus is effectively EPR-silent.  
Stoichiometric addition (1.0 Fe/per enzyme monomer) of FeII(NH4)2(SO4)2 to the 
as-isolated HppE under anaerobic conditions led to an FeII-loaded holo-protein.  
As expected, the FeII-loaded HppE is EPR-inactive.  Upon oxidation, the EPR 
spectrum of the oxidized sample displays a set of resonance at g = 4.29, 5.28, and 
8.59, that is indicative of a mononuclear non-heme ferric center with d5 electronic 
configuration of S = 5/2 and E/D of 0.145 (Figure 2-5A).   
Figure 2-5. EPR spectra of reconstituted HppE.  (A) 250 µM reconstituted 
(oxidized) HppE; (B) 250 µM reconstituted (oxidized) HppE in the 
presence of 10× excess of (S)-HPP.  Instrumental parameters: 
temperature, 2 K; microwave frequency, 9.6 GHz; microwave 
power, 0.6 mW; modulation amplitude, 5 G; time constant, 0.02 s; 
sweep rate, 50 G/s.   
The S = 5/2 EPR signal is sensitive to the binding with (S)-HPP (2-2) 
(Figure 2-5B).  The broadening and splitting of the middle Kramer's doublet (g = 
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4.29) in the presence of (S)-HPP (2-2) suggest that the substrate binds to or near 
the iron center.  Spin quantitation reveals that the total EPR-active ferric species 
accounts for about 0.7 iron per enzyme monomer, suggesting a large fraction of 
the Fe center is diamagnetic.  It should be noted that an isotropic g = 4.3 
component (S = 5/2) may also exist and be superimposed to the middle doublet of 
the signal with E/D of 0.145.  Nevertheless, this component reflects only a minor 
fraction of the total Fe and may be ascribed to adventitiously bound ferric ion.   
EPR Characterization of FeII-HppE Nitrosyl Complex.  To assess 
whether the EPR-inactive iron in the reconstituted HppE are still in ferrous state, 
nitric oxide was added to the EPR sample.  Since NO is known to complex with 
non-heme ferrous ion to produce species with electronic spin S = 3/2, the resulting 
EPR spectrum is expected to be different.  Surprisingly, the EPR spectrum of 
reconstituted HppE (Figure 2-5A) is unaffected upon the addition of NO up to 1−5 
times excess than the enzyme (data not shown).  The absence of an EPR-active 
NO adduct with S = 3/2 signature argues against the presence of a large fraction 
of ferrous ion in the oxidized HppE.  To test if the reduced iron center of HppE 
is accessible to nitric oxide, the NO experiment was also performed with the FeII-
loaded enzyme.  It was found that anaerobic addition of NO to this sample led to 
the formation of at least two major S = 3/2 species from the diamagnetic FeII 
protein (Figure 2-6A).  In addition, a signal derived from a small amount of 
ferric ion is also discernible, a phenomenon likely due to the carrying over from 
the native protein.  The spin quantitation of all EPR-active components in this 
sample is close to the full content of the total iron.   
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Figure 2-6 EPR spectra of FeII-HppE nitrosyl complexes. (A) 250 µM FeII-
loaded HppE in the presence of NO; (B) the ternary complex of FeII-
loaded HppE, substrate (10-fold excess over active sites) and NO. 
Instrumental parameters are the same as those in Figure 2-5.   
As shown in Figure 2-6A, an FeII-NO adduct has g values at 3.94 and 4.16 
(and 1.99), with an E/D value of 0.055.  This species is highly temperature 
sensitive and becomes less pronounced when temperature rises from 2 K to 10 or 
20 K (data not shown).  The resonance of another FeII-NO complex is much 
broader and has a doublet splitting with spectral features at 3.57 and 4.36 (and 
1.99) (E/D = 0.013).  Spectral simulations (Figure 2-7) show that the E/D = 
0.055 signal (Figure 2-7C) and the E/D = 0.013 signal (Figure 2-7D) account for 
about half of the iron, respectively.  The relative concentration of the two FeII-
nitrosyl centers can be varied.  This may be ascribed to the NO diffusion 
consistency in EPR tubes during sample preparations at various protein 
concentrations.  These results clearly demonstrate that the ferrous center of the 
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reduced HppE can react with the dioxygen analogue, NO.  Since no FeII-nitrosyl 
adduct was detected in the oxidized enzyme treated with NO, one may conclude 
that the iron in the oxidized epoxidase is primarily at its ferric state.  The data 
have revealed the presence of heterogeneity of the Fe center in both the reduced 
and oxidized epoxidase, each consisting of two or more components.  The nature 
of the EPR-inactive fraction of the ferric center and the underlying reason for the 
heterogeneity of the Fe centers at both reduced and oxidized forms are intriguing.   
Figure 2-7 Simulations of EPR spectra of FeII-HppE nitrosyl complexes. (A) 
Experimental spectrum in Figure 2-6A, (B) Simulated spectrum 
combining C (50%) and D (50%), (C) Simulated spectrum of the 
EPR signal with E/D = 0.055, (D) Simulated spectrum of the EPR 
signal with E/D = 0.013.  Important g values are given in spectra.  
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Figure 2-8 Simulations of EPR spectra of FeII-HppE·substrate nitrosyl 
complexes. (A) Experimental spectrum in Figure 2-6B, (B) 
Simulated spectra combining C (95%) and D (5%), (C) Simulated 
spectrum of the EPR signal with E/D = 0.066, (D) Simulated 
spectrum of the EPR signal with E/D = 0.  Important g values are 
given in spectra.   
As shown in the spectrum B of Figure 2-6, addition of (S)-HPP to the FeII-
HppE nitrosyl complex results in a significant change in the EPR spectrum.  
Most of the heterogeneity that characterizes the ferric complex and the nitrosyl 
complex of the substrate free enzyme disappears and a single species 
predominates with g values of 4.42, 3.63 and 1.97, and E/D value of 0.066.  
Spectral simulations (Figure 2-8) show that the dominant E/D = 0.066 signal 
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(Figure 2-8C) is responsible for 95% of the iron center in the spectrum B of 
Figure 2-6.  An extremely minor species (g = 4.0, E/D = 0) was also identified 
(Figure 2-8D), which accounts for about 5% of the whole spectrum (Figure 2-6B).  
Quantitation of the spectrum by double integration shows that nearly all the iron 
centers bind substrate and NO.  These results suggest that substrate binds near, 
and perhaps directly to, the ferrous active site, and in doing so organizes the metal 
center so that effectively only one species is present.   
During nitrosyl EPR sample preparation, the order of additions of 
substrate and NO was found not critical.  However, protein precipitation often 
occurred when more than enough NO gas was introduced to FeII-HppE·substrate 
complex.  Sometimes, the precipitated protein could be resuspended after gentle 
shaking.  However, the effects on EPR spectra caused by protein precipitation 
were irreversible.  For example, totally different EPR spectra were obtained by 
measuring these denatured samples (Figure 2-9D).  Most of the spectra consist 
of two major signals, as predicted by spectral simulations in Figure 2-8 (simulated 
spectra C and D).  These two signals are supposed to correspond to native and 
denatured forms of the FeII-HppE·substrate nitrosyl complex.  The ratio of the 
signal intensities may reflect the degree of denaturation of the protein induced by 
excess NO gas (Figure 2-9A-D).   
The Reaction Sequence.  In order to determine the reaction sequence, a 
set of experiments was carried out with NO, a molecular oxygen analogue.  The 
EPR spectrum of the oxidized HppE is unaffected by the anaerobic addition of 
NO to the sample (data not shown).  Since no FeII-nitrosyl adduct was detected 
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in the oxidized enzyme treated with NO, one may conclude that the iron in the 
oxidized epoxidase is primarily at its ferric state.   
Figure 2-9 EPR spectra of FeII-HppE with substrate in the presence of 
increasing amounts of NO (A → D).  Instrumental parameters are 
the same as those in Figure 2-5.  Important g values are given in 
spectra.   
Anaerobically addition of NADH/FMN, a reducing system used for in 
vitro reconstitution of the epoxidase activity of HppE, to the reconstituted HppE 
had no effects on the corresponding EPR signals (Figure 2-5A vs. Figure 2-10A).  
Neither did the addition of NO to the mixture of enzyme, substrate, and 
NADH/FMN lead to any change of its EPR spectrum (Figure 2-10B).  
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Interestingly, mixing of (S)-HPP (2-2) and NADH/FMN together with the 
reconstituted HppE rendered the majority of the ferric signals disappear.  An 
immediate explanation is that the ferric center was reduced to the EPR-silent 
ferrous state by NADH/FMN in the presence of substrate.  The introduction of 
NO gas to the sample soon verified the above hypothesis by visualizing the 
otherwise invisible ferrous ion.  A new signal with g values of 4.42 and 3.63 
appeared in the EPR spectrum (Figure 2-10C), which is reminiscent of that of the 
FeII-HppE·substrate nitrosyl complex (Figure 2-6B).  When these two spectra are 
closely compared, it becomes apparent that they are nearly identical (Figure 2-
11).  Clearly, the ferric ion reduced by NADH/FMN in the presence of substrate 
and the ferrous ion detected when complexed with NO are the same iron center, 
but in different oxidation states.  Given the substantial effects of substrate 
binding on the environment of the active site iron (Figure 2-5 and Figure 2-6) and 
on its redox potential (Figure 2-10), it is very likely that (S)-HPP directly 
coordinates to the iron center in HppE.  The reduction of the ferric center of 
HppE by NADH/FMN has also been observed in the presence of the alternative 
substrate, (R)-HPP, and the inhibitor, (S)-FHPP, (data not shown), and thus 
strongly supports the hypothesis of direct coordination of substrate to the iron 
center.   
Along with the signal of the S = 3/2 FeII-nitrosyl adduct, a radical-like 
signal also emerged at g = 2 region in the same EPR spectrum (Figure 2-10C).  
Although the identity of the S = 1/2 free radical signal has not yet been 
determined, it is likely derived from a substrate-based radical.  This series of 
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experimental results demonstrated that the reducing system only reacts with the 
E·S binary complex but not the enzyme alone.  The iron-binding pattern of both 
enantiomers of HPP may play an important role in regulating the redox potential 
of the iron center.   
Figure 2-10 EPR spectra of reconstituted HppE in the presence of FMN/NADH. 
(A) Reconstituted HppE + FMN/NADH; (B) Reconstituted HppE + 
FMN/NADH + NO; (C) Reconstituted HppE + FMN/NADH + NO 
+ substrate.  Instrumental parameters are the same as those in 
Figure 2-5.  Important g values are given in spectra.   
2.4 DISCUSSION 
The expression, purification and in vitro activity reconstitution of HppE 
have shown the dependence of its catalysis on iron.  Through in vitro iron 
reconstitution, the as-isolated apo-HppE was found to bind nearly an equivalent of 
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ferric ion per enzyme monomer and then become active to catalyze epoxidation 
reaction.  In contrast to the heme-containing proteins that have a strong 
characteristic band in the blue region (~ 400 nm) of their optical absorption 
spectra, which is known as Soret band, the similar optical features were missing 
in the spectrum of reconstituted HppE (Figure 2-4) (4).  The lacking of Soret 
band clearly indicates that HppE relies on a non-heme iron in its active site, 
instead of a heme iron, for catalysis.  Thus, HppE is a new member of the family 
of mononuclear non-heme iron-dependent enzymes.   
Figure 2-11 Comparison of EPR spectra. (A) FeII-HppE + (S)-HPP + NO (Figure 
2-6B); (B) the reconstituted HppE + FMN/NADH + (S)-HPP + NO 
(Figure 2-10C).  Important g values are given in spectra.   
EPR spectroscopy is a powerful tool to study proteins containing transition 
metals.  Many non-heme iron enzymes have been analyzed by this spectroscopic 
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technique and a great deal of structural and mechanistic information has thus been 
obtained (12, 13).  As a new mononuclear non-heme iron enzyme that catalyzes 
a unique epoxidation reaction, HppE was also subjected to EPR spectral analysis.  
The EPR spectra of HppE in its oxidized and reduced forms are typical for a non-
heme iron-containing enzyme.  Upon substrate binding, the spectral features 
were significantly affected, suggesting that the substrate may bind directly to the 
iron or closely nearby.  The most interesting finding from these EPR analyses is 
that FMN/NADH cannot reduce the ferric center of HppE unless the substrate is 
also added.  This observation strongly suggests that substrate binding has a 
significant impact on the active site iron of HppE, not only on its spectral features 
but also on its redox potential.   
Since the epoxidation reaction catalyzed by HppE involves the full 
reduction of dioxygen to water, it is necessary for the iron center to be in its 
ferrous state for the dioxygen activation step in the catalytic cycle.  The 
reduction of ferric center of HppE by FMN/NADH provides the means to produce 
the catalytically necessary ferrous center.  On the basis of our experimental 
results, a minimal reaction sequence can be formulated as shown in Figure 2-12.  
These few steps constitute the early stage of the enzymatic epoxidation, in which 
HppE and its iron center, substrate, dioxygen and electron donor are all made 
ready for the subsequent chemical steps of catalysis.  The S = 3/2 FeII-HppE·(S)-
HPP nitrosyl complex that gave rise to the homogeneous EPR signal in Figure 2-











Figure 2-12 The minimal reaction sequence in the early stage of HppE catalysis.   
The reaction sequence proposed above is analogous to the beginning steps 
in the catalytic mechanism of cytochrome P450s (Figure 1-9, A → D1).  In the 
catalysis of P450s, dioxygen is then activated by reacting with the heme ferrous 
center and receiving exogenous electrons to form the hypothetic compound I (G), 
an FeV species that is presumably responsible for the substrate oxidation (4).  It 
is generally believed that FeV is a highly unstable species and thus exists in the 
form of FeIV-oxo with a porphyrin radical cation.  However, no porphyrin ring is 
present in non-heme iron enzymes to stabilize FeV.  Alternatively, FeIV 
intermediates are more commonly accepted in the mechanisms proposed for 
mononuclear non-heme iron enzymes.  Some FeIV centers have been 
experimentally identified in enzymes and model compounds (22, 23).  As a new 
mononuclear non-heme iron enzyme, HppE is assumed to rely on a similar FeIV 
intermediate rather than a less stable FeV intermediate in its catalytic mechanism.  
On the other hand, HppE resembles P450s owing to its dependence on NADH as 
the electron source and the requirement of a reductase as the electron transfer 
mediator.  Using this reductase/NADH reduction system, electrons can be 
transferred in a step-wise manner.  In contrast, a large number of mononuclear 
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non-heme iron enzymes rely on cosubstrates like α-KG and pterin that can only 
donate two electrons together at one time.   
Recently, Hammerschmidt and co-workers reported 
that (1S, 2S)-1,2-epoxypropylphosphonic acid (2-11) may be a 
co-metabolite of fosfomycin (2-1), and both of them are 
products of the oxidation of (S)-HPP (2-2) by HppE (24).  
Several mechanisms can be envisioned to account for the above observations.  
The most likely mechanism involves a substrate radical intermediate as shown in 
Figure 2-13.  Thus, the formation of trans-epoxide may be a result of the rotation 
around C1-C2 bond at the α-C radical (2-12) stage.  It should be mentioned here 
that HppE converts not only 2-2 to 2-1, but also the R-isomer of HPP (2-10) to 2-
oxopropylphosphonic acid (2-14) with nearly equal efficiency (20).  The 
oxidation of the (R)-isomer of HPP by HppE is believed to involve the formation 
of a carbon-centered β-ketyl radical (2-13), which is distinct from the α-radical 





































Figure 2-13 The proposed substrate radical intermediates in the conversions of 
both enantiomers of HPP catalyzed by HppE (20).   
 73
On the basis of above discussion, an FeIV intermediate and a substrate-
based radical intermediate have thus been proposed to be part of the catalytic 
cycle of HppE.  The steps involving formation of these intermediate as well as 
the earlier established beginning steps involving substrate binding, iron reduction 
and dioxygen activation, constitute a nearly complete cycle of enzymatic 
epoxidation.  Now, the question comes down to the key chemical steps in the 
reaction, the formation of the substrate radical intermediate via hydrogen 
abstraction, and the formation of the final product via epoxide ring closure.  
Hydrogen abstraction is probably the most important step in enzymatic 
epoxidation since the regiospecificity and stereospecificity of the reaction are 
supposedly determined in this step.  It is currently unclear which iron-oxygen 
oxidative species is responsible for the abstraction of the hydrogen atom from the 
substrate.  After dioxygen docks on the non-heme iron center of HppE, it would 
evolve into at least four distinct species FeIII-superoxy (2-15), FeIII-peroxy (2-
16a), FeIII-hydroperoxy (2-16b), and FeIV-oxo (2-17), depending on how many 
electrons and protons are transferred to the iron-oxygen adduct.  Among them, 
FeIV-oxo (2-17) is the most reactive species and thus is commonly proposed to 
play the hydrogen abstracting role.  As a general oxidative species, FeIV-oxo is 
also able to perform other oxidative tasks including sulfoxidation, N-















HppE cannot convert an alkene like 2-3 to its corresponding epoxide product like 
fosfomycin (2-1) (7).  Therefore, relative to other iron-oxygen reactive species, 
FeIV-oxo (2-17) is less likely responsible for the C-H bond cleavage in the HppE 
reaction.  The FeIII-peroxy (2-16a) and FeIII-hydroperoxy (2-16b) species only 
differ by one proton.  To abstract a hydrogen atom from the substrate, they have 
to undergo a homolytic cleavage of the O-O bond to form the next stable 
intermediate, FeIV-oxo, and release a molecule of water for 2-16b or a hydroxide 
ion for 2-16a.  Apparently, it is more thermodynamically favorable for FeIII-
hydroperoxy (2-15b) to take the hydrogen atom.  FeIII-superoxy (2-15) has not 
often been proposed for C-H activation because the C-H bonds in substrates are 
generally stronger than the terminal O-H bond in FeIII-hydroperoxy.  In another 
word, there will be little energy gain by breaking a C-H bond and forming an O-H 
bond.  Therefore, even if the hydrogen atom were abstracted by FeIII-superoxy 
(2-15), the process will most likely end in equilibrium and need the subsequent 
steps involving cleavage of the O-O bond and formation of the FeIV-oxo species 
(2-17) to provide the driving forces to shift the equilibrium toward completion.  
In summary, the hydrogen abstraction mechanisms via different iron-oxygen 
intermediates are illustrated in Figure 2-14.   
Since the formation of an FeIV-oxo intermediate along with a substrate 
radical is very likely the outcome of the hydrogen abstraction step in enzymatic 
epoxidation, as indicated by Figure 2-14, the epoxide ring closure must be 
accomplished by a radical induced C-O bond formation.  The homolytic 
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cleavage of the Fe-O bond provides an electron to regenerate the ferric center of 























Figure 2-14 The proposed mechanisms of hydrogen abstraction in HppE 






































Figure 2-15 Proposed mechanism of HppE-catalyzed epoxidation reaction.   
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The proposed mechanism starts with HppE in its ferric state, the assumed 
resting state of the enzyme.  Its ferric center is first bound with (S)-HPP, and 
then reduced to the ferrous state by receiving an electron from NADH mediated 
by the reductase.  The resulting substrate-bound ferrous center binds dioxygen 
and activates it to form some reactive iron-oxygen species.  The direct 
coordination of (S)-HPP (2-2) to iron center of HppE is strongly hinted by the 
EPR results, and is important for facilitating electron flow between substrate and 
iron-oxygen intermediates in the following steps.  Abstraction of an α-H of (S)-
HPP (2-2), by either FeIII-superoxy (2-15) or FeIII-hydroperoxy (2-16b) as 
previously discussed (Figure 2-14), is followed by a radical induced homolytic 
cleavage of the Fe–O bond.  Accompanying the product formation, the iron 
center is reduced back to its resting ferric state.   
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Chapter 3:  Self-catalytic Hydroxylation of HppE 
3.1 INTRODUCTION 
As a newly identified mononuclear non-heme iron enzyme, HppE is 
clearly in a class of its own within this family of enzymes.  Unlike most other 
members of this superfamily, which utilize an organic co-substrate or the Rieske 
center to aid in oxygen activation (1-5), HppE has no built-in iron-sulfur cluster 
and is ascorbate-, pterin-, and α-KG-independent.  Instead, its catalytic turnover 
consumes a stoichiometric amount of NADH using molecular oxygen as the 
oxidant (6, 7).  A reductase, whose identity remains elusive, is also required to 
mediate electron transfer from NADH to the epoxidase.  The reaction catalyzed 
by HppE is beyond the scope currently encompassed by common biological 
epoxidation and C-O bond formation reactions.  It converts a secondary alcohol, 
an unusual substrate of natural enzymatic epoxidation, to an epoxide.  More 
interestingly, the alcoholic oxygen is retained in the product.  Therefore, the 
overall epoxidation reaction is actually a dehydrogenation reaction.   
In our earlier studies (7), we have found that the heterologously expressed 
HppE is an apo-protein.  This tetrameric enzyme can be reconstituted with 
FeII(NH4)2(SO4)2 to a 1:1 ratio of iron per enzyme monomer.  The anaerobically 
reconstituted Fe(II)-enzyme is colorless, but it develops a green color upon air 
exposure in the absence of substrate (7).  Inspired by the possibility that the 
green chromophore may be related to the unique catalytic property of HppE, lots 
of efforts have been devoted to determine the identity of this green chromophore 
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and to study its biogenesis.  In collaboration with Dr. Mark P. Mehn and Dr. 
Lawrence Que at the University of Minnesota, we have characterized this 
chromophore by quinone staining and resonance Raman spectroscopic techniques.  
This chapter describes the evidence collected through the collaborative efforts, 
uncovering an FeIII-catecholate complex as the chromophoric core, and Tyr105 as 
the most likely site of post-translational modification to dihydroxyphenylalanine 
(DOPA).  Also included are the possible mechanisms of DOPA formation and 
the implications on the catalytic mechanism of HppE.   
3.2 MATERIALS AND METHODS 
General.  HppE was purified from E. coli BL21(DE3)/pPL1001 
according to the published procedure (7).  The enzyme activity was determined 
as previously described (7).  DNA sequencing was carried out by the Core 
Facility of the Institute for Cellular and Molecular Biology, University of Texas at 
Austin.  All reagents and solvents were purchased from commercial sources and 
were used without further purification unless otherwise noted.  Biochemicals 
were purchased from Sigma (St. Louis, MO).  Labeled water (95% 18O) and 
labeled oxygen (99% 18O) were obtained from ICON, Inc (Summit, NJ).   
Preparation of HppE Mutants.  Site-directed mutagenesis of the HppE 
gene (fom4) was carried out using QuickChangeTM Site-directed Mutagenesis Kit 
from Strategene (La Jolla, CA).  The oligonucleotide primers used for 
mutagenesis were custom-made by Invitrogen (Carlsbad, CA), which are, for the 
Y103/105F double mutant, pFYF7: 5′-CAACGTCGACTACTTCGTCTTCAAC-
TGTCTCGTCC-3′, and pFYF8: 5′-GGACGAGACAGTTGAAGACGAAGTAG-
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TCGACGTTG-3′.  The nucleotide primers for the C107A single mutant to be 
used in mass spectral study are pFYC1: 5′-CTACGTCTACAACGCTCTC-
GTCCGCACC-3′, and pFYC2: 5′-GGTGCGGACGAGAGCGTTGTAGACGTA-
G-3′.  Mutant plasmids were constructed by PCR amplification of the HppE 
gene from pPL1001 using the above primers under the following conditions: (1) 
14 cycles at 95 °C for 30 s, 55 °C for 1 min, and 68 °C for 10 min; (2) 1 cycle at 
72 °C for 10 min.  The PCR template in each sample was digested with DpnI at 
37 °C for 1 h and the recombinant plasmid was then used to transform E. coli 
XL1-blue supercompetent cells.  After their sequences were confirmed by DNA 
sequencing, these mutant plasmids were used to transform E. coli BL21(DE3) 
competent cells for expression.  The mutant proteins were purified according to 
the same procedure used for the wild type HppE.  After reconstitution with 
FeII(NH4)2(SO4)2, the excess metals were removed by a G-10 column.  The 
resultant proteins were stored at – 80 °C.  Single mutants Y102F, Y103F and 
Y105F were constructed by Dr. Zongbao Zhao (8). 
Preparation of HppE with Various Extents of Modification.  To verify the 
role of iron in self-modification of HppE, the enzyme was expressed in iron-
depletion (ID) medium (9) that contained 45.4 mM phosphate buffer, pH 7.3, 7.57 
mM (NH4)2SO4, 0.4% glucose, 610 µM L-leucine, 406 µM MgSO4, 50 µM 
EDTA, 5 µM CaCl2, 0.6 M ZnCl2, 60 µM CuSO4, 0.6 µM MnCl2, 0.75 µM CoC12, 
5.9 µM thiamin dichloride, and 50 µg/mL kanamycin.  The phosphate buffer, 
(NH4)2SO4, glucose, and leucine solutions were all filtered through Corning 
sterile syringe filters with 0.22 µm membrane (Corning, NY) prior to media 
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preparation.  The expression and purification of HppE from iron-depletion 
medium (ID-HppE) were carried out by the same procedures as previously 
reported for HppE from LB medium (LB-HppE) (7).  Since the growth of cells 
in the ID medium is slower than that in the LB medium, extended growth time 
was required.   
To examine the effects of iron content in the growth media on the extent 
of posttranslational modification, HppE was also expressed in ID media 
supplemented with 0.1, 0.01, 0.001 and 0.0001 mM of FeII(NH4)2(SO4)2, which 
were named as low iron media 1 to 4 (LI1 – LI4), respectively.  The produced 
enzymes (LI1-HppE - LI4-HppE) were purified according to the procedure 
established for LB-HppE (7).  The extent of self-hydroxylation was analyzed by 
NBT quinone staining and electronic absorption spectroscopy.   
NBT Staining and NBT/glycinate Solution Test.  The wild type HppE 
produced in different media and its mutants were subjected to 15% SDS-PAGE 
and transblotted onto a nitro-cellulose membrane at 100 V for 1 h using a transfer 
buffer (25 mM Tris base, 192 mM glycine, 20% methanol).  Detection of the 
presence of quinoid structure was performed according to a procedure of Paz et 
al. (10) by immersing the membrane in a solution of 0.24 mM nitroblue 
tetrazolium and 2 M potassium glycinate, pH 10, for 45 min.  After the 
membrane was rinsed with H2O, the stained bands were recorded.   
NBT/glycinate solution test is based on the same principle as NBT 
staining but designed for quantitative purpose.  In this test, samples were directly 
mixed with the solution of 0.24 mM nitroblue tetrazolium and 2 M potassium 
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glycinate, pH 10.  After 1 h incubation, the quinone contents in these samples 
were determined on the basis of the intensity of purple color developed, measured 
at 560 nm by a UV-vis spectrometer.   
Preparation of HppE Samples for Raman Spectral Studies.  The apo-
enzyme used for resonance Raman studies was prepared by adjusting the apo-
HppE solution in 50 mM Tris·HCl buffer (pH 7.5) to a final concentration of 15-
20 mg/mL.  The apo-protein sample was made anaerobic by repeated cycles of 
vacuum and purging with argon, and then transferred to the spinning cell (~150 
µL) used for Raman study.  The FeII-HppE sample was prepared by 
reconstituting the apo-enzyme with 1 equivalent (relative to HppE subunit) of 
FeII(NH4)2(SO4)2 in H2O.  This colorless protein solution was exposed to 
dioxygen for at least 30 min, during which time a green color developed.  The 
protein sample was then concentrated prior to filling the spinning cell.  The 
H218O samples were prepared by the same procedure except the apo-HppE was 
lyophilized and reconstituted with FeII(NH4)2(SO4)2 in H218O (95% 18O).  
Spectroscopic Studies.  Electronic absorption spectra were obtained on a 
HP 8453 diode array spectrometer.  EPR first derivative spectra were recorded at 
X-band microwave frequency with 100-kHz field modulation on a Bruker Elexsys 
E500 spectrometer following the same protocol reported in Chapter 2.  
Resonance Raman spectra were collected on an Acton AM-506 spectrometer 
(1200 groove grating) using a Kaiser Optical holographic super-notch filter with a 
Princeton Instruments liquid N2 cooled (LN-1100PB) CCD detector with a 4 cm-1 
spectral resolution.  The laser excitation lines were obtained with a Spectra 
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Physics 2030-15 argon ion laser and a 375B CW dye (Rhodamine 6G), or a 
Spectra Physics BeamLok 2060-KR-V krypton ion laser.  The Raman 
frequencies were referenced to indene, and the entire spectral range of 400-1700 
nm was obtained by collecting spectra at 2-3 different frequency windows and 
splicing the spectra together.  All data were referenced to the non-resonance 
enhanced 1005 cm-1 band assigned to a phenylalanine ring mode prior to splicing 
to avoid artifacts (11).  Raman spectra of HppE were obtained at room 
temperature by 90º scattering from a spinning cell.  Curve fits (Gaussian 
functions) and baseline corrections (polynomial fits) were carried out using 
Grams/32 Spectral Notebase Version 4.04.  Excitation profiles were constructed 
by comparing peak area to the non-resonance enhanced vibration at 1005 cm-1.  
Epoxidase Activity Assay.  A new assay was developed which contains 
70 µM enzyme, 70 µM FeII(NH4)2(SO4)2, 15 mM (S)-HPP, 60 µM FMN, 22.5 mM 
NADH in 20 mM Tris⋅HCl buffer, pH 7.5 (totally 200 µL).  The reaction was 
carried out at room temperature with vigorous shaking and then quenched by the 
addition of 40 µL of EDTA (0.5 M).  The reaction mixture was kept on ice for 
immediate NMR analysis or frozen at – 80 °C and thawed shortly before analysis.  
The enzyme activity was calculated based on the integration of the 31P NMR 
peaks assigned to product (δ 10.9) and substrate (δ 19.9).  A sample of the wild-
type HppE was run in parallel as the standard in comparing enzyme activity of 
different mutants.   
In vitro Self-hydroxylation.  As-purified apo-proteins were diluted with 
ddH2O to 1 mg/mL and were aerobically incubated with an equivalent of 
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FeII(NH4)2(SO4)2 and ten equivalents of ascorbate at 4 °C for 1 h.  The mixtures 
were concentrated by Amicon concentrator with a membrane pore size of 10 kDa 
(Millipore, Bedford, MA).  The final protein concentrations were between 10-20 
mg/mL.  The extent of self-hydroxylation was analyzed by NBT quinone 
staining and UV-vis absorption spectroscopy as previously described.   
Preparation of HppE Samples for Mass Spectral Analysis.  The samples 
to be submitted for mass spectral analysis were prepared in forms of both gel slice 
and powder.  To prepare samples in gel, the as-purified LB-HppE and ID-HppE 
were subjected to SDS-PAGE.  The desired protein bands were cut from the gel 
and incubated in dd H2O.  To prepare samples in powder, the as-purified 
proteins were lyophilized and the resulting white powder was collected in 
eppendorf tubes.  To reduce the potential interference from protein dimerization 
via disulfide bond formation, the purified C107A mutant was also prepared and 
sent for analysis.  All samples were shipped to our collaborator Dr. Yu-Ju Chen 
at the Institute of Chemistry of Academia Sinica (Taiwan, ROC).  There, the 
protein samples were digested by trypsin prior to injection.   
3.3 RESULTS  
Optical Properties of HppE.  Both apo-HppE and anaerobically 
reconstituted FeII-HppE are nearly transparent above 300 nm (data not shown).  
However, upon exposure to molecular oxygen, a green chromophore is formed 
with visible absorption maxima at 680 and 430 nm within 1 h (Figure 3-1).  
Similar chromophores have been observed in tyrosine hydroxylase complexed 
with various catecholamines (λmax at 420 and 700 nm, ε720 = 1900 M-1cm-1/Fe) 
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(12), in ribonucleotide reductase R2 DOPA208 mutant (λmax at 460 and 720 nm, 
ε720 = 2500 M-1cm-1 per R2 subunit) (13), and in the iron-substituted zinc-
dependent recombinant phosphomannose isomerase (PMI) (λmax at 420 and 680 
nm ; ε680 = 2100 M-1cm-1 /Fe) (14).  These features are all characteristic of a 
ferric center with a chelated catecholate and arise from the catecholate-to-FeIII 
charge transfer transitions (15, 16).  However, the Fe-HppE chromophore has a 
significantly lower extinction coefficient (ε680 = 450 M-1cm-1) than those observed 
for proteins listed above and model complexes (ε = 1500-2500 M-1cm-1) (17), 
suggesting only partial formation of the chromophore in HppE.  Another 
example is taurine/α-KG dioxygenase (TauD) which, along with its cofactor α-
KG, reacts slowly with oxygen in the absence of its substrate taurine.  This 
reaction results in the hydroxylation of a nearby tyrosine residue to give rise to a 
green-brown FeIII-catecholate chromophore with λmax at 550 nm and a low 
extinction coefficient (ε = 460 M-1cm-1) (18).   
Figure 3-1. Electronic absorption spectrum of reconstituted HppE. Protein 
concentration is 1.4 mM.   
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Figure 3-2 Ponceaus (left) and NBT (right) staining of the wild type HppE and 
its mutants: lane M, marker bands; lane F1, HppE-Y102F; lane F2, 
HppE-Y103F; lane F3, HppE-Y105F; lane WT, wild type HppE.  
The extra band in lane F3 is likely the dimer of HppE-Y105F.   
Detection of the Catecholate Residue in HppE by Quinone Staining.  
Evidence for such a catecholate moiety in HppE was obtained by subjecting the 
isolated HppE to Paz's quinone-staining reagents including glycine and nitroblue 
tetrazolium (NBT) (10).  It has been shown that under basic conditions, quinone 
cofactors, such as pyrroloquinoline quinone (PQQ), can oxidize glycine.  The 
reduced quinone can then react with dioxygen to generate superoxide, which in 
turn oxidizes NBT to formazan to give a blue-purple color.  Besides PQQ, other 
quinonoid compounds, such as 1,2,4-trihydroxybenzene, menadione, and DOPA, 
are also sensitive to this NBT/glycinate staining method.  As shown in Figure 3-
2, HppE is clearly sensitive to the quinone staining treatment.  The fact that 
HppE without reconstitution is strongly stained by NBT/glycinate (see Figure 3-2, 
lane WT) not only provides evidence for the presence of a catecholate moiety, but 
also serves as an initial hint for its formation as an in vivo post-translational event. 
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Figure 3-3 Resonance Raman spectra of HppE and its mutants. (A) Wild type 
HppE + FeII + O2, (B) HppE-Y102F + FeII + O2, (C) HppE-Y103F + 
FeII + O2, (D) HppE-Y105F + FeII + O2, and (E) apo HppE, obtained 
using 632.8 nm laser excitation with 90º scattering geometry from a 
spinning cell at room temperature.  The spectra are not shown at the 
same vertical scale (note changes in the intensity of the 1005 cm-1 
band associated with the Phe residues in the enzyme that serves as an 
internal calibrant of protein concentration). 
Resonance Raman Studies of HppE.  To ascertain whether the HppE 
chromophore consists of a catecholate ligand, the reconstituted HppE was 
subjected to resonance Raman analysis by laser excitation into the green 
chromophore.  The spectrum of the reconstituted protein displays a number of 
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resonance-enhanced features at 533, 588, 635, 1267, 1318, 1425, and 1476 cm-1 
(Figure 3-3).  This spectrum could be observed with laser wavelengths at 514.5 
nm and above, but a high fluorescence background obscured the spectrum when 
excitation was performed at wavelengths below 514.5 nm.  Excitation profiles 
for selected bands are shown in the inset of Figure 3-4.   
By comparison with the thoroughly investigated resonance Raman 
features of FeIII-phenolate and FeIII-catecholate chromophores in both model 
complexes and enzymatic systems (15-17), those observed for HppE are 
characteristic of an FeIII-catecholate complex but distinct from those of an FeIII-
phenolate complex (Table 3-1).  The latter displays a different pattern of 
vibrations from those observed for the oxidized HppE, in particular, the presence 
of only a single νFe-O mode in the 560-640 cm-1 range, as well as a δC-H mode at 
~1160 cm-1 (15-17, 19).  Most of the bands in the region of 1200-1500 cm-1 
observed for HppE are assignable to aromatic ring deformation modes with 
predominant νC-C stretching character, and closely match those observed for the 
ferric-catecholate complexes of phenylalanine hydroxylase (17), tyrosine 
hydroxylase (19) and ribonucleotide reductase R2 DOPA208 mutant (20) (see 
Table 3-1). The enhanced vibrational modes between 500−700 cm-1, which are 
associated with the metal-ligand vibrations (νFe-O), are the most significant signals 
for the identification of the iron-catecholate chromophore (21).  The peaks at 
635 and 588 cm-1 can be assigned to the Fe−O stretches at C-4 and C-3 of the 
DOPA catecholate ring, respectively, and the feature at 533 cm-1 arises from the 
chelate mode of a bidentate iron-catecholate species (17, 19, 20).  Thus, the 
 90
resonance Raman spectrum of HppE is fully consistent with the presence of an 
iron-catecholate chromophore. 
Figure 3-4 Electronic absorption spectra of apo and reconstituted HppE.  
Protein concentrations are 0.15 mM.  (A) apo-HppE; (B) HppE + 
FeII + O2; (C) HppE-Y102F + FeII + O2; (D) HppE-Y103F + FeII + 
O2; (E) HppE-Y105F + FeII + O2. Inset: resonance Raman excitation 
profiles for the Fe-reconstituted WT HppE. The spectra were 
obtained on a 1 mM sample in a spinning cell at room temperature 
(90° scattering geometry). Only profiles for the bands at 592 (● ), 
635 (❍ ), 1319 (▼), and 1475 ( ) cm-1 are shown for clarity. The 
1005 cm-1 phenylalanine vibration was used as the internal standard 
and the areas of the peaks were determined by curve fitting. 
Determination of the Site of Modification by Site-Directed Mutagenesis.  
The catecholate moiety in HppE presumably arises from the hydroxylation of a 
tyrosine residue.  Interestingly, sequence alignment of HppE from Streptomyces 
wedmorensis and Pseudomonas syringae reveals only three conserved tyrosine 
residues, Y102, Y103, and Y105 (Figure 3-5).   
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Sample Raman frequencies (cm-1)  Reference
HppE + FeII + 16O2    533 588 635  1267 1318 1425 1476 (8) 
HppE + FeII + 18O2    
       
       
       
          
          
     
532 587 635  1267 1319 1425 1477 (8) 
HppE + FeII + 16O2 + H218O 534 588 636 1266 1317 1425 1476 (8) 
HppE + FeII + Asc + 16O2 531 591 636 1264 1315 1425 1478 (8) 
HppE + FeII + Asc + 18O2 525 570 633 1261 1315 1424 1478 (8) 
RNR R2 DOPA-208 512 592 619 1143 1263 1319 1350 1475 1569 (20) 
RNR R2 [3-18O, 4-16O]DOPA-208 499 584 617 1143 1263 1319 1350 1475 1569 (20) 
Phe Hydroxylase + catecholate 531  621 1151 1257 1313  1470 1568 (17) 
Tyr Hydroxylase DOPA 528 592 631  1275 1320 1425 1475  (19) 
Tyr Hydroxylase [3-18O, 4-16O]DOPA 522 580 629 1271 1320 1425 1475 (19) 
Tyr Hydroxylase [3-18O, 4-18O]DOPA 509 578 619 1266(broad) 1320    
          
     
1423 1473 (19) 
Phosphomannose Isomerase DOPA-287  591 631  1266 1330 1428 1482  (14) 
TauD DOPA-73 545  612 1141 1261 1318/1346 1424 1482  (18) 
[FeIII(salen)( catecholate)]- 511 614 1260 1324 1473 (16) 
[FeIII(catecholate)3]3- 533  622 1267 1327  1487 (21) 
Table 3-1 Resonance Raman vibrations of ferric-catecholate complexes in proteins and models.   
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S. wendomorensis MSNTKTASTG FAELLKDRRE QVKMDHAALA SLLGETPETV AAWENGEGGE   50
P. syringae  M–DVRTLAVG KAH-LEALLA TRKM---TLE HLQDVRHDAT QVYFDGLEHL   45
Consensus  M....T...G .A..L..... ..KM....L. .L........ .....G....   50
 
S. wendomorensis LTLTQLGRIA HVLGTSIGAL TPPAGNDLDD GVIIQMPDER PILKGVRDNV  100
P. syringae  QNVAQY--LA IPLSEFFVGQ TQ---SDLDD GVKIARRNGG FKREEIRGGV   90
Consensus  ....Q....A ..L....... T.....DLDD GV.I...... ......R..V  100
 
S. wendomorensis DYYVYNCLVR TKRAPSLVPL VVDVLTDNPD DAKFNSGHAG NEFLFVLEGE  150
P. syringae  HYYTYEHLVT TNQDPGLMAL RLDLHSDDEQ PLRLNGGHGS REIVYVTRGA  140
Consensus  .YY.Y..LV. T...P.L..L ..D...D... ....N.GH.. .E...V..G.  150
 
S. wendomorensis IHMKW-GDKE NPKEALLPTG ASMFVEEHVP HAFTAAKGTG SAKLIAVNF-  198
P. syringae  VRVRWVGDND ELKEDVLNEG DSIFILPNVP HSFTNHVGGA KSEIIAINYG  190
Consensus  ....W.GD.. ..KE..L..G .S.F....VP H.FT...G.. ....IA.N..  200Figure 3-5 Sequence alignment of HppE isolated from Streptomyces 
wedmorensis and Pseudomonas syringae.  The three conserved 
tyrosines are boxed. 
Site-directed mutagenesis of each tyrosine to phenylalanine has thus been 
carried out to determine which of the three conserved tyrosine residues is 
involved in the formation of the chromophore.  The reconstituted Y102F mutant 
enzyme is green in color and has a visible as well as a resonance Raman spectrum 
comparable to those of the wild type enzyme (Figures 3-4C and 3-3B), so Y102 
can be ruled out as the site of modification.  On the other hand, the reconstituted 
Y103F and Y105F mutant enzymes show little evidence for the green 
chromophore in their visible spectra (Figures 3-4D, E), and their Raman spectra 
are comparable to that observed for apo-HppE (Figures 3-3C, D, and E).  Thus, 
either Y103 or Y105 can be the precursor of DOPA in HppE.  This conclusion is 
corroborated by parallel quinone staining experiments.  As shown in Figure 3-2, 
both the wild type (lane WT) and Y102F (lane F1) HppE are stained, but not 
Y103F (lane F2) and Y105F (lane F3) mutant enzymes.  Interestingly, while the 
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Y102F and Y103F enzymes maintain about 100% of the activity of the wild type 
enzyme, the relative activity of Y105F enzyme is considerably reduced to less 
than 30%.  Clearly, Tyr105 is a key residue, which must play an important role 
in the activation of dioxygen required for the enzymatic activity of HppE.   
Post-translational DOPA Formation in vivo and/or in vitro.  To gain 
more information about this post-translational modification event, more Raman 
experiments were performed using HppE samples reconstituted with isotopic 
tracers, for instance under 18O2 atmosphere in H216O, and under 16O2 atmosphere 
in H218O.  Neither notable broadening nor significant isotopic shifting of the 
peaks was observed in any of the tested samples (see Table 3-1 and Figures 3-6A-
C).  The absence of isotope incorporation in these samples confirms that 
formation of DOPA in HppE is not an artifact of in vitro reconstitution but an in 
vivo post-translational event.  
However, when reconstitution was carried out under 18O2 atmosphere in 
the presence of ascorbate (10 equivalents), the green chromophore increased in 
intensity and isotope shifts for several Raman peaks were observed (Figures 3-6D 
and E).  The change at 591 cm-1 is most apparent, with the appearance of the 
new peak at 570 cm-1 (Table 3-1).  This peak can be attributed to the 18O 
downshift of the 591 cm-1 peak, which corresponds to the FeIII-OAr stretch at C-3 
of the DOPA ring, owing to 18O incorporation.  The feature at 531 cm-1 assigned 
to the iron-catecholate chelate mode also downshifts by 6 cm-1 and broadens 
significantly to a width twice as large as that observed in the 16O2 sample.  
Downfield shifts of 3 cm-1 are also observed for the Fe-O4 mode at 636 cm-1 and 
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the ring deformation mode at 1264 cm-1.  These isotopic shifts are reminiscent of 
those observed in the spectrum of tyrosine hydroxylase when complexed with 
dopamine specifically labeled at the 3-position of the aromatic ring (Table 3-1) 
(19). 
Figure 3-6 Resonance Raman spectra of the reconstituted HppE reconstituted in 
the presence of oxygen isotopes. (A) HppE + FeII + 16O2, (B) HppE 
+ FeII + 18O2, (C) HppE + FeII + 16O2 + H218O, (D) HppE + FeII + 
16O2 and 10 equivalents of ascorbate, and (E) HppE + FeII + 18O2 and 
10 equivalents of ascorbate. The vertical scale in the lower region 
has been magnified to two times that of the upper region for clarity.  
A greater number of accumulations were acquired for the H218O 
sample.   
 95
These results clearly indicate that HppE is capable of catalyzing tyrosine 
self-hydroxylation when provided with sufficient electrons for oxygen activation.  
However, due to the tight binding between ascorbate and the iron center to form 
an aborted complex, HppE reconstituted under such conditions is catalytically 
inactive.   
Reconstitution of Mutant Proteins in the Presence of Ascorbate.  Taking 
advantage of the newly discovered oxygenase activity of HppE, the Y103F, 
Y105F, and Y103F/Y105F mutant proteins were also subjected to aerobically 
reconstitution with FeII(NH4)2(SO4)2 in the presence of ascorbate (10 equivalents) 
to further differentiate between Tyr103 and Try105 as the site of modification.  
After one-hour incubation, the Y103F mutant protein became green in color and 
its electronic absorption spectrum clearly revealed the formation of the green 
chromophore with the maximum wavelength at 680 nm (ε680 = 360 M-1cm-1, 
Figure 3-7A).  In contrast, much less green chromophore was produced from the 
Y105F mutant under the same conditions (ε680 = 200 M-1cm-1, Figure 3-7B).  
The spectrum of the wild-type HppE at the same concentration is also included 
(ε680 = 450 M-1cm-1, Figure 3-7D) for comparison.  These observations strongly 
indicate that Tyr105 is the preferred site of modification.  However, the fact that 
the absorption at longer wavelength remains visible for the reconstituted Y105F 
mutant suggests that hydroxylation at the near-by Tyr103 can occur when Tyr105 
is mutated to a less reactive phenylalanine.  This hypothesis is supported by the 
finding that the Y103F/Y105F double mutant showed no sign of modification 
under the same reconstitution conditions (Figure 3-7C).   
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Figure 3-7 Electronic absorption spectra of WT and mutants HppE aerobically 
reconstituted with FeII and ascorbate.  (A) HppE-Y103F, (B) HppE-
Y105F, (C) HppE-Y103F/Y105F, and (D) WT HppE, 0.6 mM each, 
were reconstituted with an equivalent of FeII(NH4)2(SO4)2 and ten 
equivalents of ascorbate in 20 mM Tris•HCl buffer, pH 7.5.   
The Relationship Between Epoxidase Activity and Self-Hydroxylation.  
The earlier studies have shown that the self-modification of HppE is an in vivo 
posttranslational event and that it can be imitated in vitro under proper conditions.  
The critical role of iron in the in vitro self-modification inspired the attempt to 
express an unmodified form of HppE in iron-depletion growth medium (ID-
HppE).  The purified ID-HppE was thoroughly analyzed and confirmed to be 
free of self-modification.  The aerobically reconstituted ID-HppE was yellow in 
color and its electronic absorption spectrum exhibited no optical features 
associated with the green chromophore (Figure 3-8).  In consistence, none of the 
fingerprint bands of the FeIII-catecholate LMCT complex (533, 588 and 635 cm-1) 
was visible in the resonance Raman spectrum of the reconstituted ID-HppE 
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(Figure 3-9A).  All of these data, together with the negative result from the NBT 
staining analysis of ID-HppE (Figure 3-10, Lane 1), strongly indicate that HppE 
generated under the above conditions is unmodified and support an essential role 
played by iron in the self-modification process.   
Figure 3-8 The electronic absorption spectrum of the reconstituted ID-HppE.  
Protein concentration is 1.4 mM. 
The next important question is whether this DOPA residue has a catalytic 
role in enzymatic epoxidation.  The availability of ID-HppE provided a great 
opportunity to address this question.  When ID-HppE was incubated with 
FMN/NADH, (S)-HPP and FeII(NH4)2(SO4)2, fosfomycin was generated at a rate 
comparable to that catalyzed by LB-HppE, showing no significant difference in 
catalytic activity between modified and unmodified HppE.  The fact that no 
obvious sign of modification was detected in ID-HppE throughout the reaction 
(Figure 3-10, Lane 2) is another strong line of evidence against the catalytic 
relevance of the DOPA residue.  It should be noted that under the nearly 
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identical conditions except for the absence of (S)-HPP, ID-HppE was extensively 
modified as indicated by the strong purple band in the NBT stained membrane 
(Figure 3-10, Lane 3).  The distinct outcomes under similar incubation 
conditions clearly demonstrated that epoxidation and self-hydroxylation are two 
competing reactions and substrate binding is the key factor in determining the 
reaction course.  It appears that the epoxidation reaction is preferred over self-
hydroxylation when (S)-HPP is bound in the enzyme active site.  Accordingly, 
Tyr105 residue has access to the active site iron center only in the absence of 
substrate.   
Figure 3-9 Resonance Raman spectra of reconstituted ID-HppE. (A) ID-HppE + 
FeII + O2, (B) apo ID-HppE.  (Note: the phenylalanine band at 1005 




# ID-HppE FMN/NADH (S)-HPP Fe2+ Activity Assay 
1 + - - - - 
2 + + + + + 
3 + + - + - 
4 + + + - - 
Figure 3-10 The relationship between epoxidase activity and self-hydroxylation.  
Above: Ponceau S and NBT stained membranes (M, protein 
marker); Below: The components of sample 1 - 4.  (Note: the 
higher molecular weight bands are due to oxidative cross-linking 
between individual HppE monomers by air.)  
Apparently, studies of ID-HppE failed to establish a direct correlation 
between the epoxidase activity of HppE and its active site DOPA residue.  To 
further analyze the effects of self-modification on the epoxidase activity of HppE, 
the wild type enzyme was expressed in a series of low iron (LI) media as 
described in the experimental procedure.  The enzymes purified from these 
media, named as LI1-HppE to LI4-HppE, were analyzed by electronic absorption 
spectroscopy and the quantitative NBT/glycinate solution assay.  The results, as 
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expected, showed that the extent of self-modification is proportional to the iron 
concentration in the expression media.  As illustrated in Figure 3-11 and Table 
3-2, with the iron concentration increased from 0.0001 mM in the LI4 medium to 
0.1 mM in the LI1 medium, the experimental data of A280 and NBT assay in Table 
3-2 that are indicative of the quantity of the enzyme-based DOPA also escalated.  
However, the trend of proportionality was less apparent in the epoxidase activity 
of enzymes.  Instead, their activities are all in a narrow range, with small 
fluctuations mainly due to experimental errors (Table 3-2), suggesting that the 
enzyme-based DOPA has little effects on the catalytic activity of HppE. 
Figure 3-11 The electronic absorption spectra of reconstituted LI-HppEs.  
Protein concentrations are 1.0 mM.   
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 LI4-HppE LI3-HppE LI12-HppE LI1-HppE 
[Fe] in Medium (mM) 0.0001 0.001 0.01 0.1 
A680 (%) 11 29 65 100 
NBT assay (%) 3 15 42 100 
Activity (%) 100 116 124 100 
Table 3-2. The properties of HppE produced in low iron media (LI-HppEs). 
(Note: for better comparison, the experimental results are converted 
to percentages relative to the values of LI1-HppE.)   
EPR Spectral Analysis of ID-HppE.  ID-HppE was reconstituted with 
FeII(NH4)2(SO4)2 and (S)-HPP under anaerobic conditions.  The enzyme-
substrate complex was then added NO gas under the protection of argon.  The 
EPR spectrum of the FeII-ID-HppE·(S)-HPP nitrosyl complex is shown in Figure 
3-12, which is nearly identical to the previously reported EPR spectrum of FeII-
LB-HppE·(S)-HPP nitrosyl complex (7).  According to the spectral simulations 
in Chapter 2, they both comprise two S = 3/2 signals, corresponding to two 
different types of FeII-nitrosyl centers.  The only difference between these two 
spectra is the ratio of the intensities of two signals.  As previously postulated 
(Chapter 2), the signal accounting for the majority of the iron in ID-HppE (g = 
4.42, 3.63, E/D = 0.066) is arisen from a catalytically competent enzyme-
substrate complex, while the minor signal (g = 4.0) may arise from a denatured 
inactive form of HppE.  Thus, the EPR results also confirmed the catalytic 
competence of the unmodified ID-HppE.   
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Figure 3-12 EPR spectrum of FeII-ID-HppE·(S)-HPP nitrosyl ternary complex.  
Substrate is 10-fold excess over active sites.  Instrumental 
parameters: temperature 2 K, microwave frequency 9.6 GHz, 
microwave power 0.6 mW, modulation amplitude 5 G, time constant 
0.02 s, and a sweep rate of 50 G/s.   
Determination of the Site of Modification by Mass Spectral Analysis.  
The initial efforts to analyze posttranslational modification by mass spectroscopy 
had been hampered by low yield of modification.  Only recently, results from a 
joint effort with Dr. Chen at Academia Sinica by mass spectral analysis have 
confirmed Tyr105 as the primary modification site (Data not shown).   
3.4 DISCUSSION 
An increasing number of proteins that are post-translationally modified to 
contain a DOPA residue have been discovered in recent years.  Many DOPA-
containing proteins are found in liver flukes or in adhesive plaques of mussels 
where their DOPA residues play important roles in metal chelation facilitating the 
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iron uptake (22, 23).  There are also examples where DOPA formation occurs in 
enzymes.  Such a post-translational modification is well documented for the 
F208Y mutant of the ribonucleotide reductase (RNR) R2 protein from E. coli, 
where the newly introduced tyrosine residue (Tyr208) near the diiron active site is 
hydroxylated both in vitro and in vivo to DOPA (9).  The crystal structure of this 
mutant protein indeed showed a diiron core with a bidentate catecholate ligand 
(DOPA208) to one of the ferric ions that gives rise to its unusual blue color.  A 
tyrosine residue (Tyr287) in the active site of the zinc-dependent recombinant 
phosphomannose isomerase (PMI) can also be hydroxylated to DOPA in the 
overexpressed cells to generate a green chromophore when the zinc center is 
replaced by iron (14).  Similarly, Tyr73 is converted to DOPA in the α-KG-
dependent non-heme iron enzyme TauD to generate a green chromophore when 
the enzyme reacts with O2 in the presence of α-KG co-substrate, but in the 
absence of its substrate taurine (18).  By a combination of site-directed 
mutagenesis and resonance Raman spectral analysis in this study, we have 
established HppE as a new member of this select group of proteins with 
hydroxylated tyrosine residues.  The site of modification in HppE is most likely 
at Tyr105.    
Several of the DOPA forming enzymes mentioned above as well as 
tyrosine hydroxylase belong to a family of mononuclear non-heme iron enzymes 
with the recurring 2-His-1-carboxylate facial triad in their active sites (24, 25).  
Sequence comparisons suggest that HppE likely utilizes the combination of H138, 
H180, and E142 as ligands to the iron center, thus making it another plausible 
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addition to this family of oxygen activating enzymes.  But the reaction it 
catalyzes is unusual, entailing an oxidative dehydrogenation of HPP to form 
fosfomycin such that the alcohol oxygen of the substrate becomes the epoxide 
ring oxygen in the product.  The lack of any oxygen incorporation from O2 into 
the epoxide product is somewhat unexpected, as metalloenzyme-catalyzed 
epoxidation typically results in the incorporation of an oxygen atom from O2.  
However, our observation that HppE can carry out the hydroxylation of a tyrosine 
residue to DOPA in the presence of ascorbate with incorporation of an oxygen 
atom from O2 suggests that it may share a common mechanism for oxygen 
activation with other mononuclear non-heme iron enzymes (24).  
The mechanism of substrate hydroxylation catalyzed by non-heme iron 
enzymes typically involves a high valent iron-oxo species produced at the 
expense of two exogenous electrons in each catalytic cycle.  For tyrosine 
hydroxylase, the two electrons are provided by the tetrahydropterin cofactor, and 
for α-KG-dependent enzymes like TauD, the two electrons are derived from the 
α-KG co-substrate (24).  While the resultant FeIV-oxo species is considered the 
reactive intermediate responsible for tyrosine oxidation in both cases, the actual 
mechanism of oxygen incorporation into DOPA may not be the same.  For 
tyrosine hydroxylase where tyrosine is an external substrate, a cationic 
cyclohexadiene intermediate, perhaps from an arene oxide, is proposed to be the 
product of the initial oxygen addition (Figure 1-16) (5).  Evidence supporting 
this concerted oxygen-transfer mechanism includes the occurrence of a NIH shift 
in the subsequent rearrangement to yield DOPA, and the exclusive incorporation 
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of an oxygen atom from dioxygen into the DOPA structure (5).  In contrast, for 
self-hydroxylation of TauD where the substrate (Tyr73) is an internal active site 
residue, the reaction proceeds via a tyrosyl radical intermediate, whose formation 
is associated with the reduction of the FeIV-oxo to an FeIII-hydroxo species, with 
exclusive incorporation of an oxygen atom from water into the DOPA that is 
formed (18).  An oxygen atom from water was also incorporated into a 
hydroxylated Trp residue in another α-KG-dependent mononuclear non-heme iron 
containing dioxygenase, TfdA (26), and into a DOPA residue of RNR R2 F208Y 















Figure 3-13 Schematic illustration of the self-hydroxylation mechanism of HppE.   
The self-hydroxylation of HppE may follow a similar path as the above 
enzymes.  An FeIV-oxo intermediate may be formed with the influx of two 
reducing equivalents from ascorbate in place of tetrahydropterin or α-
ketoglutarate into the FeII-O2 adduct (Figure 3-13).  Tyrosine hydroxylation may 
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then occur as a 2e–-oxidation as proposed for tyrosine hydroxylase (5) or in two 
1e–-steps as demonstrated for TauD self-hydroxylation (18).   
However, tyrosine hydroxylase, TauD, and TfdA utilize either 
tetrahydropterin or α-KG bound at the active site as the two-electron source, while 
HppE instead uses an external reductant, either ascorbate for the in vitro 
formation of DOPA or NADH for the catalyzed epoxide formation.  This 
requirement for an external reductant resembles that for another class of non-
heme iron enzymes with a 2-His-1-carboxylate motif, the Rieske dioxygenases 
that catalyze cis-dihydroxylation of arenes, where the two electrons from NADH 
are introduced in 1e–-aliquots during the catalytic cycle (1, 24).  There is recent 
strong evidence in the Rieske dioxygenase mechanism for an FeIII-OOH 
intermediate that derives from the one-electron reduction of an initial FeII-O2 
adduct (Figure 1-20) (27, 28).  This peroxo intermediate is proposed to either 
attack the substrate directly or may evolve first to an FeIV-oxo species that then 
carries out the oxidation.  HppE self-hydroxylation may also be envisioned to 
occur by such a pathway (Figure 3-14).   
The third mechanism is a derivative of the mechanism proposed for 
epoxidation reaction catalyzed by HppE (Figure 2-13 and 2-14).  Instead of the 
FeIII-peroxo or FeIV-oxo intermediates, the mechanism uses the FeIII-superoxide 
species to initiate oxidation of the Tyr residue.  As the supporting evidence will 
be presented in Chapter 4, the proposed mechanism will also discussed later in the 















Figure 3-14 Schematic illustration of the self-hydroxylation mechanism of HppE.   
The discovery of the modified DOPA structure in HppE raised an issue 
regarding its role in enzyme catalysis.  Our studies using an unmodified form of 
HppE (ID-HppE) showed that there is no correlation between DOPA residue and 
the catalytic activity of HppE.  The conclusion was further supported by the EPR 
spectral analysis of ID-HppE.  The previously reported homogeneous EPR 
spectrum that is presumably indicative of a catalytically competent complex was 
also observed for ID-HppE complexed with FeII, (S)-HPP and nitric oxide.  Thus 
far, no obvious effects of self-modification have been detected on the epoxidase 
activity of HppE.  In fact, self-hydroxylation and epoxidation were found to be 
competitive.  Binding of substrate appears to be the switch controlling two 
different reaction pathways.  The presence of substrate turns on the epoxidation 
reaction while its absence leads to the self-hydroxylation reaction.   
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In summary, the combined spectroscopy and mutagenesis results have 
identified a ferric-catecholate complex as the chromophore for the green color of 
HppE.  More importantly, strong evidence indicates that DOPA formation in 
HppE is a self-hydroxylation reaction.  It is thus clear that HppE can act as an 
oxygenase and an activated dioxygen species is responsible for the self-
hydroxylation.  The discovery of this new activity of HppE has significant 
mechanistic implications since by extension, the same reactive intermediates may 
be involved in the catalytic mechanism for fosfomycin formation.  The catalytic 
cycles illustrated in Figures 3-13 and 3-14 can easily be adapted to HppE-
catalyzed epoxidation reaction, which may require the same oxidant (either the 
FeIV=O species in Figure 3-13 or the FeIII-OOH species in Figure 3-14) to carry 
out the 2e--oxidation of substrate in one-electron steps, parallel to the alkane 
hydroxylation mechanisms proposed for cytochrome P450 (29) and nonheme iron 
oxygenases (24).  More studies are currently in progress to uncover details of the 
DOPA formation mechanism relevant to that of HppE-catalyzed epoxidation.  
Insight gained from study of this unique non-heme iron-dependent enzyme will 
certainly enhance our understanding of this important and growing enzyme 
family.   
3.5 REFERENCES 
1. Gibson, D. T., and Parales, R. E. (2000) "Aromatic hydrocarbon 
dioxygenases in environmental biotechnology" Curr. Opin. Biotechnol. 
11, 236-243. 
2. Prescott, A. G., and Lloyd, M. D. (2000) "The iron(II) and 2-oxoacid-
dependent dioxygenases and their role in metabolism" Nat. Prod. Rep. 17, 
367-383. 
 109
3. Kappock, T. J., and Caradonna, J. P. (1996) "Pterin-Dependent Amino 
Acid Hydroxylases" Chem. Rev. 96, 2659-2756. 
4. Rocklin, A. M., Tierney, D. L., Kofman, V., Brunhuber, N. M. W., 
Hoffman, B. M., Christoffersen, R. E., Reich, N. O., Lipscomb, J. D., and 
Que, L., Jr. (1999) "Role of the nonheme Fe(II) center in the biosynthesis 
of the plant hormone ethylene" Proc. Natl. Acad. Sci. USA 96, 7905-7909. 
5. Fitzpatrick, P. F. (1999) "Tetrahydropterin-dependent amino acid 
hydroxylases" Annu. Rev. Biochem. 68, 355-381. 
6. Liu, P., Murakami, K., Seki, T., He, X., Yeung, S. M., Kuzuyama, T., 
Seto, H., and Liu, H. (2001) "Protein purification and function assignment 
of the epoxidase catalyzing the formation of fosfomycin" J. Am. Chem. 
Soc. 123, 4619-4620. 
7. Liu, P., Liu, A., Yan, F., Wolfe, M. D., Lipscomb, J. D., and Liu, H. W. 
(2003) "Biochemical and spectroscopic studies on (S)-2-
hydroxypropylphosphonic acid epoxidase: a novel mononuclear non-heme 
iron enzyme" Biochemistry 42, 11577-11586. 
8. Liu, P., Mehn, M. P., Yan, F., Zhao, Z., Que, L., Jr., and Liu, H.-W. 
(2004) "Oxygenase activity in the self-hydroxylation of (S)-2-
hydroxypropylphosphonic acid epoxidase involved in fosfomycin 
biosynthesis" J. Am. Chem. Soc. 126, 10306-10312. 
9. Aberg, A., Ormèo, M., Nordlund, P., and Sjèoberg, B. M. (1993) 
"Autocatalytic generation of dopa in the engineered protein R2 F208Y 
from Escherichia coli ribonucleotide reductase and crystal structure of the 
dopa-208 protein" Biochemistry 32, 9845-9850. 
10. Paz, M. A., Fluckiger, R., Boak, A., Kagan, H. M., and Gallop, P. M. 
(1991) "Specific detection of quinoproteins by redox-cycling staining" J. 
Biol. Chem. 266, 689-692. 
11. Lord, R. C., and Yu, N. T. (1970) "Laser-excited Raman spectroscopy of 
biomolecules. I. Native lysozyme and its constituent amino acids" J. Mol. 
Biol. 50, 509-524. 
12. Andersson, K. K., Cox, D. D., Que, L., Jr., Flatmark, T., and Haavik, J. 
(1988) "Resonance Raman studies on the blue-green-colored bovine 
adrenal tyrosine 3-monooxygenase (tyrosine hydroxylase). Evidence that 
the feedback inhibitors adrenaline and noradrenaline are coordinated to 
iron" J. Biol. Chem. 263, 18621-18626. 
13. Ormö, M., deMarê, F., Regnström, K., Aberg, A., Sahlin, M., Ling, J., 
Loehr, T. M., Sanders-Loehr, J., and Sjöberg, B. M. (1992) "Engineering 
 110
of the iron site in ribonucleotide reductase to a self-hydroxylating 
monooxygenase" J. Biol. Chem. 267, 8711-8714. 
14. Smith, J. J., Thomson, A. J., Proudfoot, A. E., and Wells, T. N. (1997) 
"Identification of an Fe(III)-dihydroxyphenylalanine site in recombinant 
phosphomannose isomerase from Candida albicans" Eur. J. Biochem. 
244, 325-333. 
15. Que, L., Jr. (1988) Biological Applications of Raman Spectroscopy, Vol. 
3, Wiley, New York. 
16. Pyrz, J. W., Roe, A. L., Stern, L. J., and Que, L., Jr. (1985) "Model studies 
of iron-tyrosinate proteins" J. Am. Chem. Soc. 107, 614-620. 
17. Cox, D. D., Benkovic, S. J., Bloom, L. M., Bradley, F. C., Nelson, M. J., 
Que, L., Jr., and Wallick, D. E. (1988) "Catecholate LMCT bands as 
probes for the active sites of nonheme iron oxygenases" J. Am. Chem. Soc. 
110, 2026-2032. 
18. Ryle, M. J., Liu, A., Muthukumaran, R. B., Ho, R. Y. N., Koehntop, K. D., 
McCracken, J., Que, L., Jr., and Hausinger, R. P. (2003) "O2- and α-
ketoglutarate-dependent tyrosyl radical formation in TauD, an α-keto 
acid-dependent non-heme iron dioxygenase" Biochemistry 42, 1854-1862. 
19. Michaud-Soret, I., Andersson, K. K., Que, L., Jr., and Haavik, J. (1995) 
"Resonance Raman studies of catecholate and phenolate complexes of 
recombinant human tyrosine hydroxylase" Biochemistry 34, 5504-5510. 
20. Ling, J., Sahlin, M., Sjèoberg, B. M., Loehr, T. M., and Sanders-Loehr, J. 
(1994) "Dioxygen is the source of the mu-oxo bridge in iron 
ribonucleotide reductase" J. Biol. Chem. 269, 5595-5601. 
21. Salama, S., Stong, J. D., Neilands, J. B., and Spiro, T. G. (1978) 
"Electronic and resonance Raman spectra of iron(III) complexes of 
enterobactin, catechol, and N-methyl-2,3-dihydroxybenzamide" 
Biochemistry 17, 3781-3785. 
22. Waite, J. H., Housley, T. J., and Tanzer, M. L. (1985) "Peptide repeats in a 
mussel glue protein: theme and variations" Biochemistry 24, 5010-5014. 
23. Waite, J. H., and Rice-Ficht, A. C. (1989) "A histidine-rich protein from 
the vitellaria of the liver fluke Fasciola hepatica" Biochemistry 28, 6104-
6110. 
24. Costas, M., Mehn, M. P., Jensen, M. P., and Que, L., Jr. (2004) "Dioxygen 
activation at mononuclear nonheme iron active sites: enzymes, models, 
and intermediates" Chem. Rev. 104, 939-986. 
 111
25. Hegg, E. L., and Que, L., Jr. (1997) "The 2-His-1-carboxylate facial triad--
an emerging structural motif in mononuclear non-heme iron(II) enzymes" 
Eur. J. Biochem. 250, 625-629. 
26. Liu, A., Ho, R. Y., Que, L., Jr., Ryle, M. J., Phinney, B. S., and Hausinger, 
R. P. (2001) "Alternative reactivity of an α-ketoglutarate-dependent 
iron(II) oxygenase: enzyme self-hydroxylation" J. Am. Chem. Soc. 123, 
5126-5127. 
27. Wolfe, M. D., and Lipscomb, J. D. (2003) "Hydrogen peroxide-coupled 
cis-diol formation catalyzed by naphthalene 1,2-dioxygenase" J. Biol. 
Chem. 278, 829-835. 
28. Karlsson, A., Parales, J. V., Parales, R. E., Gibson, D. T., Eklund, H., and 
Ramaswamy, S. (2003) "Crystal structure of naphthalene dioxygenase: 
side-on binding of dioxygen to iron" Science 299, 1039-1042. 
29. Groves, J. T. (1985) "Key elements of the chemistry of cytochrome P-450. 
The oxygen rebound mechanism" J. Chem. Ed. 62, 928-931. 
 
 112
Chapter 4:  Hidden Protein Radical in HppE 
4.1 INTRODUCTION 
In recent years, there has been rapidly growing appreciation for the 
catalytic importance of protein-centered radicals in metalloenzymes (1).  The 
very first catalytically essential protein-centered radical was identified on a 
tyrosine residue in ribonucleotide reductase by Dr. Peter Reichard and coworkers 
in 1977 (2).  Since then, many stable or transient protein radicals have been 
discovered, including the tyrosine radicals in photosystem II (3) and prostaglandin 
H synthase (4), the glycine radicals in pyruvate formate-lyase (5) and anaerobic 
ribonucleotide reductase (E. coli) (6), the cysteine radicals in ribonucleotide 
reductases (7), and the tryptophan radicals in cytochrome c peroxidase (8).  In 
addition, radicals have also been found on modified tyrosine residues in galactose 
oxidase (9) and amine oxidases (10), and modified tryptophan residue in 
methylamine dehydrogenase (11, 12).  The formation of an amino acid derived 
radical is a posttranslational modification event and always involves a metallo-
cofactor.  For instance, diferric cluster, adenylcobalamine and SAM-bound 
[Fe4S4] cluster are the metallo-cofactors responsible for the generation of protein-
centered radicals in Class I, II and III ribonucleotide reductases, respectively (1).   
HppE is a new type of mononuclear non-heme iron-dependent enzyme 
(13).  The as-purified HppE is an apoprotein that needs to be reconstituted with 
iron in vitro to restore its full catalytic activity.  As described in Chapter 2, the 
apo-HppE was reconstituted with FeII(NH4)2(SO4)2 under aerobic conditions, and 
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the resulting reconstituted HppE was considered in the form of FeIII-HppE.  The 
reconstituted HppE has been subjected to extensive EPR analyses leading to a 
preliminary catalytic model for the enzymatic epoxidation reaction (Figure 2-14).  
Interestingly, it was found that the total spin of the ferric center measured by EPR 
analyses (Figure 2-4) cannot count for the total iron content determined by iron 
titration (Chapter 2).  Initially, the hidden iron was attributed to the potential 
occupancy of EPR-silent FeII occupying in enzyme active site.  However, when 
the reconstituted HppE sample was exposed to excess nitric oxide, no ferrous ion, 
which should form an EPR-sensitive FeII nitrosyl complex, was detected (Chapter 
2).  To account for the discrepancy, we have hypothesized the formation of a 
spin-coupled [FeIII-R• ] complex (R•  stands for an organic radical) in the enzyme 
active site as a result of in vitro aerobic reconstitution of HppE.  Since FeIII has a 
d5 electronic configuration with a net spin of either S = 1/2 (low spin) or S = 5/2 
(high spin), and the organic radical has an unpaired electron with a net spin of S = 
1/2, the total spin number of the coupled complex is an integer.  In regular EPR 
spectra, the spin adduct and its metal and radical components are all invisible.  
The unpaired spin is presumably localized to an active site residue that is in close 
vicinity to the ferric center.  The only precedent of such type of metal-coupled 
protein radical is found in galactose oxidase, in which an unpaired electron on a 
modified tyrosine residue, which is also an active site metal ligand, is spin-
coupled to the enzyme cupric center (9).   
This Chapter describes our preliminary attempts to verify the presence of 
the putative FeIII-coupled protein-centered radical.  In collaboration with Dr. 
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Aimin Liu and Dr. John D. Lipscomb at the University of Minnesota, I have 
combined EPR spectral analysis with a variety of other biochemical methods 
including the uses of radical scavenger, metal chelating agent, and spin-trapping 
technique to search for the spin-coupled metal radical complex.  Although the 
study is still in progress, the preliminary data have provided evidence supporting 
the presence of such a complex.  The mechanistic implications of these results 
on  the epoxidation and self-modification reactions catalyzed by HppE are 
discussed herein.   
4.2 MATERIALS AND METHODS 
General.  HppE was purified using the same procedure as previously 
reported (13).  As-purified apo HppE was reconstituted with one equivalent of 
FeII(NH4)2(SO4)2 aerobically and the resultant reconstituted HppE is green in 
color, which is referred as the reconstituted HppE or the oxidized HppE in this 
Chapter.  Purified HppE mutants Y102F, Y103F and Y105F were kindly 
provided by Dr. Zongbao Zhao.  All chemicals including spin trapping agents 
were purchased from Sigma (St. Louis, MO), unless noted otherwise.   
Preparation of HppE Sample with Radical Scavenger.  The 330 mM 
stock solution of radical scavenger, hydroxylurea (HU), was prepared with 
Tris·HCl buffer (pH 7.5, 50 mM).  A typical EPR sample is 150 µL in total 
volume containing 250 µM reconstituted HppE and 25 mM HU in Tris·HCl buffer 
(pH 7.5, 50 mM).  The sample was left on ice for 2 h before it was frozen in 
liquid N2.   
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Preparation of HppE Sample with Metal Chelator.  The 0.5 M stock 
solution of metal chelator, ethylenediamine tetraacetic acid (EDTA), was 
prepared in ddH2O and its pH was adjusted to 8.0 with NaOH.  A typical EPR 
sample of 150 µL in volume contained 250 µM reconstituted HppE and 16 mM 
EDTA in Tris·HCl buffer (pH 7.5, 50 mM).  The sample was mixed for a few 
seconds at room temperature before it was frozen in liquid N2. 
Preparation of HppE Sample with Spin Trapping Agent.  The 1.5 M 
stock solution of spin trapping agent, 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), 
was prepared in Tris·HCl buffer (pH 7.5, 50 mM).  Prior to mixing, DMPO 
powder and buffer were both vacuumed and flushed with argon.  The solution 
was prepared, stored, and used in the dark.  A typical EPR sample of 150 µL in 
volume contained 250 µM reconstituted HppE and 500 mM DMPO in Tris·HCl 
buffer (pH 7.5, 50 mM).  The HppE mutants Y102F, Y103F and Y105F were 
aerobically reconstituted with one equivalent of FeII(NH4)2(SO4)2.  
A typical EPR sample of 200 µL in volume contained 500 µM 
reconstituted mutant and 500 mM DMPO in Tris·HCl buffer (pH 7.5, 
50 mM).  All samples were mixed for a few seconds at room 




Preparation of HppE Sample with Substrate.  The 0.2 M stock solution 
of HppE substrate, (S)-HPP, was prepared in Tris·HCl buffer (pH 7.5, 50 mM).  
The EPR sample contained 250 µM reconstituted HppE and 10-fold excess of (S)-
HPP in Tris·HCl buffer (pH 7.5, 50 mM).  The samples were incubated for 1 min 
or 1 h at room temperature before being frozen in liquid N2.   
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EPR Spectroscopy.  EPR first derivative spectra of HppE were collected 
at X-band microwave frequency with 100-kHz field modulation on a Bruker 
Elexsys E500 spectrometer.  The experimental conditions for EPR are the same 
as reported in Chapter 2.   
4.3 RESULTS  
EPR Spectra of Reconstituted HppE with Radical Scavengers.  In the first 
set of experiments, a free radical scavenger, HU, was used to quench the radical 
spin coupled to the ferric center in the active site of HppE, in hope of visualizing 
the metal with half-integer spin number (S = 1/2 or 5/2) by EPR spectroscopy.  
HU was chosen because it is capable of quenching the protein radicals specially 
without disturbing the iron center, as demonstrated in the study of ribonucleotide 
reductase (14).  Figure 4-1 shows the EPR spectra of the reconstituted HppE 
before and after incubation with HU on ice for two hours.  Interestingly, the 
intensity of EPR signal of the ferric ion increased by almost 30%.  This result 
collaborates well with the existence of the diamagnetic FeIII-radical couple in 
reconstituted HppE.  In addition, it also revealed that the radical species in the 
enzyme active site is accessible to an external radical scavenger.  However, the 
use of a radical scavenger neither provided direct evidence for the metal-coupled 
radical, nor can it distinguish the identity of the organic radical.   
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Figure 4-1 EPR spectra of the reconstituted HppE (dotted line) and the 
reconstituted HppE in the presence of 100× HU (solid line).  
Instrumental parameters: temperature, 2 K; microwave frequency, 
9.6 GHz; microwave power, 0.6 mW; modulation amplitude, 5 G; 
time constant, 0.02 s; sweep rate, 50 G/s.  The important g values 
are given in spectra.   
EPR Spectra of Reconstituted HppE with Metal Chelator.  The use of 
metal chelators like EDTA may allow us to directly detect and identify the 
postulated protein-centered radical.  This is based on the assumption that EDTA 
can tightly bind the active site ferric ion and the iron-EDTA complex can be 
removed from the enzyme active site.  If there exists the proposed FeIII-coupled 
protein-centered radical in HppE active site, and if the radical is substantially 
stable for being alone and can be trapped in frozen state, this radical may be 
discernible by EPR spectroscopy when its spin coupling to the iron is broken.  
The reconstituted HppE was quickly mixed with the strong iron-chelating agent, 
EDTA, and frozen by liquid nitrogen, followed by EPR measurement.  In 
 118
contrast to the EPR spectrum of the reconstituted HppE (Figure 4-2A), two new 
EPR features appeared after the EDTA treatment (Figure 4-2B).  A sharp and 
isotropic signal that pumps into the low field region (g = 4.3), which is distinct 
from the enzyme-bound S = 5/2 ferric signal, has been assigned to a ferric EDTA 
complex (S = 5/2).  The total spin content of iron increased nearly 30% as 
indicated by spin quantitation on the ferric EPR signals.  The increase in iron 
signal intensity again implicated the presence of EPR-silent iron in the 
reconstituted HppE, which accounts for about 30% of the total iron.   
Figure 4-2. EPR spectra of the reconstituted HppE (A) and the reconstituted 
HppE treated with EDTA (B).  Instrumental parameters are the 
same as in Figure 4-1.  The important g values are given in spectra. 
The most notable new feature after EDTA treatment is a new signal at g = 
2.0 at the high-field region of the EPR spectrum (Figure 4-3).  This EPR signal 
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can be severely saturated by microwave power at temperatures below 20 K.  The 
temperature dependence of the signal intensity obeys the Curie law expected for a 
free radical.  The power saturation analysis shows that the relaxation of this 
radical species is not strongly influenced by the metal ion (Table 4-1).  Its 
lineshape and partially resolved hyperfine coupling are remarkably similar to 
those of tyrosine and tryptophan-harbored radicals reported in literature (15).  
Spin quantitation on the free radical signal shows 0.35 spin per HppE monomer.  
It should be noted that this number is largely dependent on the freezing time since 
free radicals are usually unstable at room temperature and often decay quickly 
over time.  Since the optimal conditions for trapping this radical have not been 
fully established, the result is not always reproducible.   
Figure 4-3. EPR spectrum of the reconstituted HppE treated with EDTA (g = 2 
region).  Instrumental parameters are the same as in Figure 4-1.   
EPR Spectra of Reconstituted HppE with Spin Trapping Agents.  More 
evidence for the protein radical was acquired by spin-trapping EPR technique.  
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Spin traps, such as DMPO, 2-methyl-2-nitrosopropane (MNP) and phenyl-N-tert-
butylnitrone (PBN), are a group of relatively inert compounds that, however, can 
react with transient or unstable free radicals giving rise to longer lived radical 
adducts.  If there exists an FeIII-coupled protein radical like [Fe3+-R• ] in HppE, 
the amino acid residue R that harbors the unpaired electron may react with a spin 
trap to form a covalent adduct.  The unpaired electron typically resides at the 
spin trap part of the adduct.  Consequently, the reduction of the spin coupling 
between the metal center and the protein radical should make both visible in the 
EPR spectrum.   
Figure 4-4. EPR spectra of the reconstituted HppE (A) and the reconstituted 
HppE treated with DMPO (B).  Instrumental parameters are the 
same as in Figure 4-1.  The important g values are given in spectra. 
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Several purified spin trapping agents were tested and DMPO was found 
the most effective among them.  The DMPO treatment of the reconstituted HppE 
led to a new EPR signal around g = 2 region (Figures 4-4B and 4-5).  The 
trapped signal represents ~ 0.3 spin per monomer as indicated by spin 
quantitation.  Since neither the reconstituted HppE nor DMPO exhibits the g = 2 
feature in their respective EPR spectrum, this new feature is most likely 
originated from the spin adduct of DMPO and the protein radical.  The DMPO 
adduct of HppE was examined by EPR spectroscopy at a wide range of 
temperatures.  Its EPR relaxation property as quantified by the P1/2 values at 
various temperatures is comparable to that of the radical signal produced by 
EDTA treatment depicted above (Table 4-1).  It should be noted that the EPR 
signal of the DMPO-HppE radical adduct closely resembles that of the spin-
trapped DMPO radical in metmyoglobin, where a long-lived protein-based tyrosyl 
radical was initially produced by hydrogen peroxide treatment (16).   
Figure 4-5. EPR spectrum of the reconstituted HppE treated with DMPO (g = 2 





2 20 50 120 
Reconstituted HppE + EDTA 0.007 0.092 0.286 5.50 
Reconstituted HppE + DMPO 0.006 0.043 0.063 0.516 
Table 4-1 EPR microwave saturation behavior of the radical species in the 
reconstituted HppE after chemical treatments.  The P1/2 parameter, 
as the indicator of the relaxation property of EPR signals, shown in 
the table were calculated by an earlier reported method (17).   
At different temperatures, the EPR spectra of the HppE-DMPO adduct 
changed their line shape (Figures 4-6A and B), suggesting the existence of 
multiple paramagnetic species in the sample.  The dominant radical species 
reflected in spectrum A (dotted line) is more likely the nitroxide radical from 
DMPO (18) because the intensity if this corresponding EPR signal increases with 
the rising temperature.  In free solution, where the nitroxide group of the 
DMPO-protein radical adduct can move rapidly and isotropically, its EPR signal 
usually consists of four narrow lines with a height ratio of 1:2:2:1.  This is 
unique as compared to the EPR spectra of all other spin trap adducts.  The 4-line 
splitting pattern is due to the nuclear spins of neighboring N and H atoms (IN = 1 
and IH = 1/2) in DMPO, which all have the same coupling constant with the O-
centered nitrosyl radical on the spin trap (2×[1+1/2]+1=4) (19).  However, in the 
frozen state where molecular tumbling slows down and thus anisotropy becomes 
much more substantial, the EPR spectrum of DMPO radical is generally less 
resolved.  In Figure 4-6, only the largest hyperfine splitting can be measured 
(Azz = 34 G) while the other two smaller splittings are obscured in the central 
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region of the spectra.  The hyperfine coupling constant (Azz) of 34 G is similar to 
the constant observed in the EPR spectrum of tert-butyl nitroxide spin label in 
crystal form (18).   
Figure 4-6 EPR spectra of the reconstituted HppE treated with DMPO (g = 2 
region) at  (A) 200 K; (B) 150 K. Instrumental parameters are the 
same as in Figure 4-1 except for, microwave power, 1 mW, and scan 
time: 50.   
EPR Spectra of Reconstituted HppE mutants with Spin Trapping Agents.  
To identify the radical harboring site in HppE, three tyrosine mutants, Y102F, 
Y103F and Y105F were also aerobically reconstituted with iron in vitro and then 
treated with DMPO.  EPR spectral analysis showed that all three mutants formed 
radical adducts with DMPO (Figure 4-7), whose signals are all similar to that of 
the DMPO adduct of the wild type HppE.  Thus, it is reasonable to conclude that 
a similar type of radical was also formed in mutant proteins.  The only difference 
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between the EPR signals derived from these mutants is their intensities.  It is not 
clear what is the cause of the variation in EPR signal intensity.   
Figure 4-7 EPR spectra of the reconstituted HppE mutants treated with DMPO 
(g =2 region).  (A) Y105F; (B) Y103F; (C) Y102F.  Instrumental 
parameters are the same as in Figure 4-1.   
EPR Spectra of Reconstituted HppE with Substrate.  The EPR spectrum 
of the reconstituted HppE incubated with (S)-HPP was shown and discussed in 
Chapter 2.  However, it was discovered later that the length of incubation time 
has significant effects on the spectral properties of the enzyme-substrate complex.  
In contrast to the spectrum reported in Chapter 2 (Figure 2-4B), which was 
recorded 1 min after mixing of enzyme and substrate (Figure 4-8B), the new 
spectrum that was recorded after 1 h of incubation varies considerably (Figure 4-
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8A).  The long time incubation led to an increase in overall intensity of the 
enzyme ferric signal (S = 5/2).  This intensity enhancement is reminiscent of the 
EPR spectral change induced by the treatments of HU (Figure 4-1), EDTA 
(Figure 4-2), and DMPO (Figure 4-3), reflecting the relaxation of the spin 
coupling between ferric ion and the protein radical.  Except for HU treatment, 
which frees up the ferric ion from diamagnetic coupling by quenching the coupled 
radical, the addition of EDTA and DMPO to the reconstituted HppE resulted in 
the appearance of free radical-like signals around g = 2.  A g = 2 signal was also 
observed in the long-time incubated sample of the HppE-substrate complex 
(Figure 4-8A), in addition to the ferric signal with higher intensity.   
Figure 4-8 EPR spectra of the reconstituted HppE incubated with (S)-HPP for 1 
h (A) and for 1 min (B).  Instrumental parameters are the same as in 
Figure 4-1.  The important g values are given in spectra. 
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Figure 4-9 EPR spectrum of the reconstituted HppE incubated with (S)-HPP for 
1 h (g = 2 region).  Instrumental parameters are the same as in 
Figure 4-1.   
Figure 4-9 shows an expanded g = 2 region of spectrum A in Figure 4-8.  
The new radical-like signal has a narrow linewidth, less than 40 G, which is in 
sharp contrast to the linewidth of more than 120 G of the radical signals observed 
in the EPR spectra of the reconstituted HppE treated with EDTA (Figure 4-3) and 
DMPO (Figure 4-5).  Given that the broad EPR signals are characteristic for the 
radicals with low tumbling rate, especially protein radicals, the narrow signal 
observed at g = 2 more likely represents a free organic radical.  Further analysis 
showed an unusual temperature dependence property of this EPR signal.  In 
response to the increased temperature, its intensity was not increased but actually 
decreased.  In addition, this signal does not show any hyperfine features as most 
other free radical signals do.  All of these make it distinct from normal radicals, 
including the putative protein radical in HppE revealed by EDTA-treatment and 
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the radical trapped as a DMPO adduct in HppE.  Currently, we can only 
postulate that this is a substrate radical loosely coupled to the iron center.  As a 
part of metal-substrate complex, its EPR properties resemble those of metal ions 
more than those of organic radicals.  However, the coupling is not strong enough 
to make it as another EPR-silent FeIII-radical adduct.   

















Figure 4-10 Proposed mechanism for galactose oxidase.   
EPR is one of the most powerful tools in the study of free radicals.  The 
above results obtained from EPR spectral analysis combined with other 
techniques, may be attributed to the presence of a high spin ferric center (S = 5/2) 
is antiferromagnetically coupled with a protein radical (S = 1/2) in the active site 
of HppE.  Formation of such an FeIII-radical couple with a ground state of S = 2 
is unprecedented for a metal-radical complex, in which either metal ion or radical 
is EPR-silent.  The only close example is the complex of a cupric ion coupled 
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with a modified tyrosine radical in the active site of galactose oxidase (9) and its 
analogues (20).  In those enzymes, the active site tyrosine harboring the unpaired 
electron is one of the copper ligands.  When the substrate binds to the cupric 
center, it should also be close proximity to the tyrosyl radical, which can abstract 


























Figure 4-11 Proposed mechanism for HppE-catalyzed epoxidation involving the 
FeIII-coupled tyrosine radical.   
A catalytic role analogous to that of the CuII-coupled tyrosyl radical in 
galactose oxidase was once proposed for the FeIII-coupled protein radical in HppE 
(Figure 4-11).  Since the FeIII-radical pair is a redox equivalent of FeIV reactive 
species, it is plausible in principle that it can mediates radical formation at C1 of 
(S)-HPP via hydrogen abstraction.  The subsequent steps simply replicate the 
mechanism proposed in Figure 2-14 including the radical-induced Fe-O bond 
cleavage and epoxide ring closure (Figure 2-14).  However, this mechanism 
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cannot explain how the FeIV equivalent is generated in the absence of exogenous 
electrons from NAD(P)H, which has been known as an indispensable electron 
donor for HppE to catalyze its epoxidation reaction in vitro.  In fact, the copper 
dependent galactose oxidase catalyzes a two-electron redox cycle, in which 
dioxygen is reduced to hydrogen peroxide, whereas the non-heme iron dependent 
HppE catalyzes a four-electron redox cycle, in which dioxygen is fully reduced to 
water.  Therefore, the strategy to regenerate CuII-tyrosyl radical complex in 
galactose oxidase, which only requires two oxidative equivalents produced in the 
conversion of dioxygen to hydrogen peroxide (Figure 4-10), is not applicable to 
the epoxidation reaction catalyzed by HppE.  Besides, the mechanism shown in 
Figure 4-11 predicts a single turnover epoxidation, which has never been 
observed even in the incubation when hundred milligrams of enzyme was used.   
In addition to its epoxidase activity, HppE has recently been shown to 
have oxygenase activity as well, capable of self-hydroxylating an active site 
tyrosine residue, Tyr105, to DOPA (21).  Although the exact mode of the self-
hydroxylation reaction remains to be determined, several radical-based 
mechanisms involving a tyrosyl radical intermediate have been proposed for the 
analogous reactions occurring in TauD (22), the R2 protein mutant F208Y of 
Class I ribonucleotide reductase (23), and the conversion of phenol to catechol 
catalyzed by horseradish peroxidase (24).  A similar radical mechanism for self-
hydroxylation of HppE has also been discussed in Chapter 3 (Figure 3-13), in 
which the oxoferryl species, a product of the activation of the enzyme ferrous 
center by dioxygen and ascorbate, is responsible for the formation of the tyrosyl 
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radical intermediate.  The possible presence of the FeIII-coupled radical complex 
as implicated by the current experimental results, allows one to propose an 
alternative way to generate the tyrosyl radical, and to insert an oxygen atom into 
the phenol ring.  As shown in Figure 4-12, the tyrosyl radical and its coupled 
ferric center are produced together after two consecutive reversible reactions.  In 
the absence of exogenous electrons that are necessary for the in vitro self-
hydroxylation, the metal-radical adduct may exit the pathway by releasing the 
bound hydrogen peroxide.  Before the radical is eventually quenched, it may be 
stabilized by spin coupling to the ferric ion.  It is believed that the spin adduct 
being trapped by EDTA and DMPO treatments exists in this state.  Alternatively, 
the addition of electron donors such as ascorbate would push the reaction forward 























Figure 4-12 Proposed mechanism for self-hydroxylation of HppE involving the 
FeIII-coupled tyrosine radical.   
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If the FeIII-coupled protein radical indeed plays a part in the self-
hydroxylation as illustrated in Figure 4-12, Tyr105, as the residue to be modified, 
should also be the docking site of the protein radical as well.  Unfortunately, 
mutation of the particular residue did not prevent the formation of protein radical, 
since radical intermediate could still be trapped by DMPO treatment (Figure 4-7).  
As we have already observed in the in vitro self-hydroxylation of HppE mutants, 
when Tyr105 is not available, Tyr103 becomes the primary modification site.  
Therefore, it is conceivable that Tyr103 harbors the unpaired electron in the 
Y105F mutant, which, upon DMPO treatment, gives the observed spin-trapping 
adduct.  To test the possibility, the double mutant Y103F/Y105F was prepared 
for the future study.   
The above discussion focuses on the possible role of the FeIII-coupled 
protein radical in the self-hydroxylation of HppE and its potential relevance to the 
epoxidase activity of HppE.  However, it is also important to pay attention to the 
odd signal at g = 2 in the EPR spectrum of the reconstituted HppE which was 
incubated with substrate for longer than 1 h.  As previously rationalized, this 
signal is more likely derived from a free organic radical than from a protein-
centered radical.  According to the mechanism shown in Figure 4-12, it may be 
assigned to a metal-bound substrate radical intermediate (Figure 4-13), which 
may explain its unusual spectral properties.  The equilibrium between two key 
intermediates A and B should lean toward the retention, instead of the fission, of 
the C-H bond in substrate intermediate A, because the C-H bond is believed to be 
a stronger bond than the O-H bond.  The following steps involving the 
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exogenous electron transfer and the formation of the FeIV-oxo species provide the 
driving forces to move the reaction forward.  The cycle ends up with the radical-
induced epoxide formation and iron reduction.  This mechanism is very close to 
the one discussed in Chapter 2 (Figure 2-13), in which FeIII-superoxide is 
proposed to be responsible for hydrogen abstraction.  More experiments are in 

















































Figure 4-13 Proposed mechanism for HppE-catalyzed epoxidation involving the 
FeIII-bound substrate radical.   
It is worth noting that the above equilibrium hypothesis is consistent with 
the competitive relationship between the epoxidase and the oxygenase activities 
of HppE.  As we have demonstrated in Chapter 3, the self-modification of HppE 
 133
prevails the in the absence of substrate, and the addition of substrate switches on 
its epoxidase activity resulting in the conversion of substrate to fosfomycin.  The 
determining factor is substrate binding, which also facilitates the conversion of 
the EPR-silent protein radical to the EPR-visible substrate radical (Figure 4-8).  
It appears that substrate binds to the active site of HppE and shifts the equilibrium 
from FeIII-coupled protein radical to FeIII-bound substrate radical.   
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Chapter 5:  Active Site Structure of HppE 
5.1 INTRODUCTION 
To gain more insights into the catalytic mechanism of HppE, it is 
important to characterize the metal center, to determine its involvement in 
substrate binding, and to study its role in catalysis.  A recently reported multiple 
protein sequence alignment predicted a β-barrel fold in the tertiary structure of 
HppE, and thus categorized HppE as a member of the cupin superfamily (1).  
This structural family was named after the Latin word 'cupa', which means small 
barrel, because the β-barrel fold is the basic structural element in all cupin 
proteins.  In addition to the resemblance of their tertiary structures, two or three 
histidine residues and one glutamate residue that are associated with active site 
metal binding are conserved among most of the family members.  For HppE 
from Streptomyces wedmonresis, His138, Glu142 and His180 are the conserved 
amino acid residues that may serve as ligands for the iron center (2).  This 
potential metal binding triad is also preserved in HppE from Pseudomonas 
syringae PB-5123 (3) (Figure 5-1).  This chapter describes a combined study on 
the iron-binding site in HppE by site-directed mutagenesis and spectroscopic 
analyses.  The effects of mutation of several conserved active site residues on 
iron binding, substrate binding, self-hydroxylation and enzymatic epoxidation are 
reported.  Our studies show that the iron coordination in HppE involves a 2-His-
1-carboxylate core.  The spectral analyses also shed light on the mechanism of 
enzyme catalysis.   
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S. wendomorensis MSNTKTASTG FAELLKDRRE QVKMDHAALA SLLGETPETV AAWENGEGGE   50
P. syringae  M–DVRTLAVG KAH-LEALLA TRKM---TLE HLQDVRHDAT QVYFDGLEHL   45
Consensus  M....T...G .A..L..... ..KM....L. .L........ .....G....   50
 
S. wendomorensis LTLTQLGRIA HVLGTSIGAL TPPAGNDLDD GVIIQMPDER PILKGVRDNV  100
P. syringae  QNVAQY--LA IPLSEFFVGQ TQ---SDLDD GVKIARRNGG FKREEIRGGV   90
Consensus  ....Q....A ..L....... T.....DLDD GV.I...... ......R..V  100
 
S. wendomorensis DYYVYNCLVR TKRAPSLVPL VVDVLTDNPD DAKFNSGHAG NEFLFVLEGE  150
P. syringae  HYYTYEHLVT TNQDPGLMAL RLDLHSDDEQ PLRLNGGHGS REIVYVTRGA  140
Consensus  .YY.Y..LV. T...P.L..L ..D...D... ....N.GH.. .E...V..G.  150
 
S. wendomorensis IHMKW-GDKE NPKEALLPTG ASMFVEEHVP HAFTAAKGTG SAKLIAVNF-  198
P. syringae  VRVRWVGDND ELKEDVLNEG DSIFILPNVP HSFTNHVGGA KSEIIAINYG  190
Consensus  ....W.GD.. ..KE..L..G .S.F....VP H.FT...G.. ....IA.N..  200Figure 5-1. Sequence alignment of HppE isolated from Streptomyces 
wedmorensis and Pseudomonas syringae.  The conserved residues 
likely to constitute the proposed 2-His-1-carboxylate facial triad are 
boxed.   
5.2 MATERIALS AND METHODS 
Site-directed Mutagenesis.  Mutagenesis of the HppE gene (fom4) was 
carried out using QuickChangeTM site-directed mutagenesis kit from Strategene 
(La Jolla, CA).  The oligonucleotides used for mutagenesis were customarily 
synthesized by Integrated DNA Technology (Coralville, IA) (Table 5-1).  The 
PCR conditions are the same as previously reported in Chapter 3.  The 
constructed mutant plasmids were amplified in E. coli strain DH5α and purified 
with Qiaprep® spin miniprep kit (Qiagen, Valencia, CA).  Once the mutation 
was verified by DNA sequencing performed by the core facility of the Institute 
for Cellular and Molecular Biology, the University of Texas at Austin, the mutant 
plasmids were used to transform E. coli cell BL21(DE3) (Novagen, Madison, WI) 
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for overexpression.  The mutant Y105F was previously constructed by Dr. 
Zongbao Zhao (4).   
 




Table 5-1. Oligonucleotide primers used for site-directed mutagenesis.  (Note: 
the sites of mutation are underlined).   
Expression and Purification.  The wild-type HppE and its mutants were 
overproduced by growing the corresponding recombinant strains in LB medium 
and then purified according to previously reported procedures (5).  SDS-PAGE 
was used to monitor the elution processes during purification.  The purified 
enzymes were desalted, concentrated, and stored at – 80 °C.   
NBT Quinone Staining.  Proteins were first subjected to SDS-PAGE with 
pre-stained broad-range protein marker (New England Biolabs, Beverly, MA) and 
then transferred onto a nitro-cellulose membrane using the Mini Trans-Blot Cell 
Assembly (Bio-Rad, Hercules, CA).  The transblotting was conducted in the 
transfer buffer (25 mM Tris⋅HCl, 192 mM glycine, 20% methanol) at 100 V for 1 
h.  The DOPA-containing proteins were visualized with a temporary staining 
solution (0.1% (w/v) ponceau S, 5% (v/v) acetic acid).  After the temporary 
stains were removed by washing with ddH2O, the protein-containing nitro-
cellulose membrane was immersed in a solution of 0.24 mM nitroblue tetrazolium 
(NBT) and 2 M potassium glycinate, pH 10, in the dark for 45 min to visualize the 
DOPA-containing protein band (6).   
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Preparation of Ferric Enzyme Samples.  The apo-proteins of the wild-
type and mutant enzymes were made anaerobic by repeated cycles of vacuum and 
flushing with argon.  A molar equivalent of FeII(NH4)2(SO4)2 from an anaerobic 
stock solution was added to the apo-proteins under anaerobic conditions.  The 
FeII-loaded proteins were subsequently exposed to air until all of the iron was 
oxidized to the ferric state.   
Preparation of Cupric Enzyme Samples.  One molar equivalent of cupric 
ion from a CuCl2 stock solution (20 mM) was slowly added to the apo-proteins of 
the wild-type and mutant enzymes.  Rapid addition of the buffered cupric 
solution often led to protein precipitation.  To prepare substrate-containing 
samples, the CuII-reconstituted proteins were further incubated with ten molar 
equivalents of (S)-HPP.   
Preparation of Ferrous Enzyme Nitrosyl Samples.  The FeII-loaded 
proteins were prepared as described above.  Subsequent incubation of each 
sample with ten molar equivalents of (S)-HPP was carried out anaerobically in the 
EPR tubes.  Nitric oxide gas was introduced to the substrate-bound enzyme 
samples through a gas-tight Hamilton syringe under argon.  The samples were 
frozen by slow immersion in liquid nitrogen for later EPR analysis.   
Epoxidase Activity Assay.  A new assay was developed which contains 
70 µM enzyme, 70 µM FeII(NH4)2(SO4)2, 15 mM (S)-HPP, 60 µM FMN, 22.5 mM 
NADH in 20 mM Tris⋅HCl buffer, pH 7.5 (totally 200 µL).  The reaction was 
carried out at room temperature with vigorous shaking and then quenched by the 
addition of 40 µL of EDTA (0.5 M).  The reaction mixture was kept on ice for 
 140
immediate NMR analysis or frozen at –80 °C and thawed shortly before analysis.  
The enzyme activity was calculated based on the integration of the 31P NMR 
peaks assigned to product (δ 10.9) and substrate (δ 19.9).  A sample of wild-type 
HppE was run in parallel as the standard in comparing enzyme activity of 
different mutants.   
In vitro Self-hydroxylation.  As-purified apo-proteins were diluted with 
ddH2O to 1 mg/mL and were aerobically incubated with an equivalent of 
FeII(NH4)2(SO4)2 and ten equivalents of ascorbate at 4 °C for 1 h.  The mixtures 
were concentrated by Amicon concentrator with a membrane pore size of 10 kDa 
(Millipore, Bedford, MA).  The final protein concentrations were between 10-20 
mg/mL.  The extent of self-hydroxylation of each HppE mutant was analyzed by 
NBT quinone staining and UV-vis absorption spectroscopy.   
EPR Spectroscopy.  EPR first derivative spectra of HppE were collected 
at X-band microwave frequency with 100-kHz field modulation using either a 
Bruker Elexsys E500 in Dr. John D. Lipscomb’s lab at the University of 
Minnesota or an EMX spectrometer in Dr. Aimin Liu’s lab at the University of 
Mississippi Medical Center, both of which were equipped with a 10-kilogauss 
magnet and with an Oxford Instruments ESR900 cryostat.  A calibrated 
frequency meter and a Bruker ER035M NMR Gauss meter were used for the g-
value determinations.  Spin quantification on the EPR spectra of the mutant 
enzymes was performed by comparing the double integration using wild-type 
enzyme as a standard   
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Preparation of Selenomethionine-labeled HppE.  To prepare 
selenomethionine-labeled HppE (SeMet-HppE), the plasmid pPL001 that contains 
fom4, the gene coding for HppE, was used to transform methionine-auxotrophic 
E. coli strain B834(DE3) (Novagen, Madison, WI).  The transformed cells were 
grown in LeMaster medium supplemented with 25 mg L-selenomethionine 
(SeMet) (7).  The LeMaster medium consisted of two parts, the autoclavable and 
non-autoclavable portions.  The recipe for the autoclavable portion (2 L): 
alanine: 1.00 g; arginine HCl: 1.16 g; aspartic acid: 0.8 g; cysteine: 0.06 g; 
glutamic acid: 1.34 g; glutamine: 0.66 g; glycine: 1.08 g; histidine: 0.12 g; 
isoleucine: 0.46 g; leucine: 0.46 g; lysine HCl: 0.84 g; phenylalanine: 0.26 g; 
proline: 0.2 g; serine: 4.16 g; threonine: 0.46 g; tyrosine: 0.34 g; valine: 0.46 g; 
adenine: 1.00 g; guanosine: 1.34 g; thymine: 0.34 g; uracil: 1.00 g; sodium 
acetate: 3.00 g; succinic acid: 3.00 g; ammonium chloride 1.5 g; sodium 
hydroxide: 2.16 g; K2HPO4: 21.00 g.  After measurement, the autoclavable 
portion of the LeMaster medium was stored dry in a freezer.  The recipe for the 
nonautoclavable portion (200 mL dd H2O): 20 g of glucose; 0.5 g of 
MgSO4·7H2O; and 6.6 µL of concentrated H2SO4.  The nonautoclavable portion 
was mixed and sterilized by filtering through a 0.22 µm filter system.   
When LeMaster medium was needed, 2 L of dd H2O was used to prepare a 
suspension of the above solid mixture.  This "pre-medium" was autoclave and 
cooled to room temperature.  The suspension was removed by filtration if there 
was any.  The pH of the solution was adjusted to 7.5 as necessary.  The above 
mentioned autoclavable portion (1 L) was mixed with 100 mL of filter sterilized 
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non-autoclavable portion.  Prior to inoculation, 25 mg of DL-SeMet were added 
to complete the LeMaster medium.  When the LeMaster medium was warmed to 
37 °C, it was then inoculated by the overnight pre-culture (LB medium).  It is 
important to note that during the purification process, all of the buffers contained 
1 mM of DTT to prevent the oxidation of incorporated SeMet.   
5.3 RESULTS 
Preparation of HppE Mutants.  Using plasmid pPL1001, which contains 
HppE-encoding gene (fom4), as the template, the H138A, E142A, and H180A 
mutant plasmids were constructed.  The mutations were confirmed by DNA 
sequencing, and the mutant enzymes were expressed and purified by protocols 
previously developed for the wild-type HppE (5).  EDTA and DTT were used 
throughout purification, making the isolated proteins essentially iron-free.  The 
Y105F mutant that was prepared in an early study was also used (4).   
Figure 5-2. Ponceau S (left) and NBT (right) staining of purified HppE and its 
mutants. M). protein marker; 1). H138A; 2). E142A; 3). H180A; 4). 
Wild type (Note: Ponceau S staining shows all proteins while NBT 
staining only shows modified proteins).   
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These purified mutants proteins, along with the wild-type HppE, were 
subjected to SDS-PAGE followed by transblotting onto a nitro-cellulose 
membrane.  The protein bands on the membrane were visualized by a reversible 
red dye, ponceau S, and all proteins were shown to have been purified to near 
homogeneity (Figure 5-2).  After a thorough rinse to remove the red dye, the 
membrane was subjected to the NBT quinone staining (6).  This quinone 
staining method was designed to identify quinonoid compounds, such as 1,2,4-
trihydroxybenzene, menadione, and DOPA.  It is also a convenient assay for 
quinonoid proteins, and has been applied to detect DOPA formation in HppE as a 
result of self-hydroxylation (4).  Here, the H138A, E142A, and H180A mutants 
were found to be insensitive to the NBT staining (Figure 5-2).  Evidently, 
mutation at H138, E142, or H180 significantly impairs the oxygenase activity of 
HppE, resulting in no or little in vivo self-hydroxylation of these three mutants.   
Electronic Absorption of Reconstituted HppE Mutants.  The low aqueous 
solubility of ferric ion at neutral pH precludes the reconstitution of apo-HppE by 
mixing with ferric ion directly to generate FeIII-HppE.  To prepare FeIII-
reconstituted HppE, the apo-enzyme was incubated with a stoichiometric amount 
of FeII(NH4)2(SO4)2 and then oxidized by air.  As we have shown in Chapter 4, a 
portion of the iron possibly exists in the complex with a hidden protein radical in 
the reconstituted HppE.  Thus, the oxidized HppE does not completely equal to 
FeIII-HppE.  However, the small amount of spectroscopically invisible iron will 
have little effects on the biophysical results obtained in this study.  Thus, the 
reconstituted HppE will be considered as FeIII-enzyme in this chapter.   
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H138A, E142A & H180A
As shown in Figure 5-3, the optical spectrum of FeIII-reconstituted wild-
type HppE displays a broad peak centered around 680 nm (ε ≈ 450 M-1cm-1) that 
has been identified as the ligand-to-metal charge transfer (LMCT) band of the 
FeIII-catecholate complex (4).  When the H138A, E142A, and H180A mutants 
were aerobically reconstituted with an equivalent of FeII(NH4)2(SO4)2, a bright 
yellow color appeared in all protein solutions.  After one-hour aerobic incubation 
to give FeIII-HppE, when the yellow color reached its maximal intensity, the 
electronic absorption spectra of these reconstituted enzymes were recorded.  As 
shown in Figure 5-3, the spectra of these mutants are clearly different from that of 
the wild-type HppE, lacking the characteristic absorption band of the FeIII-
catecholate complex at 680 nm.  These data are in accord with the results 
obtained from the NBT staining experiments, confirming the absence of in vivo 









Figure 5-3 Electronic absorption spectra of FeIII-HppE and its mutants (protein 
concentrations, 0.5 mM).   
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Spectral Properties of CuII-Substituted HppE and its Mutants.  The lack 
of an EPR signal and the facile oxidation of the enzyme bound ferrous center have 
made direct spectroscopic studies a challenging task.  To circumvent these 
problems, the FeII in enzymes is often replaced by other divalent metal ions that 
are aerobically stable and spectroscopically accessible.  One of the most 
commonly used metal ion substitutes chosen as EPR spectroscopic probe is CuII 
because of its well-documented EPR properties and well-understood coordination 
chemistry.  Furthermore, CuII was found inhibitory to the epoxidase activity of 
HppE, implying that it is a competitor for the iron-binding enzyme active site.  
In the study, the wild-type apo-HppE was reconstituted with CuII at 1:1 ratio.  
The electronic and EPR spectra of the resulting CuII-HppE exhibit typical spectral 
properties of a type II copper center.  These include an absorption maximum at 
690 nm (ε = 84 M-1cm-1) which is characteristic for the low-intensity d→d 
transitions in type II CuII (Figure 5-4), and the EPR spectrum with a g// value of 
2.276 and an A// value of 172×10-4 cm-1, that are indicative of a type II Cu center 
with a tetrahedral coordination geometry (Figure 5).  In the presence of (S)-HPP 
the absorption maximum shifts to 860 nm (ε = 92 M-1cm-1) (Figure 5-4).  The 
CuII EPR signal also changes, exhibiting a smaller A// value of 135×10-4 cm-1 and 
an increased g// value of 2.366 (Figure 5-5), both of which are consistent with a 
more oxyanion-rich environment (8).  Such a large increase in g// value 
accompanying the addition of substrate strongly suggests that CuII binds in 




















Figure 5-4 Electronic absorption spectra of CuII-substituted HppE (solid line) 
and its substrate-bound complex (dotted line) (protein concentration, 
0.8 mM, in dd H2O).   
Figure 5-5 EPR spectra of the CuII-substituted HppE. (A) CuSO4 in the 
Tris·HCl buffer; (B) Complex of (S)-HPP and CuSO4; (C) CuII-
substituted HppE; and (D) CuII-substituted HppE in the presence of 
excess amount of substrate.  Samples contained 625 µM CuII and/or 
625 µM HppE. Instrumental parameters: temperature, 20 K; 
microwave power, 0.6 mW; modulation amplitude, 0.3 mT, and 
sweep speed, 1.3 mT/s.   
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Figure 5-6. EPR spectra of CuII-substituted HppE mutants. (A) E142A; (B) 
E142A in the presence of substrate; (C) H138A; (D) H138A in the 
presence of substrate; (E) H180A; (F) H180A in the presence of 
substrate; and (G) Y105F; (H) Y105F in the presence of substrate. 
Protein concentration of each mutants was 500 µM (polypeptide). 
Instrumental parameters are the same as Figure 5-5 with the 
exception microwave power is 0.1 mW and each spectrum is average 
of two scans.   
The HppE mutants were also reconstituted with CuII and characterized by 
electronic absorption and EPR spectroscopies.  The observed spectral parameters 
are listed in Table 5-2.  Overall, the spectra of the H138A, E142A and H180A 
mutants are similar to each other but significantly different from that of the wild-
type enzyme.  In particular, they do not respond to the addition of substrate HPP 
in the same way as the CuII-substituted wild-type enzyme does (Figure 5-6).  For 
example, the spectra of the CuII-HppE mutants, without bound substrate, differ 
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from the wild-type enzyme by a blue-shift of the weak cupric d→d transition 
from 690 nm to 610-615 nm and the less rhombic EPR signals with smaller g// 
and larger A// values.  When (S)-HPP is added, dramatic changes were made to 
the spectra of CuII-HppE (∆λmax ≈ 170 nm for UV-vis and ∆g// = 0.09 and ∆A// = 
37×10-4 cm-1 in EPR), while those of CuII-reconstituted H138A, E142A, and 
H180A mutants were practically unchanged (Table 5-2).  These results clearly 
indicate that alterations at these positions have great impacts on the metal 
coordination properties of HppE.   
Optical Features EPR Parameters CuII-substituted 
protein 
(S)-
HPP λmax (nm) ε (M-1cm-1/Cu) g// A//
a g⊥  
- 690 84 2.276 172 2.063 Wild type + 860 92 2.366 135 2.099 
- 611 107 2.233 187 2.054 H138A + 611 111 2.234 195 2.054 
- 615 75 2.234 185 2.055 E142A + 618 76 2.238 187 2.054 
- 610 142 2.233 183 2.053 H180A + 608 130 2.230 180 2.052 
- 648 115 2.299 152 2.067 
Y105F + 635 736
104 
102
2.298 155 2.067 
- 648 50 NRb NR 2.076 CuII (Tris⋅HCl 
buffer) + 640 55 2.279 172 2.061 
Table 5-2. Spectral parameters of copper-substituted HppE mutants.  (Note: 
aEPR hyperfine coupling parameter A is given in 10-4 cm-1; bNR, the 
spectrum has no resolved features to record the corresponding 
parameters.) 
In contrast, the spectroscopic properties of mutant Y105F seems to stand 
in between those of wild-type and other mutants (Table 5-2).  For example, the 
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addition of (S)-HPP to CuII-Y105F led to the emergence of a new peak around 
740 nm in the UV-vis absorption spectrum, nearly 100 nm apart from the original 
648 nm.  The significant change in maximum absorption has also been observed 
with the wild-type HppE upon substrate binding, and thus presumably an 
indication of coordination of (S)-HPP to Y105F-bound CuII.  However, such a 
large spectroscopic change is not reflected in the EPR spectra of CuII-Y105F.  
Probably, the signal for (S)-HPP-bound CuII as a minor species is buried in the 
background of unbound CuII.  Clearly, the mutation of Tyr105 has considerable 
impacts on the metal coordination environment in HppE active site, though its 
effects are different from those induced by the mutations of iron ligands.   
FeII·(S)-HPP Nitrosyl Complexes of HppE Mutants.  An FeII-HppE·(S)-
HPP nitrosyl ternary intermediate, which presents a nearly homogenous EPR 
signal with principal g values of 1.97, 3.63, and 4.2 (S = 3/2) and E/D of 0.066 
(Figure 5-7A), had been characterized in our earlier studies (1).  The EPR 
spectrum of this intermediate is reminiscent of those of the FeII-enzyme-substrate 
nitrosyl complexes observed in IPNS and ACCO (9, 10).  This ternary complex 
is believed to be the catalytically active form of enzyme-substrate-O2 
intermediate.  Mutation of the iron ligands is expected to change the above 
spectroscopic fingerprint of the ternary complex because the EPR lineshape has 
been shown to be very sensitive to changes in the iron ligation and environment 
for many other enzymes.  To assess the roles of H138, E142, and H180 on iron 
coordination in HppE, the H138A, E142A, and H180A mutants were 
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anaerobically reconstituted with ferrous ion, (S)-HPP, exposed to NO and then 
analyzed by EPR spectroscopy.   
As shown in Figure 5-7, in the presence of substrate and NO under 
anaerobic conditions, these mutants exhibit an EPR signal with g values of 2.013 
and 2.039 in addition to an anomalous signal from unbound NO at about g = 1.96 
(spectra B-D).  The signals appeared slightly above g = 2 are absent in the EPR 
spectrum of the wild-type enzyme (Figure 5-7A).  We assign them to 
nonspecifically bound FeII nitrosyl species that have previously been noted with 
many non-heme iron-nitrosyl complexes in proteins and model systems (11-16).  
In the g = 4 region, signals from an S = 3/2 species with different E/D values than 
that exhibited by the wild-type enzyme were observed in Figures 5-7B-D of the 
mutant enzymes.  The S = 3/2 species in each EPR spectrum were quantitated by 
double integration and compared with that of the wild type enzyme at the same 
concentration (Table 5-3).  It is clear that point mutation of His138, Glu142, and 
His180 significantly reduces the iron binding affinity, suggesting these residues as 
the metal binding ligands in the wild type HppE.  The roles of E142 and H180 
are especially critical for the metal coordination at the active site.   
The EPR spectrum of the Y105F mutant protein-substrate-NO complex 
was also recorded, and showed characteristics for an S = 3/2 species with g values 
of 1.99, 3.94, and 4.11 (E/D = 0.024) (Figure 5-7E).  Despite the fact that the 
total content of protein-bound iron in this mutant is lower than that of the wild-
type enzyme, there is no iron nonspecifically bound to protein indicated by the 
EPR data, which is in contrast to the H138A, E142A, and H180A mutants.  The 
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results suggested that the majority of the iron present in the EPR spectrum of 
Y105F is still bound to the active site.  Unlike the above three residues that have 
been implicated as metal binding ligands, Tyr105 is unlikely to be a ligand of the 
metal center in HppE, which is consistent with the lack of the characteristic FeIII-
tyrosine LMCT band in the UV-vis absorption spectrum of FeIII-reconstituted 
wild type HppE.   
Figure 5-7 EPR spectra of the FeII·substrate·NO complexes obtained with HppE 
and its mutants.  (A)Wild type, (B) H38A, (C) E142A, (D) H180A, 
and (E) Y105F.  Instrumental parameters: temperature 2 K, 
microwave frequency 9.6 GHz, modulation frequency 100 KHz, 
power, 0.6 mW, sweep time 162 s. Samples C and D possess large 
excess NO (as shown at g = 1.96) in order to detect the full amount 
of FeII at the active site.   
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Epoxidase Activity of Mutant Enzymes.  In our previous studies, holo-
HppE was generated by reconstitution of the apoenzyme with FeII under aerobic 
conditions (5).  The resultant FeIII-enzyme was passed through a gel-filtration 
column to remove the unbound iron prior to the activity assay.  However, we 
encountered problems in applying this protein preparation method to determine 
the activity of HppE mutants.  This is due to their reduced iron binding affinities, 
so a larger amount of iron was depleted from the HppE mutants during the gel-
filtration step, making comparison of enzyme activity between the wild-type and 
the mutant enzymes invalid.  In order to ensure equal conditions for all the 
enzymes, a stoichiometric amount of FeII(NH4)2(SO4)2 was added directly to the 
apo-enzyme (1:1 ratio) in the assay solution to reconstitute the enzyme in situ.  
The epoxidase activities determined under the new assay conditions are given in 
Table 5-3.  The E142A and H180A mutants are catalytically inactive.  Because 
the substitution of Glu142 or His180 by alanine leads to low iron content and 
totally abolishes the epoxidase activity of HppE, these two residues are likely part 
of the metal binding core as deduced by sequence alignment.  However, 
mutation of another putative iron-binding ligand, His138, did not completely 
inactivate the enzyme.  Instead, the H138A mutant retained 20% of the wild-type 
activity.  Table 5-3 shows that the level of residual activity of the H138A mutant 
correlates well to its iron-binding affinity, which is much higher than those found 
for the E142A and H180A mutants.  Thus, while His138 may still be an 
important ligand for metal binding, it is not an essential residue for HppE activity.  
It is worth mentioning that site-directed mutagenesis has been performed on many 
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mononuclear non-heme iron enzymes to define their metal binding sites (17-25).  
Among which, the H138A mutant of HppE is unusual since it retains more than 
an average of the residual enzyme activity than all known examples prepared thus 
far.   
 
Enzymes H138A E142A H180A Y105F Wild-type 
Active site irona (%) 26.6 3.1 4.4 16.1 100 
Self-hydroxylation  
(ε680, M-1cm-1) 
200 0 0 250 450 
Epoxidase Activity (%)b 19.9 0 0 33.4 100 
Table 5-3 Properties of iron-reconstituted HppE mutants. (Note: aThe iron 
content is calculated from the EPR spectra of FeII-enzyme·(S)-HPP 
nitrosyl complexes; bThe activity was obtained under new assay 
conditions.) 
Figure 5-8 Ponceau S (left) and NBT (right) staining of in vitro modified HppE 
and its mutants. M. protein marker; 1. H138A; 2. E142A; 3. H180A; 
4. Y105F; 5. Wild type (Note: Ponceau S staining shows all proteins 
while NBT staining only shows modified proteins).   
Self-hydroxylation Activity of Mutant Enzymes.  On the basis of the NBT 
staining and the UV-vis spectral analyses of purified proteins, mutations of 
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His138, Glu142 and His180 have clearly eliminated the post-translational 
modification that would otherwise have occurred to HppE in vivo.  The loss of 
self-hydroxylation capability of these mutants is directly associated with the 
decrease in their iron-binding affinity (Table 5-3), since the self-inflicted 
hydroxylation in HppE has been established to be iron-dependent.  To avoid 
dealing with the control of iron concentration in vivo (as in the experiments 
reported in Figures 5-2), the HppE mutants were tested in vitro for their self-
hydroxylation activity.  The proteins were reconstituted with FeII(NH4)2(SO4)2 
and ascorbate under aerobic conditions (4) and the extend of self-hydroxylation 
was visualized by NBT staining (Figure 5-8) and analyzed by UV-vis absorption 









Figure 5-9 Electronic absorption spectra of HppE mutants aerobically 
reconstituted with iron in the presence of ascorbate (Protein 
concentration, 0.6 mM).   
As summarized in Table 5-3, the self-hydroxylation activities of these 
HppE mutants show similar trends as their epoxidase activities, and are related to 
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their iron contents.  While the E142A and H180A mutants are clearly inactive, 
the H138A mutant demonstrates a moderate activity.  The evidence includes the 
weak purple stain upon treatment with NBT (Figure 5-8, lane 2), and the 
development of a green chromophore during the in vitro incubation (Figure 5-9).  
This green chromophore is presumably an FeIII-catecholate (DOPA) charge 
transfer complex, similar to that forms in the wild-type HppE (4).  The observed 
blue-shift of the absorption maximum, from 680 nm for the wild type enzyme to 
600 nm for the H138A mutant, may simply reflect the alteration of the iron 
environment in the active site of this mutant.  As previously reported, self-
hydroxylation can also occur in the Y105F mutant, and the site of modification 
has been proposed to be at Tyr103 (4).  Since the UV-vis spectrum of the self-
modified Y105F mutant and that of the wild-type enzyme are nearly 
superimposable, showing maximal absorption at 680 nm, the iron coordination 
environment of the Y105F mutant and that of the wild-type enzyme are likely to 
be alike.  Again, the mutation of Tyr105 seems to have little effect on the iron 
active site as compared to the mutations of these putative amino acid ligands, 
His138, Glu142 and His180.   
X-ray Crystal Structure of HppE.  The three-dimensional structure of 
HppE confirms its identity as a member of the cupin superfamily, possessing the 
characteristic β-barrel fold in which antiparallel β-stands are wrapped around a 
barrel core in a jelly-roll variant of a Greek Key or β-sandwich motif (Figure 5-
10).  As expected, the epoxidase is a physiological homotetramer with one iron 
per monomer, and the metal is bound to one end of each β-barrel via direct 
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coordination with facial triad ligands, 2-His-1-Glu.  The monomer consists of 
two domains: an α-domain, which is all α-helical, and a β-domain, which consists 
of all anti-parallel β-strands in a jelly-roll β-barrel motif.  In consistence with the 
results from the above site-directed mutagenetic study, the facial triad, His138, 
His180, and Glu142, is housed within the β-barrel, defining the HppE active site 
(Figure 5-11).  The facial triad ligands in all cupin enzymes occupy one end of 
the β-barrel, and the opposite end is responsible for the vast catalytic diversity of 
reactivity and substrate specificity, regioselectivity, and stereoselectivity in this 
protein family (26).  Based upon the overall HppE structure, residues on the 
“tunable” face of the β-domain that are potentially significant for catalysis 
include: Tyr105, Tyr103, Tyr102, and Arg97 (Figure 5-11).  The α-domain also 
contributes one residue to the active site, Lys23, positioned between helix 1 and 
helix 2.   
Figure 5-10 The overall structure of HppE. (Left) The HppE tetramer; (Right) a 
HppE monomer consisting of an α-domain, an interdomain linker to 
a single β-strand 1, and a β-domain.   
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Figure 5-11 The active site of HppE.  (Note: the important residues are labeled.)  
5.4 DISCUSSION 
As mentioned early, sequence analysis has suggested HppE as a member 
of the cupin superfamily (1).  The crystal structures of several cupin 
metalloproteins have recently been solved, such as MnII-bound barley germin, 
ZnII-bound phosphomannose isomerase, FeII-bound α-KG-dependent 
dioxygenases and FeII-bound aromatic ring cleaving dioxygenases (27).  In all 
these structures, the divalent metal centers have a similar coordination 
environment, having two or three histidines and one carboxylate as metal binding 
ligands.  Such a 2-His-1-carboxylate facial triad has been found in many 
mononuclear non-heme iron-dependent enzymes (28), including BphC (29, 30), 
IPNS (31), the Rieske-type dioxygenase NDO (32), the pterin-dependent PheH 
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(33), TyrH (34) and TrpH (35), and the α-KG-dependent DAOCS (36), CAS (37) 
and TauD (38).   
A similar 2-His-1-carboxylate FeII-binding triad, His138, Glu142 and 
His180, can also be located in HppE (1).  In this study, we combined site-
directed mutagenesis with EPR spectral analyses to confirm the involvement of 
these conserved residues as the metal-binding ligands.  In the EPR spectra of the 
CuII-reconstituted HppE, the large increase of the g// value due to the addition of 
(S)-HPP suggests a direct coordination of substrate to the metal active site.  In 
addition, study of the EPR-homogeneous FeII-HppE·(S)-HPP·NO ternary complex 
(5) clearly showed that single mutation at His138, Glu142, or His180 greatly 
affected the formation of this ternary complex.  These results are particularly 
revealing, since this ternary complex represents the catalytically competent form 
of HppE.  Thus, the metal binding ability of each mutant, deduced from the iron 
content of the respective ternary complex, is truly catalytically relevant.  In fact, 
the iron contents determined in this study exhibit good correlation with the 
epoxidase and self-hydroxylation activity of the HppE mutants (Table 5-3), 
confirming the iron-dependence of the catalytic activities of HppE.  Through our 
study, the putative amino acid ligands can be categorized into two groups.  
Glu142 and His180 are the metal ligands since replacement of either of these two 
residues with alanine led to significant metal ion loss from the enzyme active site.  
As a result, no enzyme activity on epoxidation and self-hydroxylation can be 
detected in mutants E142A and H180A.  On the other hand, mutant H138A also 
endures significant reduction in its active site iron content and its catalytic 
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competency in epoxidation and self-hydroxylation reactions.  However, the 
mutation of His138 does not completely knock out the ability of HppE to bind 
iron nor its catalytic activities.  In proportion to the residual 27% iron content, 
the mutant H138A retains 20% of the wild type epoxidase activity, which is in 
sharp contrast to the mutants of other two metal binding residues.  While the 
properties of the H138A and Y105F mutants are similar (Table 5-3), the H138A 
mutant is distinct from the Y105F mutant by forming a chromophore with a 
maximum absorption at 600 nm, rather than 680 nm, as a result of the in vitro 
self-hydroxylation (Figure 5-9 and Table 5-3).  The apparent disparity on optical 
absorption suggests a major alteration in iron coordination environment induced 
by the mutation of His138 to alanine.  Thus, His138, as an iron ligand, bears 
unusual characteristics.  The X-ray crystal structure of HppE resolved very 
recently has confirmed the above conclusion and also proved that the epoxidase 
belongs to the cupin structural superfamily.   
It is worth noting that the retention of ~20% of the wild-type activity of 
the HppE H138A mutant is highly unusual, because the mutation of an amino acid 
residue that serves as iron ligand in other enzymes generally led to more drastic 
reduction of enzyme activities.  In most cases, including PheH (17), TyrH (20, 
24), IPNS (18), toluene dioxygenase (22), ACCO (25), TfdA (21) and CAS (19, 
23), the catalytic activity was completely abolished because of the mutations.  
Few exceptions are known, such as the CAS H145Q and H280Q mutants (23) and 
the TyrH H336E and H336Q mutants (20), where residual catalytic activities 
ranging from < 3% for the CAS mutants (23) to about 4~12% for the TyrH 
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mutants were reported (20).  The residual activities found in these H → Q 
mutants may be attributed to the competence of glutamine to replace histidine in 
binding of iron.  However, the same reasoning is not applicable to HppE since 
the histidine at position 138 is replaced by an alanine that cannot serve as a metal 
ligand like glutamine.  In view of the good correlation between the iron content 
and the residual enzyme activities of H138A, it is likely that another amino acid 
residue in the active site may be a substitute of His138 to bind the iron and 
attenuate the effects of mutation on iron binding and catalytic activity.  As 
suggested by the crystal structure of HppE, the residues Asn135 and Asn198 may 
play the role as the backup ligands.   
Besides His138, Glu142 and His180, Tyr105 is another active site residue 
that has been identified in our earlier studies as the site of self-hydroxylation to 
give DOPA in HppE (4).  As the precursor of DOPA, Tyr105 must be in close 
proximity to the iron center in HppE.  However, UV-vis and EPR spectral 
analyses showed no evidence of direct ligation of Tyr105 to iron in the active site 
of HppE.  In contrast, DOPA105, being a bidentate ligand, forms a complex with 
FeIII in the active site of HppE to give its green color.  Since only a small portion 
(~25%) of HppE is estimated to be post-translationally modified at Tyr105 on the 
basis of the low extinction coefficient of FeIII-HppE at 680 nm (ε680 = 450 M-1cm-
1), there must exist two iron coordination environments corresponding to the 
modified and unmodified forms of HppE.  Interestingly, such a coordination 
heterogeneity around the iron binding site becomes indiscernible in the ternary 
complex of FeII-HppE, (S)-HPP and nitric oxide.  The fact that this ternary 
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complex displayed a homogeneous EPR signal, accountable for >95% iron bound 
in the active site (5), ruled out the possibility of direct ligation of DOPA to the 
ferrous center in the HppE-substrate complex.  The conclusion has been 
substantiated by the newly resolved crystal structure.  As a part of the secondary 
iron coordination sphere, Tyr105 has shown its catalytic importance by the 
significant impact of its mutation on the iron binding affinity and catalytic 
activity.  In the catalytic mechanism of HppE, Tyr105 may serve as a general 
acid/base or be part of the electron transfer conduit.   
Enzymes carrying a 2-His-1-carboxylate triad motif to bind a mononuclear 
iron catalyze a great variety of reactions.  Despite the diverse reaction types 
catalyzed by these enzymes, there is a common mechanistic theme shared among 
these catalysts.  The 2-His-1-carboxylate motif provides an iron-coordination 
platform in these enzymes, on which FeII-dependent dioxygen activation takes 
place in the presence of substrate or cofactor (28).  Our proposed enzyme 
mechanisms in previous chapters for HppE, which all rely on a ferrous center to 
activate dioxygen, fit well with this general mechanistic model.   
In summary, a 2-His-1-carboxlyate iron-binding motif has been 
experimentally identified in HppE.  Its presence is consistent with our previously 
proposed catalytic model, especially the dependence of its catalysis on dioxygen 
activation by ferrous center.  Site-specific mutation of two of these iron-binding 
residues, Glu142 and His180, resulted in complete loss in enzyme activities.  In 
contrast, the H138A mutant retains 20% of the wild type activity, suggesting the 
presence of a nearby residue capable of serving as a metal binding ligand.  The 
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site of self-hydroxylation, Tyr105, is not directly ligated to the iron center, 
although the resulting product, DOPA, does bind iron in the modified HppE.   
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Chapter 6:  Substrate Binding Mode 
6.1 INTRODUCTION 
Like many other mononuclear non-heme iron enzymes, HppE conserves 
both high regiospecificity and stereospecificity in its catalysis.  When the 
racemic substrate (R,S)-HPP was used in the in vitro epoxidation system of HppE, 
two different products were isolated (1).  Besides the natural product fosfomycin 
(6-1), the other product was identified as a ketone compound, 2-oxopropyl-
phosphonic acid (6-3).  Dr. Zongbao Zhao of our group chemically synthesized 
both enantiomers of HPP, and demonstrated that (S)-HPP (6-2), the natural 
substrate of HppE, is the precursor of fosfomycin (6-1), while (R)-HPP (6-4) is 
the precursor of the ketone product (6-3).  Such distinct outcome from a pair of 
enantiomers catalyzed by a single enzyme is rare in nature, not to mention that the 
conversion of (S)-HPP and (R)-HPP by HppE into their respective products is 
actually exclusive.  To explain the unusual results, a radical mechanism 
involving different regiospecific hydrogen abstraction has been proposed (Figure 
6-1).  The initial evidence to support the regiospecificity in HppE catalysis was 
obtained from the study using difluoro-substituted compounds (6-7 and 6-8).  
The replacement of both C1 hydrogens in (S)-HPP (6-2) with fluorine prevented 
the formation of the putative radical intermediate (6-5) and thus inhibited the 
epoxidation reaction as expected (Figure 6-2).  In contrast, the H → F 
substitution at C1 atom of (R)-HPP (6-4) did not affect the radical generation at C2 





































Figure 6-1 The distinct outcomes of the oxidation of (S)-HPP and (R)-HPP by 

























Figure 6-2 The distinct outcomes of the oxidation of (S)-FHPP and (R)-FHPP 
by HppE.   
In an earlier study to determine the stereochemical course at C-1 position 
during the epoxidation process, Hammerschmidt et al. synthesized both (S)-[1-
2H1]-2-hydroxyethylphosphonic acid (6-10) and (R)-[1-2H1]-2-hydroxyethyl-
phosphonic acid (6-11) and fed them to fosfomycin producing strain S. fradiae 
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(2).  The resulting fosfomycin (6-1) in the cell extract was transformed to 
(1R,2R)-2-amino-1-hydroxypropylphosphonic acid (6-12 and 6-13) to ease the 
isolation and characterization process.  Their final results showed that the 
deuterium of 6-11 was lost in 6-13, while the deuterium of 6-10 was retained in 6-
12.  The observation can be interpreted as a result of the stereospecific hydrogen 
abstraction in HppE catalysis.  Evidently, the putative iron-oxygen reactive 
species can precisely recognize and specifically remove the pro-R hydrogen in 










































Figure 6-3 Study of the stereochemical course of HppE catalysis at C1 position 
using deuterated 2-hydroxyethylphosphonic acids.   
The strict regiospecificity and stereospecificity in HppE catalysis, deduced 
from the results shown in Figures 6-2 and 6-3, require the formation of such an 
enzyme-substrate complex that the hydroxyl and the phosphonate groups of HPP 
are anchored in the active site in a rigid manner.  Such a rigid substrate binding 
mode would allow only the pro-R α-H in (S)-HPP (6-2) or the β-H in (R)-HPP (6-
4) to be productively poised for abstraction, then leading to the corresponding 
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products.  Therefore, the regiospecific and stereospecific hydrogen abstraction is 
not only determined by the chemical reactivity of the hydrogen atoms involved 
but also their relative positions in the active site of HppE.   
The above observations prompted us to study substrate binding modes in 
the enzyme active site of HppE, which must be a critical factor in determining the 
catalytic mechanism and product formation.  In this chapter, we report the 
spectroscopic study on the enzyme-substrate interactions of HppE at its reduced 
state in collaboration with Dr. Aimin Liu at University of Mississippi Medical 
Center.  Using nitric oxide as an O2 analogue, we were able to detect and 
characterize the FeII-loaded enzyme and its complexes with substrates and 
substrate analogues.  In consistence with the recently resolved crystal structure 
of HppE, the EPR data showed that the active site Fe of HppE is well suited for 
direct binding with substrates and substrate analogues.  The results have also 
enhanced our understanding of ring closure in all antibiotic biosyntheses and 
multiple catalytic functions that commonly observed with nonheme iron enzymes.   
6.2 MATERIALS AND METHODS 
General.  HppE from S. wedmorensis was expressed using E. coli 
BL21(DE3)/pPL1001 and purified to its homogeneity as previously described (3).  
The purified protein was stored in Tris·HCl buffer (20 mM, pH 7.5) at -80 °C for 
the biochemical and biophysical studies.  The as-isolated HppE was essentially 
an apoprotein (metal-free).  All reagents and solvents were purchased from 
commercial sources and were used without further purification unless otherwise 
noted.  Biochemicals were purchased from Sigma (St. Louis, MO).  Labeled 
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water (36.8% 17O and 48.8% 18O) were obtained from Isotec Inc. (Miamisburg, 
OH).   
Preparation of 17O-Labeled HPP.  (S)- and (R)-HPP labeled with 17O in 
their hydroxyl groups are synthesized by Dr. Sung-Ju Moon, following the 
established procedure in Chapter 2 except for the replacement of THF with pTSA 

































Figure 6-4 Synthetic scheme for (S)-2-[17O]hydroxypropyl phosphonic acid and 
(R)-2-[17O]hydroxypropyl phosphonic acid.  Reagents and 
conditions: a) NaBH4/pTSA/H217O; b) lipase/vinyl acetate/isopropyl 
ether; c) NH3/MeOH; d) TMSBr/CH2Cl2.   
(S)-HPP labeled with 17O in its phosphonate group was prepared by 
dissolving 0.04 mmol chemically synthesized and lyophilized unlabeled (S)-HPP 
in 0.2 mL of H217O.  The mixture was allowed to undergo isotope exchange for 
1-2 weeks.  17O isotope enrichment in all labeled compounds was determined by 
the Mass Spectrometry Laboratory of Department of Chemistry and Biochemistry 
at University of Texas at Austin.   
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Preparation of Substrate Analogues. Fosfomycin (6-1) 
and (S)-3-hydroxybutyric acid (HBA, 6-14) were purchased from 
Aldrich (Milwaukee, WI) and Sigma (St. Louis, MO), 
respectively.  2-Methylpropylphosphonic acid (MPP, 6-15) was chemically 
synthesized as shown in Figure 6-5.  Briefly, 1.1 mL of isobutyl bromide (6-16) 
and 3.4 mL of triethylphosphite were mixed together and incubated with 
tetrabutylammonium iodide at 150 °C for 3 h.  The product diethyl 
isobutylphosphonate (6-17) was purified by silica gel column chromatography.  
Compound 6-17 (0.5 g, 2.6 mmol) was then incubated with 0.5 mL of TMSBr and 
0.25 mL allyltrimethylsilane for 24 h at room temperature.  The final product 
MPP (6-15) was neutralized with NH4HCO3, extracted with water, and 
















Figure 6-5 Synthetic scheme for 2-methylpropylphosphonic acid (MPP, 6-15).  
Reagents and conditions: a) P(OEt)3/tetrabutylammonium iodide, 
150 °C, 2h; b) TMSBr/allyltrimethylsilane/CH2Cl2, 24 h.   
Preparation of NO Samples of FeII-HppE with Substrate and Substrate 
Analogues.  Samples were made anaerobic by repeated cycles of vacuuming and 
flushing with argon that had been passed over a column of copper catalyst (BASF 
inc.) heated at 150 ºC.  Approximately 3 h of argon bubbling was required to 
prepare 5 mL of double distilled H2O or Tris·HCl (20 mM, pH 7.5) buffer with 
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reasonably good anaerobicity.  The FeII stock solution was prepared by adding 1 
mL of anaerobic H2O through a gas-tight syringe into a serum vial containing pre-
weighted FeII(NH4)2(SO4)2·6H2O (99.997%, Aldrich) under anaerobic conditions.  
Anaerobic protein samples were prepared in a reaction vial and then transferred to 
the EPR sample tubes under the protection of argon.  Samples were frozen by 
slow immersion in liquid N2.  Nitric oxide was introduced through a gas-tight 
syringe to the headspace of the quartz EPR tubes or UV-vis cuvettes containing 
the anaerobic ferrous enzymes.  An argon flush was maintained above the 
sample to protect the sample from O2 and to minimize an anomalous EPR signal 
near g = 2 which derives from NO itself rather than the enzyme-nitrosyl complex.   
The ternary enzyme·substrate (or substrate analogues)·nitrosyl complexes 
were made by initially adding either substrate (or substrate analogues)·or NO to 
the enzyme at its reduced state, followed by the addition of the third component.  
For the isotope-labeling experiments, 17OH-labeled substrates were first added to 
the enzyme, followed by NO gas.  Control samples were prepared in parallel 
using natural-abundant substrate.   
EPR Spectroscopy.  EPR spectra were recorded at X-band with a Bruker 
E500 spectrometer equipped with an Oxford Instruments ESR-10 liquid helium 
cryostat.  Temperature was controlled by a digitalized Oxford temperature 
controller.  A Bruker ER035M Gauss Meter was used during measurements for 
the g-value determination. EPR spectra of the S = 3/2 complexes were analyzed 
according to the spin Hamiltonian:   
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where B0 is the magnetic field, D is the axial zero-field splitting parameter and 
E/D indicates the degree of rhombic distortion in the electronic environment. 
Changes in the E/D are diagnostic of changes in the environment of the iron.  
E/D values were determined by program RHOMBO (from Dr. W. R. Hagen, 
calculating all effective g values for high-spin Kramers systems) and verified by 
computer simulation of the observed EPR data using programs of W95EPR (from 
Dr. F. Neese) (4) and SimFonia (Bruker).  Energy level calculations were 
conducted by Dr. Aimin Liu with the program EPR-NMR version 6.3 developed 
by Drs. J. A. Weil and M. J. Mombourquette.  
6.3 RESULTS 
NO Binding to the Ferrous Center in the Absence of Substrate.  Since the 
as-isolated HppE is essentially metal-free, it was reconstituted with a 
stoichiometric amount of FeII(NH4)2(SO4)2 under anaerobic conditions (3).  The 
resultant FeII-HppE was a colorless protein with an identical optical spectrum as 
that of apo-enzyme, in which there is no apparent optical features above 300 nm 
(Figure 6-6A and B).  Likewise, this sample exhibits no detectable EPR signals 
at cryogenic temperatures.  However, addition of NO to the reduced enzyme 
yielded a pale yellow complex with two absorption bands at 445 nm (ε ≈ 750 M-
1cm-1 per iron) and 640 nm (ε ≈ 250 M-1cm-1 per iron) (Figure 6-6C).  These 
bands are characteristic for the charge transfer transitions previously observed in 
ferrous-nitrosyl complexes of enzymes and model compounds (Table 6-1).  A 
shoulder at 340 nm (ε ≈ 1000 M-1cm-1 per iron) was also noted in the spectrum.  
This feature was observed in an earlier study of IPNS and was assigned to 
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nonspecific interactions of NO with proteins because of the dependence of its 
intensity on the NO concentration (5).  When the FeII-HppE·nitrosyl binary 
complex was allowed to undergo repeated cycles of evacuation and flushing with 
argon, it returned to the colorless form.  A green chromophore slowly developed 
during O2 exposure.  The resulting spectrum (Figure 6-6D) is identical to the 
oxidized FeIII-HppE obtained from the reconstitution of apo-HppE with 
FeII(NH4)2(SO4)2 in the presence of O2 (6).  These results strongly suggest that 
the ferrous center of HppE is accessible by external small molecules such as NO 
and O2, and the binding of NO is facile and reversible under appropriate 














Figure 6-6 Electronic absorption spectra of FeII-HppE. (A) As-isolated HppE 
(metal-free, 200 µM); (B) FeII-HppE (180 µM); (C) sample B 
exposed to NO; and (D) sample C treated with repeated cycles of 
evacuation and flushing with argon, followed by O2 exposure.   
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The corresponding EPR spectrum of the FeII-HppE·nitrosyl binary 
complex was previously reported (Chapter 2) (3).  Two types of high-spin (S = 
3/2) centers of FeII-nitrosyl complexes were identified by spectral simulation.   
NO Binding to the Ferrous Center in the Presence of Substrate.  The 
EPR spectrum of the nitrosyl adduct of the reduced HppE is composed of two 
superimposed S = 3/2 species with different relaxation properties.  These 
resonances disappeared in the EPR spectrum of the ternary complex of reduced 
HppE, (S)-HPP (6-2), and NO as previously reported (Chapter 2) (3).  
Interestingly, when (S)-HPP (6-2) in the FeII-HppE·substrate·NO complex was 
replaced with (R)-HPP (6-4), the same type of EPR signal was observed (Figure 
6-7 solid line).  This EPR signal (S = 3/2) is comprised of the same principal g-
values of 2.00, 3.63, and 4.41 with E/D = 0.077 (Table 6-1).   
The above result strongly indicated that both (S)- and (R)-HPP bind to the 
metal center of HppE in nearly the same patterns.  However, a small but 
reproducible difference in spectral width was discernible between the spectra of 
the two substrates (≈ 5 G) (Figure 6-7 solid and dotted lines).  Although the 
exact cause for the small spectral difference is not known, it is presumably due to 
the chiral inequality between the two enantiomers.  Because of the distinct 
chiralities at C2 position of (S)- and (R)-HPP, the average distances from the 
hydrogen atoms at C1 and C2 to the iron center should also be different between 
these two enzyme-substrate complexes.  The total paramagnetic effects of these 
hydrogen atoms on the iron-nitrosyl complex are also expected to be different in 
these two different samples.  These observation lead to the proposed mechanistic 
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model to account for the different turnover products obtained with (S)- and (R)-
HPP (Figure 6-18).  
Figure 6-7 EPR Spectra of the ternary complex of FeII-HppE·substrate·NO.  
For better comparison, the spectra of (R)-HPP (solid line) and (S)-
HPP (dotted line) are overlaid.  Instrumental parameters: 
temperature 2 K, microwave frequency 9.6 GHz, microwave power 
0.6 mW, modulation amplitude 5 G, time constant 0.02 s, and a 
sweep rate of 50 G/s.  The important g values are given in spectra.   
The energy level separations for the EPR signal of ternary complex of 
reduced HppE, substrate and NO are depicted by the pattern of splitting shown in 
Figure 6-8.  The zero-field splitting is a result of interelectronic interactions and 
ligand fields of low symmetry and is quantified as a correction to the energies of 
the individual states arising from spin-orbit coupling (7).  Figure 6-8 illustrates 
the presence of a zero-filed splitting phenomenon for this species with the axial 
parameter D ≠ 0 (8, 9).  In fact, the energy level splitting experiences an 
asymmetry in its environment that is consistent with our observed E/D value.  
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Studies of ferrous enzymes and inorganic model complexes have shown that 
binding of NO to ferrous ion generates species exhibiting such S = 3/2 EPR 
resonances (5, 10-17).  The crystal structures of some of these complexes, for 
example, IPNS (18), have shown that the nitrogen of NO is coordinated directly 
to the iron.  Together, the appearance of the characteristic S = 3/2 EPR 
resonances, and the facile reversibility of the binding process, are compelling 
evidence indicating the direct ligation of NO to the ferrous center, either in the 
absence or in the presence of substrate.   

















Figure 6-8 Energy levels for the S = 3/2 EPR signal of the ternary complex FeII-
HppE·substrate·NO. 
The increased rhombicity, upon substrate addition, makes all three axes of 
the ligand field distinct from each other.  This has been a common feature for 
many of the metalloproteins-substrate complexes.  However, the ∆(gz-gy) 
derivation of 0.78 (4.41 – 3.63 = 0.78) for the ternary complex of HppE is the 
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largest so far among characterized FeII-substrate nitrosyl complexes (Table 6-1).  
For example, in the cases of IPNS-ACV-NO and ACCO-ACC-NO complexes, the 
∆(gz-gy) is 0.41 (5, 15).  The Fe-NO distance of IPNS ternary complex has been 
estimated to be 2.13 Å based on the crystal structure (18).  In another example, 
the gy to gz peak-to-peak width of the ternary complex of the α-KG-dependent 
enzyme TfdA is 8.9 millitesla (6.4 mT in the absence of substrate) (13), whereas 
this deviation is about four times greater (36.4 mT) for the EPR signals of the 
HppE ternary complex.  The remarkable large splitting of the gy and gz 
components suggests a dramatic redistribution of the electron density upon NO 
coordination.  This redistribution allows the enzyme ferrous center to exhibit like 
a ferric ion with S = 5/2 spin state, which is antiferromagnetically coupled to NO- 
(S = 1) through direct orbital overlap.  This proposal is consistent with the 
conclusion from previous studies on the {FeNO}7 complexes using magnetic 
circular dichroism and X-ray absorption edge spectroscopic studies as well as Xα 
calculations (12, 17).   
 
Species g λ (nm) Refs 
FeII-HppE·NO 1.99, 3.57, 3.91, 4.36 
1.99, 3.65, 3.94, 4.16 
340, 445, 640 (3)  
FeII-HppE ·(S)-HPP·NO 1.99, 3.63, 4.42 N/D (3)  
FeII-IPNS·NO 
FeII-IPNS·ACV·NO 
2.00, 3.95, 4.09 




FeII-TfdA·α-KG·2,4D·NO 2.02, 3.99, 4.04 449, 657 (13) 
FeII-TauD·α-KG·Taurine·NO 2.01, 4.02, 4.05 456, 662 (16) 
Gentisate 1,2-dioxygenase·NO 
(two different sources) 
1.99, 3.85, 4.19 
2.0, 3.98, 4.06 
N/D (19) 
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ACCO·ACC·NO 3.81, 4.22  (15) 
Reduced 3,4-PCD·NO 
Reduced 3,4-PCD·PCA·NO 
1.987, 3.679, 4.330 
1.85, 2.99, 4.92  
 (14) 
Reduced 4,5-PCD·PCA·NO 3.91, 4.09 
3.82, 3.87, 4.12, 4.17 
 (10, 11) 
Reduced SOR·NO 2.00, 3.76, 4.34 
2.00, 4.00 
475 (12) 
FeII(EDTA)-NO 2.00, 3.95, 4.11 340, 430, 640 (17) 
Table 6-1 Spectral properties of FeII-nitrosyl complexes.   
NO Binding to the Ferrous Center in the Presence of Substrate Analogues.  
To determine the role of each functional group of HPP in iron binding, substrate 
analogues were designed to selectively replace the hydroxyl and the phosphonate 
groups with methyl group in MPP (6-15) and carboxylate group in HBA (6-14), 
respectively.  The EPR spectra of the ternary complexes formed with reduced 
HppE, nitric acid and these substrate analogues were shown in Figure 6-9 (B and 
C).  In comparison with the spectrum of (S)-HPP (6-2) (Figure 6-9A), the EPR 
signal of HBA (6-14) is narrower and less heterogeneous.  Two species were 
identified by spectral simulation (Figure 6-10), characterized by g values of 4.256, 
3.804 and 1.993 (E/D = 0.038, Figure 6-10B), and 4.05, 3.98, and 1.999 (E/D = 
0.006, Figure 6-10C), respectively.  Similarly, the EPR spectrum of MPP 
becomes even more heterogeneous, which comprises three distinct species with g 
values of 4.448, 3.613, and 1.975 (E/D = 0.070, Figure 6-11B), 4.173, 3.886, and 
1.999 (E/D = 0.024, Figure 6-11C) and 4.02 and 2.0 (E/D = 0, Figure 6-11D).  It 
is clear that binding of the phosphonate group to FeII has a greater effect to the 
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unusually broad EPR signal of the ternary complex of FeII-HppE·(S)-HPP·NO.  
Given that the phosphonate is highly negatively charged at neutral pH, a direct 
interaction between (S)-HPP (6-2) and the ferrous center via the phosphonate 
group can be established.  On the other hand, the hydroxyl group of (S)-HPP (6-
2) also plays an important role in positioning the substrate in the active site, since 
multiple binding modes appeared when it was replaced with a methyl group 
(Figure 6-9C). 
Figure 6-9 EPR spectra of reduced HppE nitrosyl complexes with substrate or 
substrate analogues. The ternary complex is comprised of 250 mM 
FeII-HppE, NO, and 2.5 mM (S)-HPP (A), or HBP (B), or MPP (C) 
or fosfomycin (D).  Instrumental parameters are the same as shown 
in Figure 6-7.  The important g values are given in spectra 
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Figure 6-10 Simulations of the experimental EPR spectra of the ternary complex 
FeII-HppE·HBC·NO. (A) Experimental spectrum; (B) Simulated 
spectrum of E/D = 0.038 species (C) Simulated spectrum of E/D = 
0.006 species (D) Simulated spectrum consisting of 75% (B) and 
25% (C).  The important g values are given in spectra 
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Figure 6-11 Simulations of the experimental EPR spectra of the ternary complex 
FeII-HppE·MPP·NO. (A) Experimental spectrum; (B) Simulated 
spectrum of E/D = 0.07 species; (C) Simulated spectrum of E/D = 
0.024 species; (D) Simulated spectrum of E/D = 0 species; (E) 
Simulated spectrum consisting of 60% (B) 30% (C) and 10% (D).  
The important g values are given in spectra 
Interestingly, when fosfomycin (6-1) was tested as a substrate analogue, 
its binding exhibited similar effects on the EPR spectrum of the FeII-HppE 
nitrosyl adduct as observed with MPP (6-15) (Figure 6-9C and D).  The 
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simulation analysis of its spectrum revealed the presence of a nearly identical set 
of EPR-sensitive species with g values of 4.47, 3.60, and 1.97 (E/D = 0.073, 
Figure 6-12B), 4.233, 3.835 and 1.998 (E/D = 0.033, Figure 6-12C), and 4.03 and 
2.0 (E/D = 0, Figure 6-12D).  The only difference between these two spectra is 
the contribution percentage of each species to the whole spectrum.  The 
resemblance in binding patterns between MPP and fosfomycin suggested that the 
epoxide oxygen play little role to bind metal.  Since the fosfomycin is the 
product and needs to be released, it is not surprising that (S)-HPP (6-2) binds 
more tightly to HppE active site than fosfomycin does (6-1).   
NO Binding to the Ferrous Center in the Presence of Isotope-labeled 
Substrates.  Since the S = 3/2 EPR signal is derived from the ferrous nitrosyl 
complex bound with (S)-HPP (6-2) in HppE, the presence of any paramagnetic 
isotope as part of any of the component forming the complex would in principle 
affect the EPR signal.  The extent of effects is determined by the type of 
interaction and the distance between interacting species.  For example, when 
57FeII was used to prepare the ternary complex of FeII-HppE·(S)-HPP·NO, the 
hyperfine interaction between the electronic spin of ferrous ion and its I = 1/2 
nuclear ground state (57Fe) resulted in approximately 36 Gauss broadening of the 
spectral feature around g = 4.41 in the EPR spectra when compared to that of 56Fe 
(I = 0) sample (Figure 6-13A and C).   
 184
Figure 6-12 Simulations of experimental EPR spectra of ternary complex FeII-
HppE·MPP·NO. (A) Experimental spectrum; (B) Simulated 
spectrum of E/D = 0.073 species; (C) Simulated spectrum of E/D = 
0.033 species; (D) Simulated spectrum of E/D = 0 species; (E) 
Simulated spectrum consisting of 40% (B) 40% (C) and 20% (D).  
The important g values are given in spectra 
Similarly, 17O-enriched HPP was prepared in order to evaluate whether the 
substrate binds directly to the iron center in the reduced HppE and, more 
importantly, to identify the binding group(s) of the substrate (i.e. –OH vs. –PO3).  
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In the EPR spectrum of FeII-HppE nitrosyl complex bound with chemically 
synthesized 17OH-enriched (S)-HPP, broadening effect is apparent.  Considering 
the low 17O enrichment in HPP, the 20 G increase in the linewidth of the 
resonance at 4.41 is significant and strongly supports the direct coordination of 
the hydroxyl oxygen of (S)-HPP to the ferrous center (Figure 6-14B and C).   






Figure 6-13 The g = 4.41 component of the EPR signal of isotope-labeled ternary 
complexes of FeII-HppE·(S)-HPP·NO. (A) 57Fe-HppE + 16OH-(S)-
HPP; (B) 16OH-(S)-HPP; (C) 56Fe-HppE +17OH-(S)-HPP.  
Instrumental parameters are the same as shown in Figure 6-7.   
Unfortunately, no isotope broadening was observed for the gy (3.63) 
component in each of the above cases.  While the isotope effect is also expected 
for the gz component (2.00), this component is often overlapped with an 
anomalous resonance arising from NO itself in the samples (not shown).  This 
NO-derived signal was particularly prevalent in samples prepared with excess 
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NO.  Thus, unlike the gx = 4.41 resonance, the gz component is masked here and 
uninformative.   
HPP with 17O enriched in the phosphonate group was prepared by 
incubating unlabeled HPP in H217O for weeks.  When this P17O3-HPP was bound 
in the FeII-HppE nitrosyl complex, it drastically broadened both gx and gy 
components of the EPR signal of the complex (Figure 6-14).  Such a significant 
isotope effect strongly supports the direct coordination between the phosphonate 
oxygen and the ferrous center.  Together with the coordination between the 
hydroxyl oxygen of HPP and the enzyme metal center, a bidentate binding pattern 
of HPP to the active site iron in HppE can now be established.   
Figure 6-14 EPR Spectra of ternary complexes of FeII-HppE·P17O3-(R)-HPP·NO.  
Instrumental parameters are the same as shown in Figure 6-7.   
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Crystal Structure of CoII-reconstituted HppE bound with (S)-HPP.  To 
investigate substrate binding without turnover, CoII-HppE, which has been shown 
to be catalytically inactive (20), was used to prepare an inert enzyme-substrate 
model system.  The presence of a moderately heavy atom in the substrate, such 
as phosphorous, gave rise to a high electron density peak showing the position of 
the phosphonic acid moiety and the orientation of the substrate (Figure 6-15).  
Surprisingly, the structure of CoII-HppE in complex with substrate reveals two 
modes of substrate binding.  In one of the two molecules of HppE present in the 
asymmetric unit, substrate binds in a monodentate fashion with one of the oxygen 
atoms of the phosphonate moiety coordinating the metal and displacing one 
bound water (Figure 6-16A).  In the other molecule, (S)-HPP (6-2) forms a 
bidentate interaction with the metal center via the 2-hydroxyl oxygen as well as 
an oxygen atom from the phosphonate group, and leaving a coordination site open 
for subsequent dioxygen binding (Figure 6-16B).   
The bidentate binding of (S)-HPP (6-2) induces a conformational change 
in the β-barrel, while substrate bound in a monodentate fashion physically 
precludes this conformational change from occurring.  The conformational 
change involves β-strands 2 and 3 (Figure 6-16C, colored in green and yellow), 
which form a β-hairpin substructure and act as a cantilever responding to the 
positioning of substrate in the bidentate orientation by moving in and sealing off 
the active site.  Movements near the hinge or fulcrum of the hairpin are subtle 
while those near the end are more appreciable (Figure 6-16C).  Specifically, 
Tyr105 moves toward the metal center by 1.5 Å, positioning its hydroxyl group 
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within hydrogen bonding distance to a phosphonate oxygen of (S)-HPP (6-2) (2.7 
Å), while Tyr102 moves 8.0 Å toward the metal.  Alignment of the two substrate 
binding modes reveals that the monodentate binding position of (S)-HPP sterically 
precludes strand 3 motion toward the metal center.   
Figure 6-15 Crystal structure of HppE bound with substrate. (A) The CoII-
HppE·(S)-HPP active site illustrating monodentate substrate binding. 
(B) The active site illustrating bidentate substrate binding.  (C) 
Conformational changes of enzyme upon substrate binding.  
Comparison between structures of FeII-HppE and CoII-HppE·(S)-
HPP shows that a cantilever hairpin changes conformation between a 
substrate-free state (green) and a substrate-bound state (yellow).  
(D) A structural model of the ternary complex of HppE.  The open 
coordination site in CoII-HppE·(S)-HPP is occupied by dioxygen in 
this model.   
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With the substrate in the bidentate position and the cantilever closed, the 
methyl group of (S)-HPP (6-2) lies within a small hydrophobic cavity consisting 
of Phe182, Val122, Leu193, Leu144, and Ala195.  Tyr105, Lys23, and Asn135 
are within hydrogen bonding distance to the phosphonic acid oxygens of (S)-HPP 
(6-2), while Tyr103 hydrogen bonds to substrate through a bridging water 
molecule (Figure 6-16).   
Figure 6-16 Schematic illustration of interactions of bidentate bound (S)-HPP 
with protein and metal.   
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6.4 DISCUSSION 
Nitric oxide was chosen as an O2 surrogate in this study because of its 
preference to bind to ferrous ions and to form EPR-visible S = 1/2 (21-24) or S = 
3/2 (10, 11, 14, 17, 25-29) fingerprinting signals of {FeNO}7 according to the 
Enemark-Feltham formalism (30).  It has been used extensively as a probe to 
study oxygen binding site in other nonheme iron enzymes such as IPNS, LPO, 
PCD dioxygenases, and a few α-KG-dependent dioxygenases (10, 11, 14, 17, 19, 
27, 29).  Using this probe, we have conducted the EPR and optical absorption 
studies on the reduced HppE.  The results presented here unambiguously 
demonstrated that the reduced iron center of HppE is fairly accessible to its 
substrates and NO.  If NO is an effective analog of O2 in this system, O2 would 
occupy the same site and be activated.  The substrate ligation to iron was 
deduced from the isotope effects brought by the 17O-enrichment in the hydroxyl 
groups of both (S)- and (R)-HPP on the linewidth of the EPR signal of the enzyme 
ternary complex.  The EPR resonances were broadened by the hyperfine 
interactions between the iron-nitrosyl center and the 17O nucleus (I = 5/2) in 
substrate, which constituted a strong line of evidence for direct coordination of 
the hydroxyl and the phosphonate groups of (S)- and (R)-HPP to the active site 
iron in the reduced enzyme nitrosyl complex.  Such evident broadening effects 
usually require the strong hyperfine interactions between the coupled nuclei 
connected by chemical bond since the interactions through space are generally too 
weak to affect the EPR spectrum.  The σ-bond connecting iron center and 
hydroxyl oxygen of (S)-HPP is believed to provide a convenient path for fast 
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electron transfer from the substrate radical to iron and thus may greatly facilitate 
the formation of the final product.  Although the isotope-labeling technique has 
not been applied to study the coordination pattern of the product, fosfomycin (6-
1), to the enzyme active site, the preliminary results from EPR study strongly 
argued against the coordination between the epoxide oxygen and the iron center 





























































Figure 6-17 Comparison of the mechanisms proposed for the epoxidation 
reactions catalyzed by (a) HppE and (b) P-450.   
Figure 6-17A shows a revised mechanistic model highlighting the 
coordination patterns of the ferrous center of HppE in the catalytic cycle.  The 
 192
direct ligation of substrate to iron is now integrated into the proposed mechanism 
of HppE, in which the generation of an enzyme-bound substrate radical via 
hydrogen abstraction by an iron-oxygen species is followed by an intramolecular 
rearrangement of the substrate radical leading to epoxide formation.  The two 
binding modes (mono- and bidentate) of substrate to the iron center revealed by 
X-ray crystallographic study suggest a two-step substrate binding process, which 
is also incorporated into the revised mechanism.  Since the iron in the {Fe-NO}7 
complex exhibits strong properties of ferric ion, the binding pattern and dynamics 
of HPP established in the reduced HppE can now be extended to the oxidized 
form of the enzyme.  The most important aspect of this model is that both 
substrate and O2 bind directly to the iron, resulting in the formation of an 
activated iron-oxygen species, which is proximal to the pro-R α-H atom to be 
abstracted in (S)-HPP (6-2).   
The formation of enzyme-bound substrate radical and the subsequent 
intramolecular rearrangement of the radical intermediate have been proposed for 
many other oxidative cyclization reactions.  In the epoxidation reaction 
catalyzed by cytochrome P450, the high-valent iron-oxo species (Compound I) is 
believe to be the oxidizing agent responsible for the insertion of oxygen to the 
olefin substrates (31).  However, the detailed mechanism for oxygen 
incorporation by P450 has been a controversial topic.  More recent experimental 
results obtained with model compounds (32), seem to favor a step-wise 
mechanism (Figure 6-17B).  Briefly, the C-O bonds are formed in two 
consecutive steps, the first one resulting in radical intermediate formation and the 
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second step leading to epoxide ring closure via intramolecular rearrangement 
(Figure 6-17B).  Apparently, the epoxidation reactions catalyzed by HppE and 
P450 follow a similar path for the ring closure step.  However, the first C-O 
bond formation reaction is not necessary for HppE.  A similar mechanistic 
model has been proposed in other non-heme iron enzyme catalyzed reactions.  
For example, IPNS catalyzes a two-staged bicyclization reaction, in which the 
substrate binds directly to the active site iron via its thiol group throughout the 
reaction course (5).  The second stage of the reaction is the abstraction of the 
valinyl β-hydrogen initiated by the thiol sulfur-coordinated iron-oxo species.  
The resulting radical intermediate then undergoes a rearrangement, giving rise to 
the thiazolidine ring product.  The two-step mechanism resembles those of 
aforementioned epoxidation reactions, except that an Fe-S bond replaces the Fe-O 
bond, and the product is a five-member ring instead of an epoxide ring, in the case 
of IPNS.  Interestingly, such direct ligation of substrate to iron center seems not 
to be the case in the cyclization reaction catalyzed by CAS, as indicated by the 
recently solved crystal structure of CAS bound with substrate and cosubstrate α-
KG (33).  Only α-KG is bonded to the active site iron in a bidentate mode.  
However, it is still possible that the hydroxyl group of substrate can bind to the 
iron soon after the first oxidative half-reaction is over, in which α-KG is cleaved 























Figure 6-18 Proposed model to account for the stereochemistry in HppE 
catalysis. (Note: the iron-superoxide used here as an iron-oxygen 
reaction species is only for illustrative purpose.)   
In this study, (R)-HPP has been shown to bind to HppE in a very similar 
manner as (S)-HPP.  The EPR spectra of their enzyme-substrate nitrosyl ternary 
complexes are nearly identical except for a minor difference in linewidth.  As 
previously mentioned, (S)- and (R)-HPP are converted exclusively to their 
respective epoxide and ketone products, which preludes the possibility of radical 
rearrangement between C1 and C2.  Because of the similar binding modes and 
the distinct outcomes of product formation of (S)- and (R)-HPP, the hydrogen 
atom presented closest to the iron center must be the pro-R α-H in the case of (S)-
HPP and the β-H in the case of (R)-HPP, respectively.  The formation of such 
enzyme-substrate complexes allows the reactive iron-oxygen species specifically 
abstract the nearest hydrogen atom in each substrate, giving rise to distinct 
substrate radical intermediates and the final products.  In a good agreement with 
this model, (S)-FHPP (6-7), as both its α-H atoms are replaced by fluorine while 
its β-H is too far from the reactive center, cannot be turned over by HppE.  
However, it still can bind to HppE, so it serves as a competitive inhibitor of HppE 
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(1).  Indeed, the earlier EPR experimental results have shown that α-
difluorinated substrate analogues bind to the enzyme in almost the same way as 
(S)- and (R)-HPP.   
In summary, this study has provided a clear picture for the binding of 
substrates and substrate analogues to HppE in the presence of dioxygen analogue, 
nitric oxide.  By using isotope-labeled substrate, a bidentate mode of substrate 
binding to the active site iron has been established.  The crystallographic results 
led to further details revealing multiple binding modes, and thus implicated a 
likely two-step substrate binding process.  The EPR spectral data offered many 
mechanistic insights that are consistent with the previously determined 
stereochemistry of enzyme catalysis.  Comparable to other epoxidation and 
cyclization, HppE-catalyzed epoxidation also involves the generation of an 
enzyme-bound substrate radical intermediate.  Continued mechanistic studies are 
in progress for a better understanding of the catalytic mechanism of HppE.   
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LIST OF ABBREVIATIONS  
ACC    1-aminocyclo-propane-1-carboxylic acid 
ACCO    1-aminocyclopropane-1-carboxylate oxidase 
ACV    δ-(L-α-aminoadipoyl)-L-cysteinyl-D-valine 
AEP    2-aminoethylphosphonic acid 
BphC    2,3-dihydroxybiphenyl 1,2-dioxygenase 
BSA    bovine serum albumin 
CAS    clavaminic acid synthase 
DAOCS   deacetoxycephalosporin C synthase 
DEAE    diethylaminoethyl 
DOPA    L-3,4-dioxyphenylalanine 
DTT    dithiothreitol 
E3    CDP-4-keto-6-deoxy-∆3,4-glucoseen reductase 
EDTA    ethylenediaminetetraacetic acid 
EPR    electron paramagnetic resonance 
ESEEM   electron spin echo envelope modulation 
FAD    flavin adenine dinucleotide 
FMN    flavin mononucleotide 
FPLC    fast protein liquid chromatography 
H6H    hyoscyamine 6β-hydroxylase  
HPP    2-hydroxypropyl phosphonic acid 
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HppE    (S)-2-hydroxypropylphosphonic acid epoxidase 
ID medium   Iron-depletion medium 
IPNS    isopenicillin N synthase  
IPTG    isopropylthio-β-galactoside 
LB medium   Luria-Bertani medium 
LI medium   Low-iron medium 
LMCT    ligand-to-metal charge transfer 
MLCT    metal-to-ligand charge transfer 
MMO    methane monooxygenase 
MMOH   methane monooxygenase hydroxylase component 
MMOR   methane monooxygenase B component 
NAD+    nicotinamide adenine dinucleotide, reduced form  
NADH    nicotinamide adenine dinucleotide, oxidized form 
NBT    nitroblue tetrazolium  
NDO    naphthalene 1,2-dioxygenase;  
NO    nitric oxide;  
P450CAM   camphor inducible bacterial P450 monooxygenase  
PCR    polymerase chain reaction 
PEP    phosphoenolpyruvate  
PMI    phosphomannose isomerase 
PnAA    phosphonoacetaldehyde 
PnPy    phosphonopyruvate 
PPOH    cis-propenylphosphonic acid 
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PQQ    pyrroloquinoline quinone  
RNR    ribonucleotide reductase  
rR    resonance Raman 
SDS    sodium dodecyl sulfate 
PAGE    polyacrylamide gel electrophoresis 
SeMet    seleno-DL-methionine 
SLO    soybean lipoxygenase 
TauD    taurine dioxygenase;  
TfdA    2,4-dichlorophenoxyacetic acid dioxygenase;  
TLC    thin layer chromatography 
Tris    tris(hydroxymethyl)aminomethane 
TyrH    tyrosine hydroxylase  
UDP-GlcNAc   UDP-N-acetylglucosamine 
UDP-MurNAc-pentapeptide UDP-acetylmuramyl-pentapeptide 
WT    wild-type 
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